id	sid	tid	token	lemma	pos
bjp-16772	1	1	introduction	introduction	NOUN
bjp-16772	1	2	cardiovascular	cardiovascular	ADJ
bjp-16772	1	3	disease	disease	NOUN
bjp-16772	1	4	(	(	PUNCT
bjp-16772	1	5	cvd	cvd	PROPN
bjp-16772	1	6	)	)	PUNCT
bjp-16772	1	7	is	be	AUX
bjp-16772	1	8	one	one	NUM
bjp-16772	1	9	of	of	ADP
bjp-16772	1	10	the	the	DET
bjp-16772	1	11	leading	lead	VERB
bjp-16772	1	12	causes	cause	NOUN
bjp-16772	1	13	of	of	ADP
bjp-16772	1	14	morbidity	morbidity	NOUN
bjp-16772	1	15	and	and	CCONJ
bjp-16772	1	16	mortality	mortality	NOUN
bjp-16772	1	17	throughout	throughout	ADP
bjp-16772	1	18	the	the	DET
bjp-16772	1	19	world	world	NOUN
bjp-16772	1	20	.	.	PUNCT
bjp-16772	2	1	approximately	approximately	ADV
bjp-16772	2	2	17	17	NUM
bjp-16772	2	3	million	million	NUM
bjp-16772	2	4	people	people	NOUN
bjp-16772	2	5	die	die	VERB
bjp-16772	2	6	of	of	ADP
bjp-16772	2	7	cvds	cvds	PROPN
bjp-16772	2	8	each	each	DET
bjp-16772	2	9	year	year	NOUN
bjp-16772	2	10	,	,	PUNCT
bjp-16772	2	11	particularly	particularly	ADV
bjp-16772	2	12	heart	heart	NOUN
bjp-16772	2	13	attacks	attack	NOUN
bjp-16772	2	14	and	and	CCONJ
bjp-16772	2	15	strokes	stroke	NOUN
bjp-16772	2	16	in	in	ADP
bjp-16772	2	17	both	both	DET
bjp-16772	2	18	developed	developed	ADJ
bjp-16772	2	19	and	and	CCONJ
bjp-16772	2	20	developing	develop	VERB
bjp-16772	2	21	countries	country	NOUN
bjp-16772	2	22	.	.	PUNCT
bjp-16772	3	1	in	in	ADP
bjp-16772	3	2	2007	2007	NUM
bjp-16772	3	3	,	,	PUNCT
bjp-16772	3	4	in	in	ADP
bjp-16772	3	5	scotland	scotland	NOUN
bjp-16772	3	6	,	,	PUNCT
bjp-16772	3	7	10,300	10,300	NUM
bjp-16772	3	8	patients	patient	NOUN
bjp-16772	3	9	died	die	VERB
bjp-16772	3	10	from	from	ADP
bjp-16772	3	11	coronary	coronary	ADJ
bjp-16772	3	12	heart	heart	NOUN
bjp-16772	3	13	disease	disease	NOUN
bjp-16772	3	14	(	(	PUNCT
bjp-16772	3	15	chd	chd	NOUN
bjp-16772	3	16	)	)	PUNCT
bjp-16772	3	17	and	and	CCONJ
bjp-16772	3	18	5,800	5,800	NUM
bjp-16772	3	19	from	from	ADP
bjp-16772	3	20	cerebrovascular	cerebrovascular	ADJ
bjp-16772	3	21	disease	disease	NOUN
bjp-16772	3	22	,	,	PUNCT
bjp-16772	3	23	from	from	ADP
bjp-16772	3	24	a	a	DET
bjp-16772	3	25	combined	combine	VERB
bjp-16772	3	26	72,000	72,000	NUM
bjp-16772	3	27	hospital	hospital	NOUN
bjp-16772	3	28	admissions	admission	NOUN
bjp-16772	3	29	(	(	PUNCT
bjp-16772	3	30	sign	sign	NOUN
bjp-16772	3	31	,	,	PUNCT
bjp-16772	3	32	management	management	NOUN
bjp-16772	3	33	of	of	ADP
bjp-16772	3	34	coronary	coronary	ADJ
bjp-16772	3	35	heart	heart	NOUN
bjp-16772	3	36	disease	disease	NOUN
bjp-16772	3	37	,	,	PUNCT
bjp-16772	3	38	2010	2010	NUM
bjp-16772	3	39	)	)	PUNCT
bjp-16772	3	40	.	.	PUNCT
bjp-16772	4	1	lipid	lipid	NOUN
bjp-16772	4	2	lowering	lower	VERB
bjp-16772	4	3	agent	agent	NOUN
bjp-16772	4	4	,	,	PUNCT
bjp-16772	4	5	statins	statin	NOUN
bjp-16772	4	6	are	be	AUX
bjp-16772	4	7	the	the	DET
bjp-16772	4	8	most	most	ADV
bjp-16772	4	9	used	used	ADJ
bjp-16772	4	10	drugs	drug	NOUN
bjp-16772	4	11	in	in	ADP
bjp-16772	4	12	the	the	DET
bjp-16772	4	13	uk	uk	PROPN
bjp-16772	4	14	and	and	CCONJ
bjp-16772	4	15	other	other	ADJ
bjp-16772	4	16	part	part	NOUN
bjp-16772	4	17	of	of	ADP
bjp-16772	4	18	the	the	DET
bjp-16772	4	19	globe	globe	NOUN
bjp-16772	4	20	for	for	ADP
bjp-16772	4	21	the	the	DET
bjp-16772	4	22	wide	wide	ADJ
bjp-16772	4	23	evidence	evidence	NOUN
bjp-16772	4	24	of	of	ADP
bjp-16772	4	25	safety	safety	NOUN
bjp-16772	4	26	,	,	PUNCT
bjp-16772	4	27	cost	cost	NOUN
bjp-16772	4	28	effectiveness	effectiveness	NOUN
bjp-16772	4	29	,	,	PUNCT
bjp-16772	4	30	potency	potency	NOUN
bjp-16772	4	31	in	in	ADP
bjp-16772	4	32	decreasing	decrease	VERB
bjp-16772	4	33	chd	chd	NOUN
bjp-16772	4	34	and	and	CCONJ
bjp-16772	4	35	stroke	stroke	NOUN
bjp-16772	4	36	risk	risk	NOUN
bjp-16772	4	37	both	both	CCONJ
bjp-16772	4	38	in	in	ADP
bjp-16772	4	39	primary	primary	ADJ
bjp-16772	4	40	and	and	CCONJ
bjp-16772	4	41	secondary	secondary	ADJ
bjp-16772	4	42	cases	case	NOUN
bjp-16772	4	43	(	(	PUNCT
bjp-16772	4	44	mason	mason	PROPN
bjp-16772	4	45	et	et	PROPN
bjp-16772	4	46	al	al	PROPN
bjp-16772	4	47	.	.	PROPN
bjp-16772	4	48	,	,	PUNCT
bjp-16772	4	49	2009	2009	NUM
bjp-16772	4	50	;	;	PUNCT
bjp-16772	4	51	mcelduff	mcelduff	NOUN
bjp-16772	4	52	et	et	PROPN
bjp-16772	4	53	al	al	PROPN
bjp-16772	4	54	.	.	PROPN
bjp-16772	4	55	,	,	PUNCT
bjp-16772	4	56	2006	2006	NUM
bjp-16772	4	57	)	)	PUNCT
bjp-16772	4	58	.	.	PUNCT
bjp-16772	5	1	the	the	DET
bjp-16772	5	2	daily	daily	PROPN
bjp-16772	5	3	dose	dose	NOUN
bjp-16772	5	4	of	of	ADP
bjp-16772	5	5	40	40	NUM
bjp-16772	5	6	mg	mg	PROPN
bjp-16772	5	7	simvastatin	simvastatin	PROPN
bjp-16772	5	8	was	be	AUX
bjp-16772	5	9	suggested	suggest	VERB
bjp-16772	5	10	by	by	ADP
bjp-16772	5	11	nice	nice	ADJ
bjp-16772	5	12	as	as	ADP
bjp-16772	5	13	the	the	DET
bjp-16772	5	14	first	first	ADJ
bjp-16772	5	15	-	-	PUNCT
bjp-16772	5	16	line	line	NOUN
bjp-16772	5	17	treatment	treatment	NOUN
bjp-16772	5	18	option	option	NOUN
bjp-16772	5	19	for	for	ADP
bjp-16772	5	20	reducing	reduce	VERB
bjp-16772	5	21	the	the	DET
bjp-16772	5	22	cvd	cvd	PROPN
bjp-16772	5	23	incidence	incidence	NOUN
bjp-16772	5	24	.	.	PUNCT
bjp-16772	6	1	according	accord	VERB
bjp-16772	6	2	to	to	ADP
bjp-16772	6	3	the	the	DET
bjp-16772	6	4	ncep	ncep	PROPN
bjp-16772	6	5	atp	atp	PROPN
bjp-16772	6	6	iii	iii	PROPN
bjp-16772	6	7	guidelines	guideline	NOUN
bjp-16772	6	8	2004	2004	NUM
bjp-16772	6	9	(	(	PUNCT
bjp-16772	6	10	national	national	ADJ
bjp-16772	6	11	cholesterol	cholesterol	NOUN
bjp-16772	6	12	education	education	NOUN
bjp-16772	6	13	programme	programme	NOUN
bjp-16772	6	14	/	/	SYM
bjp-16772	6	15	adult	adult	NOUN
bjp-16772	6	16	treatment	treatment	NOUN
bjp-16772	6	17	panel	panel	NOUN
bjp-16772	6	18	iii	iii	NUM
bjp-16772	6	19	guidelines	guideline	NOUN
bjp-16772	6	20	)	)	PUNCT
bjp-16772	6	21	(	(	PUNCT
bjp-16772	6	22	grundy	grundy	PROPN
bjp-16772	6	23	et	et	PROPN
bjp-16772	6	24	al	al	PROPN
bjp-16772	6	25	.	.	PROPN
bjp-16772	6	26	,	,	PUNCT
bjp-16772	6	27	2004	2004	NUM
bjp-16772	6	28	)	)	PUNCT
bjp-16772	6	29	,	,	PUNCT
bjp-16772	6	30	in	in	ADP
bjp-16772	6	31	addition	addition	NOUN
bjp-16772	6	32	to	to	ADP
bjp-16772	6	33	the	the	DET
bjp-16772	6	34	current	current	ADJ
bjp-16772	6	35	goal	goal	NOUN
bjp-16772	6	36	of	of	ADP
bjp-16772	6	37	100	100	NUM
bjp-16772	6	38	mg	mg	PROPN
bjp-16772	6	39	/	/	SYM
bjp-16772	6	40	dl	dl	PROPN
bjp-16772	6	41	,	,	PUNCT
bjp-16772	6	42	the	the	DET
bjp-16772	6	43	new	new	ADJ
bjp-16772	6	44	goal	goal	NOUN
bjp-16772	6	45	for	for	ADP
bjp-16772	6	46	ldl	ldl	NOUN
bjp-16772	6	47	-	-	PUNCT
bjp-16772	6	48	c	c	PROPN
bjp-16772	6	49	has	have	AUX
bjp-16772	6	50	been	be	AUX
bjp-16772	6	51	recommended	recommend	VERB
bjp-16772	6	52	as	as	ADP
bjp-16772	6	53	70	70	NUM
bjp-16772	6	54	mg	mg	PROPN
bjp-16772	6	55	/	/	SYM
bjp-16772	6	56	dl	dl	PROPN
bjp-16772	6	57	for	for	ADP
bjp-16772	6	58	the	the	DET
bjp-16772	6	59	patients	patient	NOUN
bjp-16772	6	60	with	with	ADP
bjp-16772	6	61	increased	increase	VERB
bjp-16772	6	62	risk	risk	NOUN
bjp-16772	6	63	of	of	ADP
bjp-16772	6	64	cvd	cvd	PROPN
bjp-16772	6	65	events	event	NOUN
bjp-16772	6	66	.	.	PUNCT
bjp-16772	7	1	multiple	multiple	ADJ
bjp-16772	7	2	studies	study	NOUN
bjp-16772	7	3	have	have	AUX
bjp-16772	7	4	demonstrated	demonstrate	VERB
bjp-16772	7	5	the	the	DET
bjp-16772	7	6	incremental	incremental	ADJ
bjp-16772	7	7	benefits	benefit	NOUN
bjp-16772	7	8	with	with	ADP
bjp-16772	7	9	aggressive	aggressive	ADJ
bjp-16772	7	10	statin	statin	ADJ
bjp-16772	7	11	treatment	treatment	NOUN
bjp-16772	7	12	over	over	ADP
bjp-16772	7	13	moderate	moderate	ADJ
bjp-16772	7	14	statin	statin	PROPN
bjp-16772	7	15	therapy	therapy	NOUN
bjp-16772	7	16	in	in	ADP
bjp-16772	7	17	high	high	ADJ
bjp-16772	7	18	risk	risk	NOUN
bjp-16772	7	19	patients	patient	NOUN
bjp-16772	7	20	(	(	PUNCT
bjp-16772	7	21	pedersen	pedersen	PROPN
bjp-16772	7	22	et	et	PROPN
bjp-16772	7	23	al	al	PROPN
bjp-16772	7	24	.	.	PROPN
bjp-16772	7	25	,	,	PUNCT
bjp-16772	7	26	2005	2005	NUM
bjp-16772	7	27	;	;	PUNCT
bjp-16772	7	28	rosa	rosa	PROPN
bjp-16772	7	29	et	et	PROPN
bjp-16772	7	30	al	al	PROPN
bjp-16772	7	31	.	.	PROPN
bjp-16772	7	32	,	,	PUNCT
bjp-16772	7	33	2005	2005	NUM
bjp-16772	7	34	)	)	PUNCT
bjp-16772	7	35	.	.	PUNCT
bjp-16772	8	1	on	on	ADP
bjp-16772	8	2	the	the	DET
bjp-16772	8	3	contrary	contrary	ADJ
bjp-16772	8	4	high	high	PROPN
bjp-16772	8	5	dose	dose	NOUN
bjp-16772	8	6	simvastatin	simvastatin	NOUN
bjp-16772	8	7	(	(	PUNCT
bjp-16772	8	8	80	80	NUM
bjp-16772	8	9	mg	mg	NOUN
bjp-16772	8	10	)	)	PUNCT
bjp-16772	8	11	may	may	AUX
bjp-16772	8	12	not	not	PART
bjp-16772	8	13	be	be	AUX
bjp-16772	8	14	suitable	suitable	ADJ
bjp-16772	8	15	for	for	ADP
bjp-16772	8	16	prescribing	prescribe	VERB
bjp-16772	8	17	due	due	ADP
bjp-16772	8	18	to	to	ADP
bjp-16772	8	19	the	the	DET
bjp-16772	8	20	risk	risk	NOUN
bjp-16772	8	21	of	of	ADP
bjp-16772	8	22	developing	develop	VERB
bjp-16772	8	23	rhabdomyolysis	rhabdomyolysis	NOUN
bjp-16772	8	24	(	(	PUNCT
bjp-16772	8	25	lemos	lemos	PROPN
bjp-16772	8	26	et	et	PROPN
bjp-16772	8	27	al	al	PROPN
bjp-16772	8	28	.	.	PROPN
bjp-16772	8	29	,	,	PUNCT
bjp-16772	8	30	2004	2004	NUM
bjp-16772	8	31	;	;	PUNCT
bjp-16772	8	32	bruckert	bruckert	PROPN
bjp-16772	8	33	et	et	PROPN
bjp-16772	8	34	al	al	PROPN
bjp-16772	8	35	.	.	PROPN
bjp-16772	8	36	,	,	PUNCT
bjp-16772	8	37	2005	2005	NUM
bjp-16772	8	38	;	;	PUNCT
bjp-16772	8	39	search	search	NOUN
bjp-16772	8	40	,	,	PUNCT
bjp-16772	8	41	2010	2010	NUM
bjp-16772	8	42	;	;	PUNCT
bjp-16772	8	43	davidson	davidson	PROPN
bjp-16772	8	44	et	et	PROPN
bjp-16772	8	45	al	al	PROPN
bjp-16772	8	46	.	.	PROPN
bjp-16772	8	47	,	,	PUNCT
bjp-16772	8	48	2007	2007	NUM
bjp-16772	8	49	)	)	PUNCT
bjp-16772	8	50	the	the	DET
bjp-16772	8	51	aims	aim	NOUN
bjp-16772	8	52	of	of	ADP
bjp-16772	8	53	this	this	DET
bjp-16772	8	54	study	study	NOUN
bjp-16772	8	55	were	be	AUX
bjp-16772	8	56	using	use	VERB
bjp-16772	8	57	a	a	DET
bjp-16772	8	58	routinely	routinely	ADV
bjp-16772	8	59	collected	collect	VERB
bjp-16772	8	60	prescribing	prescribing	NOUN
bjp-16772	8	61	database	database	NOUN
bjp-16772	8	62	to	to	PART
bjp-16772	8	63	assess	assess	VERB
bjp-16772	8	64	the	the	DET
bjp-16772	8	65	prescribing	prescribing	NOUN
bjp-16772	8	66	trends	trend	NOUN
bjp-16772	8	67	of	of	ADP
bjp-16772	8	68	statins	statin	NOUN
bjp-16772	8	69	in	in	ADP
bjp-16772	8	70	primary	primary	ADJ
bjp-16772	8	71	care	care	NOUN
bjp-16772	8	72	throughout	throughout	ADP
bjp-16772	8	73	scotland	scotland	PROPN
bjp-16772	8	74	,	,	PUNCT
bjp-16772	8	75	together	together	ADV
bjp-16772	8	76	with	with	ADP
bjp-16772	8	77	demographic	demographic	ADJ
bjp-16772	8	78	data	datum	NOUN
bjp-16772	8	79	and	and	CCONJ
bjp-16772	8	80	also	also	ADV
bjp-16772	8	81	the	the	DET
bjp-16772	8	82	prescribed	prescribed	ADJ
bjp-16772	8	83	pattern	pattern	NOUN
bjp-16772	8	84	a	a	DET
bjp-16772	8	85	journal	journal	NOUN
bjp-16772	8	86	of	of	ADP
bjp-16772	8	87	the	the	DET
bjp-16772	8	88	bangladesh	bangladesh	NOUN
bjp-16772	8	89	pharmacological	pharmacological	ADJ
bjp-16772	8	90	society	society	NOUN
bjp-16772	8	91	(	(	PUNCT
bjp-16772	8	92	bdps	bdps	NOUN
bjp-16772	8	93	)	)	PUNCT
bjp-16772	8	94	bangladesh	bangladesh	PROPN
bjp-16772	8	95	j	j	PROPN
bjp-16772	8	96	pharmacol	pharmacol	PROPN
bjp-16772	8	97	2013	2013	NUM
bjp-16772	8	98	;	;	PUNCT
bjp-16772	8	99	8	8	NUM
bjp-16772	8	100	:	:	SYM
bjp-16772	8	101	401	401	NUM
bjp-16772	8	102	-	-	SYM
bjp-16772	8	103	409	409	NUM
bjp-16772	8	104	journal	journal	NOUN
bjp-16772	8	105	homepage	homepage	NOUN
bjp-16772	8	106	:	:	PUNCT
bjp-16772	8	107	www.banglajol.info	www.banglajol.info	PROPN
bjp-16772	8	108	abstracted	abstract	VERB
bjp-16772	8	109	/	/	SYM
bjp-16772	8	110	indexed	index	VERB
bjp-16772	8	111	in	in	ADP
bjp-16772	8	112	academic	academic	ADJ
bjp-16772	8	113	search	search	NOUN
bjp-16772	8	114	complete	complete	ADJ
bjp-16772	8	115	,	,	PUNCT
bjp-16772	8	116	agroforestry	agroforestry	NOUN
bjp-16772	8	117	abstracts	abstract	NOUN
bjp-16772	8	118	,	,	PUNCT
bjp-16772	8	119	asia	asia	PROPN
bjp-16772	8	120	journals	journal	NOUN
bjp-16772	8	121	online	online	ADV
bjp-16772	8	122	,	,	PUNCT
bjp-16772	8	123	bangladesh	bangladesh	NOUN
bjp-16772	8	124	journals	journal	NOUN
bjp-16772	8	125	online	online	ADV
bjp-16772	8	126	,	,	PUNCT
bjp-16772	8	127	biological	biological	ADJ
bjp-16772	8	128	abstracts	abstract	NOUN
bjp-16772	8	129	,	,	PUNCT
bjp-16772	8	130	biosis	biosis	NOUN
bjp-16772	8	131	previews	preview	NOUN
bjp-16772	8	132	,	,	PUNCT
bjp-16772	8	133	cab	cab	NOUN
bjp-16772	8	134	abstracts	abstract	NOUN
bjp-16772	8	135	,	,	PUNCT
bjp-16772	8	136	current	current	ADJ
bjp-16772	8	137	abstracts	abstract	NOUN
bjp-16772	8	138	,	,	PUNCT
bjp-16772	8	139	directory	directory	NOUN
bjp-16772	8	140	of	of	ADP
bjp-16772	8	141	open	open	ADJ
bjp-16772	8	142	access	access	NOUN
bjp-16772	8	143	journals	journal	NOUN
bjp-16772	8	144	,	,	PUNCT
bjp-16772	8	145	embase	embase	NOUN
bjp-16772	8	146	/	/	SYM
bjp-16772	8	147	excerpta	excerpta	NOUN
bjp-16772	8	148	medica	medica	NOUN
bjp-16772	8	149	,	,	PUNCT
bjp-16772	8	150	global	global	ADJ
bjp-16772	8	151	health	health	NOUN
bjp-16772	8	152	,	,	PUNCT
bjp-16772	8	153	google	google	PROPN
bjp-16772	8	154	scholar	scholar	NOUN
bjp-16772	8	155	,	,	PUNCT
bjp-16772	8	156	hinari	hinari	X
bjp-16772	8	157	(	(	PUNCT
bjp-16772	8	158	who	who	PRON
bjp-16772	8	159	)	)	PUNCT
bjp-16772	8	160	,	,	PUNCT
bjp-16772	8	161	international	international	ADJ
bjp-16772	8	162	pharmaceutical	pharmaceutical	ADJ
bjp-16772	8	163	abstracts	abstract	NOUN
bjp-16772	8	164	,	,	PUNCT
bjp-16772	8	165	open	open	ADJ
bjp-16772	8	166	j	j	PROPN
bjp-16772	8	167	-	-	PUNCT
bjp-16772	8	168	gate	gate	NOUN
bjp-16772	8	169	,	,	PUNCT
bjp-16772	8	170	science	science	NOUN
bjp-16772	8	171	citation	citation	NOUN
bjp-16772	8	172	index	index	NOUN
bjp-16772	8	173	expanded	expand	VERB
bjp-16772	8	174	,	,	PUNCT
bjp-16772	8	175	scopus	scopus	NOUN
bjp-16772	8	176	and	and	CCONJ
bjp-16772	8	177	social	social	ADJ
bjp-16772	8	178	sciences	sciences	PROPN
bjp-16772	8	179	citation	citation	NOUN
bjp-16772	8	180	index	index	NOUN
bjp-16772	8	181	issn	issn	PROPN
bjp-16772	8	182	:	:	PUNCT
bjp-16772	8	183	1991	1991	NUM
bjp-16772	8	184	-	-	PUNCT
bjp-16772	8	185	0088	0088	NUM
bjp-16772	8	186	abstract	abstract	ADJ
bjp-16772	8	187	statins	statin	NOUN
bjp-16772	8	188	are	be	AUX
bjp-16772	8	189	highly	highly	ADV
bjp-16772	8	190	effective	effective	ADJ
bjp-16772	8	191	in	in	ADP
bjp-16772	8	192	managing	manage	VERB
bjp-16772	8	193	hypercholesterolaemia	hypercholesterolaemia	NOUN
bjp-16772	8	194	in	in	ADP
bjp-16772	8	195	patients	patient	NOUN
bjp-16772	8	196	with	with	ADP
bjp-16772	8	197	or	or	CCONJ
bjp-16772	8	198	without	without	ADP
bjp-16772	8	199	chronic	chronic	ADJ
bjp-16772	8	200	heart	heart	NOUN
bjp-16772	8	201	disease	disease	NOUN
bjp-16772	8	202	due	due	ADP
bjp-16772	8	203	to	to	ADP
bjp-16772	8	204	extensive	extensive	ADJ
bjp-16772	8	205	evidence	evidence	NOUN
bjp-16772	8	206	for	for	ADP
bjp-16772	8	207	safety	safety	NOUN
bjp-16772	8	208	,	,	PUNCT
bjp-16772	8	209	effi	effi	PROPN
bjp-16772	8	210	-cacy	-cacy	PROPN
bjp-16772	8	211	and	and	CCONJ
bjp-16772	8	212	cost	cost	NOUN
bjp-16772	8	213	effectiveness	effectiveness	NOUN
bjp-16772	8	214	.	.	PUNCT
bjp-16772	9	1	observational	observational	PROPN
bjp-16772	9	2	cross	cross	PROPN
bjp-16772	9	3	sectional	sectional	ADJ
bjp-16772	9	4	retrospective	retrospective	ADJ
bjp-16772	9	5	cohort	cohort	NOUN
bjp-16772	9	6	study	study	NOUN
bjp-16772	9	7	was	be	AUX
bjp-16772	9	8	done	do	VERB
bjp-16772	9	9	in	in	ADP
bjp-16772	9	10	approximately	approximately	ADV
bjp-16772	9	11	200	200	NUM
bjp-16772	9	12	primary	primary	ADJ
bjp-16772	9	13	care	care	NOUN
bjp-16772	9	14	practices	practice	NOUN
bjp-16772	9	15	in	in	ADP
bjp-16772	9	16	scotland	scotland	PROPN
bjp-16772	9	17	.	.	PUNCT
bjp-16772	10	1	frequency	frequency	NOUN
bjp-16772	10	2	,	,	PUNCT
bjp-16772	10	3	rates	rate	NOUN
bjp-16772	10	4	and	and	CCONJ
bjp-16772	10	5	time	time	NOUN
bjp-16772	10	6	trends	trend	NOUN
bjp-16772	10	7	for	for	ADP
bjp-16772	10	8	statin	statin	ADJ
bjp-16772	10	9	prescriptions	prescription	NOUN
bjp-16772	10	10	together	together	ADV
bjp-16772	10	11	with	with	ADP
bjp-16772	10	12	demographic	demographic	ADJ
bjp-16772	10	13	data	datum	NOUN
bjp-16772	10	14	and	and	CCONJ
bjp-16772	10	15	the	the	DET
bjp-16772	10	16	prescribing	prescribing	NOUN
bjp-16772	10	17	patterns	pattern	NOUN
bjp-16772	10	18	for	for	ADP
bjp-16772	10	19	high	high	ADJ
bjp-16772	10	20	dose	dose	NOUN
bjp-16772	10	21	simvastatin	simvastatin	NOUN
bjp-16772	10	22	and	and	CCONJ
bjp-16772	10	23	newer	new	ADJ
bjp-16772	10	24	statins	statin	NOUN
bjp-16772	10	25	in	in	ADP
bjp-16772	10	26	its	its	PRON
bjp-16772	10	27	place	place	NOUN
bjp-16772	10	28	was	be	AUX
bjp-16772	10	29	measured	measure	VERB
bjp-16772	10	30	.	.	PUNCT
bjp-16772	11	1	63	63	NUM
bjp-16772	11	2	,	,	PUNCT
bjp-16772	11	3	27	27	NUM
bjp-16772	11	4	,	,	PUNCT
bjp-16772	11	5	5	5	NUM
bjp-16772	11	6	,	,	PUNCT
bjp-16772	11	7	4	4	NUM
bjp-16772	11	8	and	and	CCONJ
bjp-16772	11	9	1	1	NUM
bjp-16772	11	10	%	%	NOUN
bjp-16772	11	11	patients	patient	NOUN
bjp-16772	11	12	were	be	AUX
bjp-16772	11	13	prescribed	prescribe	VERB
bjp-16772	11	14	simvastatin	simvastatin	NOUN
bjp-16772	11	15	,	,	PUNCT
bjp-16772	11	16	atorvastatin	atorvastatin	PROPN
bjp-16772	11	17	,	,	PUNCT
bjp-16772	11	18	pravastatin	pravastatin	NOUN
bjp-16772	11	19	,	,	PUNCT
bjp-16772	11	20	rosuvastatin	rosuvastatin	NOUN
bjp-16772	11	21	and	and	CCONJ
bjp-16772	11	22	fluvastatin	fluvastatin	NOUN
bjp-16772	11	23	respectively	respectively	ADV
bjp-16772	11	24	(	(	PUNCT
bjp-16772	11	25	n	n	NOUN
bjp-16772	11	26	=	=	SYM
bjp-16772	11	27	1,91370	1,91370	PROPN
bjp-16772	11	28	)	)	PUNCT
bjp-16772	11	29	.	.	PUNCT
bjp-16772	12	1	prevalence	prevalence	NOUN
bjp-16772	12	2	for	for	ADP
bjp-16772	12	3	individual	individual	ADJ
bjp-16772	12	4	statin	statin	PROPN
bjp-16772	12	5	as	as	ADV
bjp-16772	12	6	well	well	ADV
bjp-16772	12	7	as	as	ADP
bjp-16772	12	8	for	for	ADP
bjp-16772	12	9	all	all	DET
bjp-16772	12	10	statin	statin	ADJ
bjp-16772	12	11	prescriptions	prescription	NOUN
bjp-16772	12	12	,	,	PUNCT
bjp-16772	12	13	significantly	significantly	ADV
bjp-16772	12	14	increased	increase	VERB
bjp-16772	12	15	(	(	PUNCT
bjp-16772	12	16	p<0.05	p<0.05	NOUN
bjp-16772	12	17	)	)	PUNCT
bjp-16772	12	18	.	.	PUNCT
bjp-16772	13	1	except	except	SCONJ
bjp-16772	13	2	rosuvastatin	rosuvastatin	VERB
bjp-16772	13	3	the	the	DET
bjp-16772	13	4	incidence	incidence	NOUN
bjp-16772	13	5	of	of	ADP
bjp-16772	13	6	other	other	ADJ
bjp-16772	13	7	statins	statin	NOUN
bjp-16772	13	8	prescription	prescription	NOUN
bjp-16772	13	9	significantly	significantly	ADV
bjp-16772	13	10	decreased	decrease	VERB
bjp-16772	13	11	(	(	PUNCT
bjp-16772	13	12	p<0.05	p<0.05	NOUN
bjp-16772	13	13	)	)	PUNCT
bjp-16772	13	14	.	.	PUNCT
bjp-16772	14	1	the	the	DET
bjp-16772	14	2	highest	high	ADJ
bjp-16772	14	3	number	number	NOUN
bjp-16772	14	4	of	of	ADP
bjp-16772	14	5	patients	patient	NOUN
bjp-16772	14	6	,	,	PUNCT
bjp-16772	14	7	884	884	NUM
bjp-16772	14	8	(	(	PUNCT
bjp-16772	14	9	24	24	NUM
bjp-16772	14	10	%	%	NOUN
bjp-16772	14	11	)	)	PUNCT
bjp-16772	14	12	switched	switch	VERB
bjp-16772	14	13	to	to	ADP
bjp-16772	14	14	atorvastatin	atorvastatin	NOUN
bjp-16772	14	15	from	from	ADP
bjp-16772	14	16	high	high	ADJ
bjp-16772	14	17	dose	dose	NOUN
bjp-16772	14	18	simvastatin	simvastatin	PROPN
bjp-16772	14	19	.	.	PUNCT
bjp-16772	15	1	increase	increase	NOUN
bjp-16772	15	2	in	in	ADP
bjp-16772	15	3	prevalent	prevalent	ADJ
bjp-16772	15	4	use	use	NOUN
bjp-16772	15	5	and	and	CCONJ
bjp-16772	15	6	decrease	decrease	NOUN
bjp-16772	15	7	in	in	ADP
bjp-16772	15	8	incident	incident	NOUN
bjp-16772	15	9	use	use	NOUN
bjp-16772	15	10	of	of	ADP
bjp-16772	15	11	statins	statin	NOUN
bjp-16772	15	12	,	,	PUNCT
bjp-16772	15	13	implies	imply	VERB
bjp-16772	15	14	the	the	DET
bjp-16772	15	15	diminished	diminished	ADJ
bjp-16772	15	16	cardiovascular	cardiovascular	ADJ
bjp-16772	15	17	disease	disease	NOUN
bjp-16772	15	18	related	relate	VERB
bjp-16772	15	19	mortality	mortality	NOUN
bjp-16772	15	20	and	and	CCONJ
bjp-16772	15	21	subsequent	subsequent	ADJ
bjp-16772	15	22	increased	increase	VERB
bjp-16772	15	23	life	life	NOUN
bjp-16772	15	24	expectancy	expectancy	NOUN
bjp-16772	15	25	of	of	ADP
bjp-16772	15	26	patients	patient	NOUN
bjp-16772	15	27	with	with	ADP
bjp-16772	15	28	cardiovascular	cardiovascular	ADJ
bjp-16772	15	29	disease	disease	NOUN
bjp-16772	15	30	.	.	PUNCT
bjp-16772	16	1	article	article	NOUN
bjp-16772	16	2	info	info	NOUN
bjp-16772	16	3	received	receive	VERB
bjp-16772	16	4	:	:	PUNCT
bjp-16772	16	5	1	1	NUM
bjp-16772	16	6	november	november	PROPN
bjp-16772	16	7	2013	2013	NUM
bjp-16772	16	8	accepted	accept	VERB
bjp-16772	16	9	:	:	PUNCT
bjp-16772	17	1	3	3	NUM
bjp-16772	17	2	december	december	PROPN
bjp-16772	17	3	2013	2013	NUM
bjp-16772	17	4	available	available	ADJ
bjp-16772	17	5	online	online	NOUN
bjp-16772	17	6	:	:	PUNCT
bjp-16772	17	7	9	9	NUM
bjp-16772	17	8	december	december	PROPN
bjp-16772	17	9	2013	2013	NUM
bjp-16772	17	10	doi	doi	NOUN
bjp-16772	17	11	:	:	PUNCT
bjp-16772	17	12	10.3329	10.3329	NUM
bjp-16772	17	13	/	/	SYM
bjp-16772	17	14	bjp.v8i4.16772	bjp.v8i4.16772	NOUN
bjp-16772	17	15	cite	cite	VERB
bjp-16772	17	16	this	this	DET
bjp-16772	17	17	article	article	NOUN
bjp-16772	17	18	:	:	PUNCT
bjp-16772	17	19	helali	helali	PROPN
bjp-16772	17	20	am	am	PROPN
bjp-16772	17	21	,	,	PUNCT
bjp-16772	17	22	mclay	mclay	PROPN
bjp-16772	17	23	j	j	PROPN
bjp-16772	17	24	,	,	PUNCT
bjp-16772	17	25	mohamed	mohame	VERB
bjp-16772	17	26	in	in	ADP
bjp-16772	17	27	.	.	PUNCT
bjp-16772	18	1	prescribing	prescribing	NOUN
bjp-16772	18	2	trends	trend	NOUN
bjp-16772	18	3	of	of	ADP
bjp-16772	18	4	statins	statin	NOUN
bjp-16772	18	5	in	in	ADP
bjp-16772	18	6	scotland	scotland	PROPN
bjp-16772	18	7	:	:	PUNCT
bjp-16772	18	8	a	a	DET
bjp-16772	18	9	drug	drug	NOUN
bjp-16772	18	10	utilization	utilization	NOUN
bjp-16772	18	11	study	study	NOUN
bjp-16772	18	12	.	.	PUNCT
bjp-16772	19	1	bangladesh	bangladesh	PROPN
bjp-16772	19	2	j	j	PROPN
bjp-16772	19	3	pharmacol	pharmacol	PROPN
bjp-16772	19	4	.	.	PUNCT
bjp-16772	20	1	2013	2013	NUM
bjp-16772	20	2	;	;	PUNCT
bjp-16772	20	3	8	8	NUM
bjp-16772	20	4	:	:	SYM
bjp-16772	20	5	401	401	NUM
bjp-16772	20	6	-	-	SYM
bjp-16772	20	7	09	09	NUM
bjp-16772	20	8	.	.	PUNCT
bjp-16772	21	1	this	this	DET
bjp-16772	21	2	work	work	NOUN
bjp-16772	21	3	is	be	AUX
bjp-16772	21	4	licensed	license	VERB
bjp-16772	21	5	under	under	ADP
bjp-16772	21	6	a	a	DET
bjp-16772	21	7	creative	creative	ADJ
bjp-16772	21	8	commons	common	NOUN
bjp-16772	21	9	attribution	attribution	NOUN
bjp-16772	21	10	3.0	3.0	NUM
bjp-16772	21	11	license	license	NOUN
bjp-16772	21	12	.	.	PUNCT
bjp-16772	22	1	you	you	PRON
bjp-16772	22	2	are	be	AUX
bjp-16772	22	3	free	free	ADJ
bjp-16772	22	4	to	to	PART
bjp-16772	22	5	copy	copy	VERB
bjp-16772	22	6	,	,	PUNCT
bjp-16772	22	7	distribute	distribute	VERB
bjp-16772	22	8	and	and	CCONJ
bjp-16772	22	9	perform	perform	VERB
bjp-16772	22	10	the	the	DET
bjp-16772	22	11	work	work	NOUN
bjp-16772	22	12	.	.	PUNCT
bjp-16772	23	1	you	you	PRON
bjp-16772	23	2	must	must	AUX
bjp-16772	23	3	attribute	attribute	VERB
bjp-16772	23	4	the	the	DET
bjp-16772	23	5	work	work	NOUN
bjp-16772	23	6	in	in	ADP
bjp-16772	23	7	the	the	DET
bjp-16772	23	8	manner	manner	NOUN
bjp-16772	23	9	specified	specify	VERB
bjp-16772	23	10	by	by	ADP
bjp-16772	23	11	the	the	DET
bjp-16772	23	12	author	author	NOUN
bjp-16772	23	13	or	or	CCONJ
bjp-16772	23	14	licensor	licensor	NOUN
bjp-16772	23	15	.	.	PUNCT
bjp-16772	24	1	prescribing	prescribe	VERB
bjp-16772	24	2	trends	trend	NOUN
bjp-16772	24	3	of	of	ADP
bjp-16772	24	4	statins	statin	NOUN
bjp-16772	24	5	in	in	ADP
bjp-16772	24	6	scotland	scotland	PROPN
bjp-16772	24	7	:	:	PUNCT
bjp-16772	24	8	a	a	DET
bjp-16772	24	9	drug	drug	NOUN
bjp-16772	24	10	utilization	utilization	NOUN
bjp-16772	24	11	study	study	NOUN
bjp-16772	24	12	asadul	asadul	ADV
bjp-16772	24	13	mazid	mazid	PROPN
bjp-16772	24	14	helali1	helali1	PROPN
bjp-16772	24	15	,	,	PUNCT
bjp-16772	24	16	james	james	PROPN
bjp-16772	24	17	mclay1	mclay1	PROPN
bjp-16772	24	18	and	and	CCONJ
bjp-16772	24	19	isa	isa	PROPN
bjp-16772	24	20	naina	naina	PROPN
bjp-16772	24	21	mohamed2	mohamed2	PROPN
bjp-16772	24	22	1division	1division	NUM
bjp-16772	24	23	of	of	ADP
bjp-16772	24	24	applied	apply	VERB
bjp-16772	24	25	health	health	NOUN
bjp-16772	24	26	sciences	sciences	PROPN
bjp-16772	24	27	,	,	PUNCT
bjp-16772	24	28	institute	institute	NOUN
bjp-16772	24	29	of	of	ADP
bjp-16772	24	30	child	child	PROPN
bjp-16772	24	31	health	health	PROPN
bjp-16772	24	32	,	,	PUNCT
bjp-16772	24	33	university	university	PROPN
bjp-16772	24	34	of	of	ADP
bjp-16772	24	35	aberdeen	aberdeen	PROPN
bjp-16772	24	36	,	,	PUNCT
bjp-16772	24	37	scotland	scotland	PROPN
bjp-16772	24	38	,	,	PUNCT
bjp-16772	24	39	uk	uk	PROPN
bjp-16772	24	40	;	;	PUNCT
bjp-16772	24	41	2department	2department	NUM
bjp-16772	24	42	of	of	ADP
bjp-16772	24	43	pharmacology	pharmacology	NOUN
bjp-16772	24	44	,	,	PUNCT
bjp-16772	24	45	faculty	faculty	NOUN
bjp-16772	24	46	of	of	ADP
bjp-16772	24	47	medicine	medicine	NOUN
bjp-16772	24	48	,	,	PUNCT
bjp-16772	24	49	universiti	universiti	PROPN
bjp-16772	24	50	kebangsaan	kebangsaan	PROPN
bjp-16772	24	51	malaysia	malaysia	PROPN
bjp-16772	24	52	,	,	PUNCT
bjp-16772	24	53	(	(	PUNCT
bjp-16772	24	54	national	national	PROPN
bjp-16772	24	55	university	university	PROPN
bjp-16772	24	56	of	of	ADP
bjp-16772	24	57	malaysia	malaysia	PROPN
bjp-16772	24	58	)	)	PUNCT
bjp-16772	24	59	,	,	PUNCT
bjp-16772	24	60	malaysia	malaysia	PROPN
bjp-16772	24	61	.	.	PUNCT
bjp-16772	25	1	for	for	ADP
bjp-16772	25	2	high	high	ADJ
bjp-16772	25	3	dose	dose	NOUN
bjp-16772	25	4	simvastatin	simvastatin	NOUN
bjp-16772	25	5	and	and	CCONJ
bjp-16772	25	6	newer	new	ADJ
bjp-16772	25	7	statins	statin	NOUN
bjp-16772	25	8	in	in	ADP
bjp-16772	25	9	its	its	PRON
bjp-16772	25	10	place	place	NOUN
bjp-16772	25	11	.	.	PUNCT
bjp-16772	26	1	material	material	NOUN
bjp-16772	26	2	and	and	CCONJ
bjp-16772	26	3	methods	method	NOUN
bjp-16772	26	4	using	use	VERB
bjp-16772	26	5	primary	primary	ADJ
bjp-16772	26	6	care	care	NOUN
bjp-16772	26	7	data	datum	NOUN
bjp-16772	26	8	from	from	ADP
bjp-16772	26	9	the	the	DET
bjp-16772	26	10	primary	primary	ADJ
bjp-16772	26	11	care	care	NOUN
bjp-16772	26	12	clinical	clinical	ADJ
bjp-16772	26	13	informatics	informatic	NOUN
bjp-16772	26	14	unit	unit	NOUN
bjp-16772	26	15	(	(	PUNCT
bjp-16772	26	16	pcciu	pcciu	ADJ
bjp-16772	26	17	)	)	PUNCT
bjp-16772	26	18	database	database	NOUN
bjp-16772	26	19	,	,	PUNCT
bjp-16772	26	20	we	we	PRON
bjp-16772	26	21	assessed	assess	VERB
bjp-16772	26	22	patients	patient	NOUN
bjp-16772	26	23	’	'	PUNCT
bjp-16772	26	24	age	age	NOUN
bjp-16772	26	25	in	in	ADP
bjp-16772	26	26	years	year	NOUN
bjp-16772	26	27	(	(	PUNCT
bjp-16772	26	28	date	date	NOUN
bjp-16772	26	29	was	be	AUX
bjp-16772	26	30	counted	count	VERB
bjp-16772	26	31	from	from	ADP
bjp-16772	26	32	the	the	DET
bjp-16772	26	33	first	first	ADJ
bjp-16772	26	34	date	date	NOUN
bjp-16772	26	35	of	of	ADP
bjp-16772	26	36	prescribed	prescribe	VERB
bjp-16772	26	37	statins	statin	NOUN
bjp-16772	26	38	)	)	PUNCT
bjp-16772	26	39	and	and	CCONJ
bjp-16772	26	40	sex	sex	NOUN
bjp-16772	26	41	of	of	ADP
bjp-16772	26	42	individual	individual	ADJ
bjp-16772	26	43	patients	patient	NOUN
bjp-16772	26	44	prescribed	prescribe	VERB
bjp-16772	26	45	any	any	DET
bjp-16772	26	46	statin	statin	NOUN
bjp-16772	26	47	,	,	PUNCT
bjp-16772	26	48	number	number	NOUN
bjp-16772	26	49	of	of	ADP
bjp-16772	26	50	patients	patient	NOUN
bjp-16772	26	51	prescribed	prescribe	VERB
bjp-16772	26	52	individual	individual	ADJ
bjp-16772	26	53	statin	statin	PROPN
bjp-16772	26	54	(	(	PUNCT
bjp-16772	26	55	simvastatin	simvastatin	PROPN
bjp-16772	26	56	,	,	PUNCT
bjp-16772	26	57	atorvastatin	atorvastatin	PROPN
bjp-16772	26	58	,	,	PUNCT
bjp-16772	26	59	rosuvastatin	rosuvastatin	NOUN
bjp-16772	26	60	,	,	PUNCT
bjp-16772	26	61	pravastatin	pravastatin	NOUN
bjp-16772	26	62	and	and	CCONJ
bjp-16772	26	63	fluvastatin	fluvastatin	NOUN
bjp-16772	26	64	)	)	PUNCT
bjp-16772	26	65	,	,	PUNCT
bjp-16772	26	66	percentages	percentage	NOUN
bjp-16772	26	67	of	of	ADP
bjp-16772	26	68	patients	patient	NOUN
bjp-16772	26	69	prescribed	prescribe	VERB
bjp-16772	26	70	high	high	ADJ
bjp-16772	26	71	dose	dose	PROPN
bjp-16772	26	72	(	(	PUNCT
bjp-16772	26	73	80	80	NUM
bjp-16772	26	74	mg	mg	NOUN
bjp-16772	26	75	)	)	PUNCT
bjp-16772	26	76	simvastatin	simvastatin	NOUN
bjp-16772	26	77	and	and	CCONJ
bjp-16772	26	78	the	the	DET
bjp-16772	26	79	patients	patient	NOUN
bjp-16772	26	80	those	those	PRON
bjp-16772	26	81	switched	switch	VERB
bjp-16772	26	82	from	from	ADP
bjp-16772	26	83	high	high	ADJ
bjp-16772	26	84	dose	dose	NOUN
bjp-16772	26	85	simvastatin	simvastatin	NOUN
bjp-16772	26	86	to	to	ADP
bjp-16772	26	87	other	other	ADJ
bjp-16772	26	88	statin	statin	NOUN
bjp-16772	26	89	within	within	ADP
bjp-16772	26	90	the	the	DET
bjp-16772	26	91	study	study	NOUN
bjp-16772	26	92	period	period	NOUN
bjp-16772	26	93	.	.	PUNCT
bjp-16772	27	1	patient	patient	NOUN
bjp-16772	27	2	’s	’s	PART
bjp-16772	27	3	age	age	NOUN
bjp-16772	27	4	was	be	AUX
bjp-16772	27	5	categorized	categorize	VERB
bjp-16772	27	6	into	into	ADP
bjp-16772	27	7	6	6	NUM
bjp-16772	27	8	categories	category	NOUN
bjp-16772	27	9	;	;	PUNCT
bjp-16772	27	10	<	<	X
bjp-16772	27	11	=	=	NOUN
bjp-16772	27	12	40	40	NUM
bjp-16772	27	13	years	year	NOUN
bjp-16772	27	14	,	,	PUNCT
bjp-16772	27	15	41	41	NUM
bjp-16772	27	16	-	-	SYM
bjp-16772	27	17	50	50	NUM
bjp-16772	27	18	,	,	PUNCT
bjp-16772	27	19	5160	5160	NUM
bjp-16772	27	20	,	,	PUNCT
bjp-16772	27	21	61	61	NUM
bjp-16772	27	22	-	-	SYM
bjp-16772	27	23	70	70	NUM
bjp-16772	27	24	,	,	PUNCT
bjp-16772	27	25	71	71	NUM
bjp-16772	27	26	-	-	SYM
bjp-16772	27	27	80	80	NUM
bjp-16772	27	28	years	year	NOUN
bjp-16772	27	29	and	and	CCONJ
bjp-16772	27	30	>	>	SYM
bjp-16772	27	31	80	80	NUM
bjp-16772	27	32	years	year	NOUN
bjp-16772	27	33	.	.	PUNCT
bjp-16772	28	1	age	age	NOUN
bjp-16772	28	2	categorization	categorization	NOUN
bjp-16772	28	3	was	be	AUX
bjp-16772	28	4	done	do	VERB
bjp-16772	28	5	due	due	ADP
bjp-16772	28	6	to	to	ADP
bjp-16772	28	7	agestandardized	agestandardize	VERB
bjp-16772	28	8	prevalence	prevalence	NOUN
bjp-16772	28	9	and	and	CCONJ
bjp-16772	28	10	incidence	incidence	NOUN
bjp-16772	28	11	of	of	ADP
bjp-16772	28	12	cvd	cvd	PROPN
bjp-16772	28	13	related	related	ADJ
bjp-16772	28	14	diagnosis	diagnosis	NOUN
bjp-16772	28	15	such	such	ADJ
bjp-16772	28	16	as	as	ADP
bjp-16772	28	17	,	,	PUNCT
bjp-16772	28	18	angina	angina	PROPN
bjp-16772	28	19	,	,	PUNCT
bjp-16772	28	20	mi	mi	NOUN
bjp-16772	28	21	,	,	PUNCT
bjp-16772	28	22	heart	heart	NOUN
bjp-16772	28	23	failure	failure	NOUN
bjp-16772	28	24	,	,	PUNCT
bjp-16772	28	25	stoke	stoke	NOUN
bjp-16772	28	26	frequently	frequently	ADV
bjp-16772	28	27	occurs	occur	VERB
bjp-16772	28	28	within	within	ADP
bjp-16772	28	29	these	these	DET
bjp-16772	28	30	age	age	NOUN
bjp-16772	28	31	groups	group	NOUN
bjp-16772	28	32	in	in	ADP
bjp-16772	28	33	the	the	DET
bjp-16772	28	34	uk	uk	PROPN
bjp-16772	28	35	(	(	PUNCT
bjp-16772	28	36	davis	davis	PROPN
bjp-16772	28	37	et	et	PROPN
bjp-16772	28	38	al	al	PROPN
bjp-16772	28	39	.	.	PROPN
bjp-16772	28	40	,	,	PUNCT
bjp-16772	28	41	2007	2007	NUM
bjp-16772	28	42	)	)	PUNCT
bjp-16772	28	43	and	and	CCONJ
bjp-16772	28	44	thereby	thereby	ADV
bjp-16772	28	45	individuals	individual	NOUN
bjp-16772	28	46	of	of	ADP
bjp-16772	28	47	this	this	DET
bjp-16772	28	48	age	age	NOUN
bjp-16772	28	49	range	range	NOUN
bjp-16772	28	50	are	be	AUX
bjp-16772	28	51	commonly	commonly	ADV
bjp-16772	28	52	prescribed	prescribe	VERB
bjp-16772	28	53	chronic	chronic	ADJ
bjp-16772	28	54	medicine	medicine	NOUN
bjp-16772	28	55	like	like	ADP
bjp-16772	28	56	statin	statin	PROPN
bjp-16772	28	57	.	.	PUNCT
bjp-16772	29	1	the	the	DET
bjp-16772	29	2	pcciu	pcciu	PROPN
bjp-16772	29	3	database	database	NOUN
bjp-16772	29	4	contains	contain	VERB
bjp-16772	29	5	prescribing	prescribe	VERB
bjp-16772	29	6	information	information	NOUN
bjp-16772	29	7	for	for	ADP
bjp-16772	29	8	approximately	approximately	ADV
bjp-16772	29	9	1	1	NUM
bjp-16772	29	10	million	million	NUM
bjp-16772	29	11	patients	patient	NOUN
bjp-16772	29	12	registered	register	VERB
bjp-16772	29	13	with	with	ADP
bjp-16772	29	14	200	200	NUM
bjp-16772	29	15	primary	primary	ADJ
bjp-16772	29	16	care	care	NOUN
bjp-16772	29	17	practices	practice	NOUN
bjp-16772	29	18	and	and	CCONJ
bjp-16772	29	19	it	it	PRON
bjp-16772	29	20	covers	cover	VERB
bjp-16772	29	21	around	around	ADV
bjp-16772	29	22	20	20	NUM
bjp-16772	29	23	%	%	NOUN
bjp-16772	29	24	of	of	ADP
bjp-16772	29	25	the	the	DET
bjp-16772	29	26	scottish	scottish	ADJ
bjp-16772	29	27	population	population	NOUN
bjp-16772	29	28	(	(	PUNCT
bjp-16772	29	29	the	the	DET
bjp-16772	29	30	official	official	ADJ
bjp-16772	29	31	gateway	gateway	NOUN
bjp-16772	29	32	to	to	ADP
bjp-16772	29	33	scotland	scotland	PROPN
bjp-16772	29	34	,	,	PUNCT
bjp-16772	29	35	2010	2010	NUM
bjp-16772	29	36	)	)	PUNCT
bjp-16772	29	37	with	with	ADP
bjp-16772	29	38	regard	regard	NOUN
bjp-16772	29	39	to	to	ADP
bjp-16772	29	40	age	age	NOUN
bjp-16772	29	41	,	,	PUNCT
bjp-16772	29	42	gender	gender	NOUN
bjp-16772	29	43	,	,	PUNCT
bjp-16772	29	44	deprivation	deprivation	NOUN
bjp-16772	29	45	,	,	PUNCT
bjp-16772	29	46	and	and	CCONJ
bjp-16772	29	47	urban	urban	ADJ
bjp-16772	29	48	/	/	SYM
bjp-16772	29	49	rural	rural	ADJ
bjp-16772	29	50	ratio	ratio	NOUN
bjp-16772	29	51	mix	mix	NOUN
bjp-16772	29	52	.	.	PUNCT
bjp-16772	30	1	currently	currently	ADV
bjp-16772	30	2	pcciu	pcciu	ADJ
bjp-16772	30	3	data	datum	NOUN
bjp-16772	30	4	is	be	AUX
bjp-16772	30	5	used	use	VERB
bjp-16772	30	6	by	by	ADP
bjp-16772	30	7	the	the	DET
bjp-16772	30	8	scottish	scottish	ADJ
bjp-16772	30	9	government	government	NOUN
bjp-16772	30	10	,	,	PUNCT
bjp-16772	30	11	nhs	nhs	NOUN
bjp-16772	30	12	boards	board	NOUN
bjp-16772	30	13	,	,	PUNCT
bjp-16772	30	14	charities	charity	NOUN
bjp-16772	30	15	,	,	PUNCT
bjp-16772	30	16	researchers	researcher	NOUN
bjp-16772	30	17	and	and	CCONJ
bjp-16772	30	18	many	many	ADJ
bjp-16772	30	19	others	other	NOUN
bjp-16772	30	20	associated	associate	VERB
bjp-16772	30	21	with	with	ADP
bjp-16772	30	22	the	the	DET
bjp-16772	30	23	primary	primary	ADJ
bjp-16772	30	24	health	health	NOUN
bjp-16772	30	25	care	care	NOUN
bjp-16772	30	26	,	,	PUNCT
bjp-16772	30	27	scotland	scotland	PROPN
bjp-16772	30	28	(	(	PUNCT
bjp-16772	30	29	primary	primary	ADJ
bjp-16772	30	30	care	care	NOUN
bjp-16772	30	31	clinical	clinical	ADJ
bjp-16772	30	32	information	information	NOUN
bjp-16772	30	33	units	unit	NOUN
bjp-16772	30	34	,	,	PUNCT
bjp-16772	30	35	2010	2010	NUM
bjp-16772	30	36	)	)	PUNCT
bjp-16772	30	37	.	.	PUNCT
bjp-16772	31	1	prescribing	prescribe	VERB
bjp-16772	31	2	data	datum	NOUN
bjp-16772	31	3	for	for	ADP
bjp-16772	31	4	patients	patient	NOUN
bjp-16772	31	5	prescribed	prescribe	VERB
bjp-16772	31	6	any	any	DET
bjp-16772	31	7	statin	statin	ADJ
bjp-16772	31	8	and	and	CCONJ
bjp-16772	31	9	selective	selective	ADJ
bjp-16772	31	10	information	information	NOUN
bjp-16772	31	11	regarding	regard	VERB
bjp-16772	31	12	patient	patient	ADJ
bjp-16772	31	13	contacts	contact	NOUN
bjp-16772	31	14	with	with	ADP
bjp-16772	31	15	their	their	PRON
bjp-16772	31	16	primary	primary	ADJ
bjp-16772	31	17	care	care	NOUN
bjp-16772	31	18	physicians	physician	NOUN
bjp-16772	31	19	for	for	ADP
bjp-16772	31	20	the	the	DET
bjp-16772	31	21	5	5	NUM
bjp-16772	31	22	years	year	NOUN
bjp-16772	31	23	,	,	PUNCT
bjp-16772	31	24	from	from	ADP
bjp-16772	31	25	march	march	PROPN
bjp-16772	31	26	1	1	NUM
bjp-16772	31	27	,	,	PUNCT
bjp-16772	31	28	2005	2005	NUM
bjp-16772	31	29	,	,	PUNCT
bjp-16772	31	30	to	to	ADP
bjp-16772	31	31	february	february	PROPN
bjp-16772	31	32	28	28	NUM
bjp-16772	31	33	,	,	PUNCT
bjp-16772	31	34	2010	2010	NUM
bjp-16772	31	35	,	,	PUNCT
bjp-16772	31	36	were	be	AUX
bjp-16772	31	37	extracted	extract	VERB
bjp-16772	31	38	.	.	PUNCT
bjp-16772	32	1	this	this	PRON
bjp-16772	32	2	is	be	AUX
bjp-16772	32	3	the	the	DET
bjp-16772	32	4	most	most	ADV
bjp-16772	32	5	current	current	ADJ
bjp-16772	32	6	5	5	NUM
bjp-16772	32	7	years	year	NOUN
bjp-16772	32	8	data	datum	NOUN
bjp-16772	32	9	available	available	ADJ
bjp-16772	32	10	from	from	ADP
bjp-16772	32	11	the	the	DET
bjp-16772	32	12	pcciu	pcciu	PROPN
bjp-16772	32	13	database	database	NOUN
bjp-16772	32	14	.	.	PUNCT
bjp-16772	33	1	to	to	PART
bjp-16772	33	2	determine	determine	VERB
bjp-16772	33	3	accurate	accurate	ADJ
bjp-16772	33	4	prevalence	prevalence	NOUN
bjp-16772	33	5	of	of	ADP
bjp-16772	33	6	patients	patient	NOUN
bjp-16772	33	7	prescribed	prescribe	VERB
bjp-16772	33	8	statins	statin	NOUN
bjp-16772	33	9	in	in	ADP
bjp-16772	33	10	the	the	DET
bjp-16772	33	11	scottish	scottish	ADJ
bjp-16772	33	12	population	population	NOUN
bjp-16772	33	13	,	,	PUNCT
bjp-16772	33	14	the	the	DET
bjp-16772	33	15	periods	period	NOUN
bjp-16772	33	16	between	between	ADP
bjp-16772	33	17	march	march	PROPN
bjp-16772	33	18	1	1	NUM
bjp-16772	33	19	,	,	PUNCT
bjp-16772	33	20	2005	2005	NUM
bjp-16772	33	21	,	,	PUNCT
bjp-16772	33	22	and	and	CCONJ
bjp-16772	33	23	august	august	PROPN
bjp-16772	33	24	31	31	NUM
bjp-16772	33	25	,	,	PUNCT
bjp-16772	33	26	2005	2005	NUM
bjp-16772	33	27	,	,	PUNCT
bjp-16772	33	28	and	and	CCONJ
bjp-16772	33	29	another	another	DET
bjp-16772	33	30	period	period	NOUN
bjp-16772	33	31	between	between	ADP
bjp-16772	33	32	september	september	PROPN
bjp-16772	33	33	1	1	NUM
bjp-16772	33	34	,	,	PUNCT
bjp-16772	33	35	2009	2009	NUM
bjp-16772	33	36	,	,	PUNCT
bjp-16772	33	37	and	and	CCONJ
bjp-16772	33	38	february	february	PROPN
bjp-16772	33	39	28	28	NUM
bjp-16772	33	40	,	,	PUNCT
bjp-16772	33	41	2010	2010	NUM
bjp-16772	33	42	were	be	AUX
bjp-16772	33	43	assigned	assign	VERB
bjp-16772	33	44	as	as	ADP
bjp-16772	33	45	wash	wash	NOUN
bjp-16772	33	46	out	out	ADP
bjp-16772	33	47	periods	period	NOUN
bjp-16772	33	48	.	.	PUNCT
bjp-16772	34	1	whereas	whereas	SCONJ
bjp-16772	34	2	,	,	PUNCT
bjp-16772	34	3	for	for	ADP
bjp-16772	34	4	determining	determine	VERB
bjp-16772	34	5	the	the	DET
bjp-16772	34	6	incidence	incidence	NOUN
bjp-16772	34	7	,	,	PUNCT
bjp-16772	34	8	the	the	DET
bjp-16772	34	9	period	period	NOUN
bjp-16772	34	10	between	between	ADP
bjp-16772	34	11	march	march	PROPN
bjp-16772	34	12	1	1	NUM
bjp-16772	34	13	,	,	PUNCT
bjp-16772	34	14	2005	2005	NUM
bjp-16772	34	15	and	and	CCONJ
bjp-16772	34	16	august	august	PROPN
bjp-16772	34	17	31	31	NUM
bjp-16772	34	18	,	,	PUNCT
bjp-16772	34	19	2006	2006	NUM
bjp-16772	34	20	was	be	AUX
bjp-16772	34	21	framed	frame	VERB
bjp-16772	34	22	as	as	SCONJ
bjp-16772	34	23	wash	wash	VERB
bjp-16772	34	24	out	out	ADP
bjp-16772	34	25	periods	period	NOUN
bjp-16772	34	26	.	.	PUNCT
bjp-16772	35	1	the	the	DET
bjp-16772	35	2	actual	actual	ADJ
bjp-16772	35	3	study	study	NOUN
bjp-16772	35	4	period	period	NOUN
bjp-16772	35	5	for	for	ADP
bjp-16772	35	6	prevalence	prevalence	NOUN
bjp-16772	35	7	and	and	CCONJ
bjp-16772	35	8	incidence	incidence	NOUN
bjp-16772	35	9	of	of	ADP
bjp-16772	35	10	the	the	DET
bjp-16772	35	11	patients	patient	NOUN
bjp-16772	35	12	prescribed	prescribe	VERB
bjp-16772	35	13	statin	statin	PROPN
bjp-16772	35	14	were	be	AUX
bjp-16772	35	15	from	from	ADP
bjp-16772	35	16	september	september	PROPN
bjp-16772	35	17	2005	2005	NUM
bjp-16772	35	18	to	to	ADP
bjp-16772	35	19	september	september	PROPN
bjp-16772	35	20	2009	2009	NUM
bjp-16772	35	21	and	and	CCONJ
bjp-16772	35	22	from	from	ADP
bjp-16772	35	23	september	september	PROPN
bjp-16772	35	24	2006	2006	NUM
bjp-16772	35	25	to	to	ADP
bjp-16772	35	26	february	february	PROPN
bjp-16772	35	27	2010	2010	NUM
bjp-16772	35	28	respectively	respectively	ADV
bjp-16772	35	29	.	.	PUNCT
bjp-16772	36	1	a	a	DET
bjp-16772	36	2	switching	switch	VERB
bjp-16772	36	3	period	period	NOUN
bjp-16772	36	4	of	of	ADP
bjp-16772	36	5	180	180	NUM
bjp-16772	36	6	days	day	NOUN
bjp-16772	36	7	was	be	AUX
bjp-16772	36	8	used	use	VERB
bjp-16772	36	9	to	to	PART
bjp-16772	36	10	identify	identify	VERB
bjp-16772	36	11	patients	patient	NOUN
bjp-16772	36	12	that	that	PRON
bjp-16772	36	13	switched	switch	VERB
bjp-16772	36	14	from	from	ADP
bjp-16772	36	15	high	high	ADJ
bjp-16772	36	16	dose	dose	NOUN
bjp-16772	36	17	(	(	PUNCT
bjp-16772	36	18	80	80	NUM
bjp-16772	36	19	mg	mg	NOUN
bjp-16772	36	20	)	)	PUNCT
bjp-16772	36	21	simvastatin	simvastatin	NOUN
bjp-16772	36	22	to	to	ADP
bjp-16772	36	23	low	low	ADJ
bjp-16772	36	24	dose	dose	NOUN
bjp-16772	36	25	statins	statin	NOUN
bjp-16772	36	26	.	.	PUNCT
bjp-16772	37	1	patients	patient	NOUN
bjp-16772	37	2	,	,	PUNCT
bjp-16772	37	3	those	those	PRON
bjp-16772	37	4	switched	switch	VERB
bjp-16772	37	5	or	or	CCONJ
bjp-16772	37	6	did	do	AUX
bjp-16772	37	7	not	not	PART
bjp-16772	37	8	switch	switch	VERB
bjp-16772	37	9	to	to	AUX
bjp-16772	37	10	low	low	ADJ
bjp-16772	37	11	dose	dose	NOUN
bjp-16772	37	12	within	within	ADP
bjp-16772	37	13	the	the	DET
bjp-16772	37	14	180	180	NUM
bjp-16772	37	15	days	day	NOUN
bjp-16772	37	16	switching	switch	VERB
bjp-16772	37	17	period	period	NOUN
bjp-16772	37	18	from	from	ADP
bjp-16772	37	19	the	the	DET
bjp-16772	37	20	date	date	NOUN
bjp-16772	37	21	of	of	ADP
bjp-16772	37	22	discontinuing	discontinue	VERB
bjp-16772	37	23	high	high	ADJ
bjp-16772	37	24	dose	dose	NOUN
bjp-16772	37	25	simvastatin	simvastatin	NOUN
bjp-16772	37	26	were	be	AUX
bjp-16772	37	27	assigned	assign	VERB
bjp-16772	37	28	as	as	ADP
bjp-16772	37	29	‘	'	PUNCT
bjp-16772	37	30	switched	switch	VERB
bjp-16772	37	31	’	'	PUNCT
bjp-16772	37	32	or	or	CCONJ
bjp-16772	37	33	‘	'	PUNCT
bjp-16772	37	34	not	not	PART
bjp-16772	37	35	switched	switch	VERB
bjp-16772	37	36	’	'	PUNCT
bjp-16772	37	37	.	.	PUNCT
bjp-16772	38	1	subgroup	subgroup	NOUN
bjp-16772	38	2	analysis	analysis	NOUN
bjp-16772	38	3	was	be	AUX
bjp-16772	38	4	performed	perform	VERB
bjp-16772	38	5	on	on	ADP
bjp-16772	38	6	patients	patient	NOUN
bjp-16772	38	7	(	(	PUNCT
bjp-16772	38	8	september	september	PROPN
bjp-16772	38	9	2005august	2005august	NUM
bjp-16772	38	10	2009	2009	NUM
bjp-16772	38	11	)	)	PUNCT
bjp-16772	38	12	,	,	PUNCT
bjp-16772	38	13	for	for	ADP
bjp-16772	38	14	whom	whom	PRON
bjp-16772	38	15	data	datum	NOUN
bjp-16772	38	16	on	on	ADP
bjp-16772	38	17	switching	switch	VERB
bjp-16772	38	18	to	to	ADP
bjp-16772	38	19	low	low	ADJ
bjp-16772	38	20	dose	dose	NOUN
bjp-16772	38	21	statin	statin	PROPN
bjp-16772	38	22	,	,	PUNCT
bjp-16772	38	23	their	their	PRON
bjp-16772	38	24	age	age	NOUN
bjp-16772	38	25	group	group	NOUN
bjp-16772	38	26	and	and	CCONJ
bjp-16772	38	27	gender	gender	NOUN
bjp-16772	38	28	was	be	AUX
bjp-16772	38	29	available	available	ADJ
bjp-16772	38	30	.	.	PUNCT
bjp-16772	39	1	another	another	DET
bjp-16772	39	2	subgroup	subgroup	NOUN
bjp-16772	39	3	analysis	analysis	NOUN
bjp-16772	39	4	was	be	AUX
bjp-16772	39	5	executed	execute	VERB
bjp-16772	39	6	on	on	ADP
bjp-16772	39	7	patients	patient	NOUN
bjp-16772	39	8	(	(	PUNCT
bjp-16772	39	9	september	september	PROPN
bjp-16772	39	10	2005	2005	NUM
bjp-16772	39	11	august	august	PROPN
bjp-16772	39	12	2009	2009	NUM
bjp-16772	39	13	)	)	PUNCT
bjp-16772	39	14	,	,	PUNCT
bjp-16772	39	15	for	for	ADP
bjp-16772	39	16	whom	whom	PRON
bjp-16772	39	17	data	datum	NOUN
bjp-16772	39	18	on	on	ADP
bjp-16772	39	19	using	use	VERB
bjp-16772	39	20	of	of	ADP
bjp-16772	39	21	usual	usual	ADJ
bjp-16772	39	22	dose	dose	NOUN
bjp-16772	39	23	or	or	CCONJ
bjp-16772	39	24	high	high	ADJ
bjp-16772	39	25	dose	dose	NOUN
bjp-16772	39	26	simvastatin	simvastatin	NOUN
bjp-16772	39	27	,	,	PUNCT
bjp-16772	39	28	age	age	NOUN
bjp-16772	39	29	group	group	NOUN
bjp-16772	39	30	and	and	CCONJ
bjp-16772	39	31	gender	gender	NOUN
bjp-16772	39	32	was	be	AUX
bjp-16772	39	33	available	available	ADJ
bjp-16772	39	34	.	.	PUNCT
bjp-16772	40	1	number	number	NOUN
bjp-16772	40	2	of	of	ADP
bjp-16772	40	3	patients	patient	NOUN
bjp-16772	40	4	prescribed	prescribe	VERB
bjp-16772	40	5	high	high	ADJ
bjp-16772	40	6	dose	dose	NOUN
bjp-16772	40	7	simvastatin	simvastatin	NOUN
bjp-16772	40	8	and	and	CCONJ
bjp-16772	40	9	usual	usual	ADJ
bjp-16772	40	10	doses	dose	NOUN
bjp-16772	40	11	were	be	AUX
bjp-16772	40	12	described	describe	VERB
bjp-16772	40	13	as	as	ADP
bjp-16772	40	14	80	80	NUM
bjp-16772	40	15	mg	mg	ADP
bjp-16772	40	16	or	or	CCONJ
bjp-16772	40	17	low	low	ADJ
bjp-16772	40	18	dose	dose	NOUN
bjp-16772	40	19	.	.	PUNCT
bjp-16772	41	1	patients	patient	NOUN
bjp-16772	41	2	started	start	VERB
bjp-16772	41	3	on	on	ADP
bjp-16772	41	4	the	the	DET
bjp-16772	41	5	medicines	medicine	NOUN
bjp-16772	41	6	of	of	ADP
bjp-16772	41	7	interest	interest	NOUN
bjp-16772	41	8	between	between	ADP
bjp-16772	41	9	september	september	PROPN
bjp-16772	41	10	1	1	NUM
bjp-16772	41	11	,	,	PUNCT
bjp-16772	41	12	2005	2005	NUM
bjp-16772	41	13	,	,	PUNCT
bjp-16772	41	14	and	and	CCONJ
bjp-16772	41	15	august	august	PROPN
bjp-16772	41	16	31	31	NUM
bjp-16772	41	17	,	,	PUNCT
bjp-16772	41	18	2009	2009	NUM
bjp-16772	41	19	,	,	PUNCT
bjp-16772	41	20	were	be	AUX
bjp-16772	41	21	identified	identify	VERB
bjp-16772	41	22	and	and	CCONJ
bjp-16772	41	23	then	then	ADV
bjp-16772	41	24	tracked	track	VERB
bjp-16772	41	25	as	as	ADP
bjp-16772	41	26	an	an	DET
bjp-16772	41	27	exposed	exposed	ADJ
bjp-16772	41	28	cohort	cohort	NOUN
bjp-16772	41	29	.	.	PUNCT
bjp-16772	42	1	the	the	DET
bjp-16772	42	2	time	time	NOUN
bjp-16772	42	3	between	between	ADP
bjp-16772	42	4	the	the	DET
bjp-16772	42	5	first	first	ADJ
bjp-16772	42	6	and	and	CCONJ
bjp-16772	42	7	last	last	ADJ
bjp-16772	42	8	prescription	prescription	NOUN
bjp-16772	42	9	for	for	ADP
bjp-16772	42	10	the	the	DET
bjp-16772	42	11	specific	specific	ADJ
bjp-16772	42	12	statin	statin	PROPN
bjp-16772	42	13	was	be	AUX
bjp-16772	42	14	then	then	ADV
bjp-16772	42	15	determined	determine	VERB
bjp-16772	42	16	.	.	PUNCT
bjp-16772	43	1	patients	patient	NOUN
bjp-16772	43	2	’	'	PUNCT
bjp-16772	43	3	characteristics	characteristic	NOUN
bjp-16772	43	4	were	be	AUX
bjp-16772	43	5	summarized	summarize	VERB
bjp-16772	43	6	as	as	ADP
bjp-16772	43	7	means	mean	NOUN
bjp-16772	43	8	(	(	PUNCT
bjp-16772	43	9	sd	sd	NOUN
bjp-16772	43	10	)	)	PUNCT
bjp-16772	43	11	,	,	PUNCT
bjp-16772	43	12	median	median	NOUN
bjp-16772	43	13	and	and	CCONJ
bjp-16772	43	14	percentages	percentage	NOUN
bjp-16772	43	15	.	.	PUNCT
bjp-16772	44	1	test	test	NOUN
bjp-16772	44	2	of	of	ADP
bjp-16772	44	3	significance	significance	NOUN
bjp-16772	44	4	included	include	VERB
bjp-16772	44	5	the	the	DET
bjp-16772	44	6	chi	chi	NOUN
bjp-16772	44	7	-	-	PUNCT
bjp-16772	44	8	square	square	NOUN
bjp-16772	44	9	(	(	PUNCT
bjp-16772	44	10	χ2	χ2	PROPN
bjp-16772	44	11	test	test	NOUN
bjp-16772	44	12	)	)	PUNCT
bjp-16772	44	13	,	,	PUNCT
bjp-16772	44	14	continuity	continuity	NOUN
bjp-16772	44	15	correction	correction	NOUN
bjp-16772	44	16	,	,	PUNCT
bjp-16772	44	17	fisher	fisher	PROPN
bjp-16772	44	18	’s	’s	PART
bjp-16772	44	19	exact	exact	ADJ
bjp-16772	44	20	test	test	NOUN
bjp-16772	44	21	,	,	PUNCT
bjp-16772	44	22	pearson	pearson	PROPN
bjp-16772	44	23	chi	chi	PROPN
bjp-16772	44	24	square	square	PROPN
bjp-16772	44	25	test	test	NOUN
bjp-16772	44	26	.	.	PUNCT
bjp-16772	45	1	curve	curve	NOUN
bjp-16772	45	2	estimation	estimation	NOUN
bjp-16772	45	3	of	of	ADP
bjp-16772	45	4	linear	linear	PROPN
bjp-16772	45	5	regression	regression	NOUN
bjp-16772	45	6	analysis	analysis	NOUN
bjp-16772	45	7	was	be	AUX
bjp-16772	45	8	also	also	ADV
bjp-16772	45	9	used	use	VERB
bjp-16772	45	10	to	to	PART
bjp-16772	45	11	determine	determine	VERB
bjp-16772	45	12	the	the	DET
bjp-16772	45	13	significance	significance	NOUN
bjp-16772	45	14	value	value	NOUN
bjp-16772	45	15	.	.	PUNCT
bjp-16772	46	1	a	a	DET
bjp-16772	46	2	two	two	NUM
bjp-16772	46	3	tailed	tail	VERB
bjp-16772	46	4	p<0.05	p<0.05	NOUN
bjp-16772	46	5	value	value	NOUN
bjp-16772	46	6	was	be	AUX
bjp-16772	46	7	considered	consider	VERB
bjp-16772	46	8	significant	significant	ADJ
bjp-16772	46	9	.	.	PUNCT
bjp-16772	47	1	all	all	DET
bjp-16772	47	2	statistical	statistical	ADJ
bjp-16772	47	3	analysis	analysis	NOUN
bjp-16772	47	4	was	be	AUX
bjp-16772	47	5	carried	carry	VERB
bjp-16772	47	6	out	out	ADP
bjp-16772	47	7	using	use	VERB
bjp-16772	47	8	the	the	DET
bjp-16772	47	9	spss	spss	PROPN
bjp-16772	47	10	version	version	NOUN
bjp-16772	47	11	17.0	17.0	NUM
bjp-16772	47	12	software	software	NOUN
bjp-16772	47	13	.	.	PUNCT
bjp-16772	48	1	any	any	DET
bjp-16772	48	2	records	record	NOUN
bjp-16772	48	3	for	for	ADP
bjp-16772	48	4	a	a	DET
bjp-16772	48	5	patient	patient	NOUN
bjp-16772	48	6	,	,	PUNCT
bjp-16772	48	7	dead	dead	ADJ
bjp-16772	48	8	or	or	CCONJ
bjp-16772	48	9	moved	move	VERB
bjp-16772	48	10	from	from	ADP
bjp-16772	48	11	the	the	DET
bjp-16772	48	12	practice	practice	NOUN
bjp-16772	48	13	following	follow	VERB
bjp-16772	48	14	discontinuation	discontinuation	NOUN
bjp-16772	48	15	of	of	ADP
bjp-16772	48	16	the	the	DET
bjp-16772	48	17	drug	drug	NOUN
bjp-16772	48	18	were	be	AUX
bjp-16772	48	19	excluded	exclude	VERB
bjp-16772	48	20	from	from	ADP
bjp-16772	48	21	the	the	DET
bjp-16772	48	22	analysis	analysis	NOUN
bjp-16772	48	23	.	.	PUNCT
bjp-16772	49	1	the	the	DET
bjp-16772	49	2	study	study	NOUN
bjp-16772	49	3	did	do	AUX
bjp-16772	49	4	not	not	PART
bjp-16772	49	5	require	require	VERB
bjp-16772	49	6	ethical	ethical	ADJ
bjp-16772	49	7	approval	approval	NOUN
bjp-16772	49	8	but	but	CCONJ
bjp-16772	49	9	it	it	PRON
bjp-16772	49	10	was	be	AUX
bjp-16772	49	11	reviewed	review	VERB
bjp-16772	49	12	and	and	CCONJ
bjp-16772	49	13	approved	approve	VERB
bjp-16772	49	14	by	by	ADP
bjp-16772	49	15	the	the	DET
bjp-16772	49	16	primary	primary	ADJ
bjp-16772	49	17	care	care	NOUN
bjp-16772	49	18	clinical	clinical	ADJ
bjp-16772	49	19	information	information	NOUN
bjp-16772	49	20	unit	unit	NOUN
bjp-16772	49	21	(	(	PUNCT
bjp-16772	49	22	pcciu	pcciu	PROPN
bjp-16772	49	23	)	)	PUNCT
bjp-16772	49	24	advisory	advisory	ADJ
bjp-16772	49	25	group	group	NOUN
bjp-16772	49	26	.	.	PUNCT
bjp-16772	50	1	results	result	VERB
bjp-16772	50	2	interrogation	interrogation	NOUN
bjp-16772	50	3	of	of	ADP
bjp-16772	50	4	the	the	DET
bjp-16772	50	5	pcciu	pcciu	ADJ
bjp-16772	50	6	electronic	electronic	ADJ
bjp-16772	50	7	prescribing	prescribing	NOUN
bjp-16772	50	8	database	database	NOUN
bjp-16772	50	9	identified	identify	VERB
bjp-16772	50	10	191370	191370	NUM
bjp-16772	50	11	patients	patient	NOUN
bjp-16772	50	12	prescribed	prescribe	VERB
bjp-16772	50	13	statins	statin	NOUN
bjp-16772	50	14	between	between	ADP
bjp-16772	50	15	march	march	PROPN
bjp-16772	50	16	2005	2005	NUM
bjp-16772	50	17	to	to	ADP
bjp-16772	51	1	february	february	PROPN
bjp-16772	51	2	2010	2010	NUM
bjp-16772	51	3	,	,	PUNCT
bjp-16772	51	4	in	in	ADP
bjp-16772	51	5	which	which	PRON
bjp-16772	51	6	120,278	120,278	NUM
bjp-16772	51	7	(	(	PUNCT
bjp-16772	51	8	63	63	NUM
bjp-16772	51	9	%	%	NOUN
bjp-16772	51	10	)	)	PUNCT
bjp-16772	51	11	patients	patient	NOUN
bjp-16772	51	12	were	be	AUX
bjp-16772	51	13	prescribed	prescribe	VERB
bjp-16772	51	14	simvastatin	simvastatin	NOUN
bjp-16772	51	15	,	,	PUNCT
bjp-16772	51	16	52125	52125	NUM
bjp-16772	51	17	(	(	PUNCT
bjp-16772	51	18	27	27	NUM
bjp-16772	51	19	%	%	NOUN
bjp-16772	51	20	)	)	PUNCT
bjp-16772	51	21	patients	patient	NOUN
bjp-16772	51	22	prescribed	prescribe	VERB
bjp-16772	51	23	atorvastatin	atorvastatin	NOUN
bjp-16772	51	24	,	,	PUNCT
bjp-16772	51	25	10247	10247	NUM
bjp-16772	51	26	(	(	PUNCT
bjp-16772	51	27	5	5	NUM
bjp-16772	51	28	%	%	NOUN
bjp-16772	51	29	)	)	PUNCT
bjp-16772	51	30	patients	patient	NOUN
bjp-16772	51	31	prescribed	prescribe	VERB
bjp-16772	51	32	pravastatin	pravastatin	NOUN
bjp-16772	51	33	,	,	PUNCT
bjp-16772	51	34	8005	8005	NUM
bjp-16772	51	35	(	(	PUNCT
bjp-16772	51	36	4	4	NUM
bjp-16772	51	37	%	%	NOUN
bjp-16772	51	38	)	)	PUNCT
bjp-16772	51	39	patients	patient	NOUN
bjp-16772	51	40	prescribed	prescribe	VERB
bjp-16772	51	41	rosuvastatin	rosuvastatin	NOUN
bjp-16772	51	42	and	and	CCONJ
bjp-16772	51	43	715	715	NUM
bjp-16772	51	44	(	(	PUNCT
bjp-16772	51	45	1	1	NUM
bjp-16772	51	46	%	%	NOUN
bjp-16772	51	47	)	)	PUNCT
bjp-16772	51	48	patients	patient	NOUN
bjp-16772	51	49	prescribed	prescribe	VERB
bjp-16772	51	50	fluvastatin	fluvastatin	NOUN
bjp-16772	51	51	.	.	PUNCT
bjp-16772	52	1	52	52	NUM
bjp-16772	52	2	%	%	NOUN
bjp-16772	52	3	patients	patient	NOUN
bjp-16772	52	4	were	be	AUX
bjp-16772	52	5	males	male	NOUN
bjp-16772	52	6	and	and	CCONJ
bjp-16772	52	7	48	48	NUM
bjp-16772	52	8	%	%	NOUN
bjp-16772	52	9	were	be	AUX
bjp-16772	52	10	female	female	ADJ
bjp-16772	52	11	.	.	PUNCT
bjp-16772	53	1	the	the	DET
bjp-16772	53	2	highest	high	ADJ
bjp-16772	53	3	proportion	proportion	NOUN
bjp-16772	53	4	of	of	ADP
bjp-16772	53	5	patients	patient	NOUN
bjp-16772	53	6	30	30	NUM
bjp-16772	53	7	%	%	NOUN
bjp-16772	53	8	were	be	AUX
bjp-16772	53	9	in	in	ADP
bjp-16772	53	10	61	61	NUM
bjp-16772	53	11	-	-	SYM
bjp-16772	53	12	70	70	NUM
bjp-16772	53	13	year	year	NOUN
bjp-16772	53	14	age	age	NOUN
bjp-16772	53	15	group	group	NOUN
bjp-16772	53	16	and	and	CCONJ
bjp-16772	53	17	the	the	DET
bjp-16772	53	18	lowest	low	ADJ
bjp-16772	53	19	proportion	proportion	NOUN
bjp-16772	53	20	2	2	NUM
bjp-16772	53	21	%	%	NOUN
bjp-16772	53	22	were	be	AUX
bjp-16772	53	23	in	in	ADP
bjp-16772	53	24	<	<	X
bjp-16772	53	25	=	=	SYM
bjp-16772	53	26	40	40	NUM
bjp-16772	53	27	year	year	NOUN
bjp-16772	53	28	age	age	NOUN
bjp-16772	53	29	group	group	NOUN
bjp-16772	53	30	.	.	PUNCT
bjp-16772	54	1	the	the	DET
bjp-16772	54	2	mean	mean	ADJ
bjp-16772	54	3	,	,	PUNCT
bjp-16772	54	4	median	median	ADJ
bjp-16772	54	5	age	age	NOUN
bjp-16772	54	6	and	and	CCONJ
bjp-16772	54	7	standard	standard	ADJ
bjp-16772	54	8	deviation	deviation	NOUN
bjp-16772	54	9	of	of	ADP
bjp-16772	54	10	patients	patient	NOUN
bjp-16772	54	11	those	those	PRON
bjp-16772	54	12	were	be	AUX
bjp-16772	54	13	prescribed	prescribe	VERB
bjp-16772	54	14	statins	statin	NOUN
bjp-16772	54	15	in	in	ADP
bjp-16772	54	16	the	the	DET
bjp-16772	54	17	study	study	NOUN
bjp-16772	54	18	period	period	NOUN
bjp-16772	54	19	are	be	AUX
bjp-16772	54	20	detailed	detail	VERB
bjp-16772	54	21	in	in	ADP
bjp-16772	54	22	table	table	NOUN
bjp-16772	54	23	i.	i.	NOUN
bjp-16772	54	24	patients	patient	NOUN
bjp-16772	54	25	those	those	PRON
bjp-16772	54	26	were	be	AUX
bjp-16772	54	27	prescribed	prescribe	VERB
bjp-16772	54	28	simvastatin	simvastatin	NOUN
bjp-16772	54	29	and	and	CCONJ
bjp-16772	54	30	atorvastatin	atorvastatin	NOUN
bjp-16772	54	31	,	,	PUNCT
bjp-16772	54	32	48	48	NUM
bjp-16772	54	33	%	%	NOUN
bjp-16772	54	34	(	(	PUNCT
bjp-16772	54	35	57,720	57,720	NUM
bjp-16772	54	36	)	)	PUNCT
bjp-16772	54	37	and	and	CCONJ
bjp-16772	54	38	49	49	NUM
bjp-16772	54	39	%	%	NOUN
bjp-16772	54	40	(	(	PUNCT
bjp-16772	54	41	25,652	25,652	NUM
bjp-16772	54	42	)	)	PUNCT
bjp-16772	54	43	were	be	AUX
bjp-16772	54	44	females	female	NOUN
bjp-16772	54	45	respectively	respectively	ADV
bjp-16772	54	46	with	with	ADP
bjp-16772	54	47	the	the	DET
bjp-16772	54	48	highest	high	ADJ
bjp-16772	54	49	proportion	proportion	NOUN
bjp-16772	54	50	lies	lie	VERB
bjp-16772	54	51	in	in	ADP
bjp-16772	54	52	the	the	DET
bjp-16772	54	53	7180	7180	NUM
bjp-16772	54	54	years	year	NOUN
bjp-16772	54	55	age	age	NOUN
bjp-16772	54	56	group	group	NOUN
bjp-16772	54	57	,	,	PUNCT
bjp-16772	54	58	while	while	SCONJ
bjp-16772	54	59	52	52	NUM
bjp-16772	54	60	%	%	NOUN
bjp-16772	54	61	(	(	PUNCT
bjp-16772	54	62	62,558	62,558	NUM
bjp-16772	54	63	)	)	PUNCT
bjp-16772	54	64	and	and	CCONJ
bjp-16772	54	65	51	51	NUM
bjp-16772	54	66	%	%	NOUN
bjp-16772	54	67	(	(	PUNCT
bjp-16772	54	68	26,473	26,473	NUM
bjp-16772	54	69	)	)	PUNCT
bjp-16772	54	70	were	be	AUX
bjp-16772	54	71	males	male	NOUN
bjp-16772	54	72	accordingly	accordingly	ADV
bjp-16772	54	73	with	with	ADP
bjp-16772	54	74	the	the	DET
bjp-16772	54	75	highest	high	ADJ
bjp-16772	54	76	proportion	proportion	NOUN
bjp-16772	54	77	in	in	ADP
bjp-16772	54	78	the	the	DET
bjp-16772	54	79	61	61	NUM
bjp-16772	54	80	-	-	SYM
bjp-16772	54	81	70	70	NUM
bjp-16772	54	82	years	year	NOUN
bjp-16772	54	83	group	group	NOUN
bjp-16772	54	84	for	for	ADP
bjp-16772	54	85	both	both	DET
bjp-16772	54	86	the	the	DET
bjp-16772	54	87	drugs	drug	NOUN
bjp-16772	54	88	.	.	PUNCT
bjp-16772	55	1	for	for	ADP
bjp-16772	55	2	rosuvastatin	rosuvastatin	NOUN
bjp-16772	55	3	,	,	PUNCT
bjp-16772	55	4	pravastatin	pravastatin	NOUN
bjp-16772	55	5	and	and	CCONJ
bjp-16772	55	6	fluvastatin	fluvastatin	NOUN
bjp-16772	55	7	49	49	NUM
bjp-16772	55	8	%	%	NOUN
bjp-16772	55	9	female	female	ADJ
bjp-16772	55	10	and	and	CCONJ
bjp-16772	55	11	51	51	NUM
bjp-16772	55	12	%	%	NOUN
bjp-16772	55	13	male	male	NOUN
bjp-16772	55	14	were	be	AUX
bjp-16772	55	15	prescribed	prescribe	VERB
bjp-16772	55	16	individual	individual	ADJ
bjp-16772	55	17	drugs	drug	NOUN
bjp-16772	55	18	,	,	PUNCT
bjp-16772	55	19	with	with	SCONJ
bjp-16772	55	20	the	the	DET
bjp-16772	55	21	highest	high	ADJ
bjp-16772	55	22	proportion	proportion	NOUN
bjp-16772	55	23	lies	lie	VERB
bjp-16772	55	24	in	in	ADP
bjp-16772	55	25	the	the	DET
bjp-16772	55	26	71	71	NUM
bjp-16772	55	27	-	-	SYM
bjp-16772	55	28	80	80	NUM
bjp-16772	55	29	years	year	NOUN
bjp-16772	55	30	age	age	NOUN
bjp-16772	55	31	group	group	NOUN
bjp-16772	55	32	in	in	ADP
bjp-16772	55	33	both	both	CCONJ
bjp-16772	55	34	the	the	DET
bjp-16772	55	35	gender	gender	NOUN
bjp-16772	55	36	(	(	PUNCT
bjp-16772	55	37	table	table	NOUN
bjp-16772	55	38	i	i	NOUN
bjp-16772	55	39	)	)	PUNCT
bjp-16772	55	40	.	.	PUNCT
bjp-16772	56	1	prescriptions	prescription	NOUN
bjp-16772	56	2	for	for	ADP
bjp-16772	56	3	simvastatin	simvastatin	NOUN
bjp-16772	56	4	,	,	PUNCT
bjp-16772	56	5	atorvastatin	atorvastatin	PROPN
bjp-16772	56	6	,	,	PUNCT
bjp-16772	56	7	rosuvastatin	rosuvastatin	NOUN
bjp-16772	56	8	increased	increase	VERB
bjp-16772	56	9	gradually	gradually	ADV
bjp-16772	56	10	from	from	ADP
bjp-16772	56	11	01/09/2005	01/09/2005	NUM
bjp-16772	56	12	to	to	ADP
bjp-16772	56	13	01/09/2009	01/09/2009	NUM
bjp-16772	56	14	402	402	NUM
bjp-16772	56	15	bangladesh	bangladesh	NOUN
bjp-16772	56	16	j	j	PROPN
bjp-16772	56	17	pharmacol	pharmacol	PROPN
bjp-16772	56	18	2013	2013	NUM
bjp-16772	56	19	;	;	PUNCT
bjp-16772	56	20	8	8	NUM
bjp-16772	56	21	:	:	SYM
bjp-16772	56	22	401	401	NUM
bjp-16772	56	23	-	-	SYM
bjp-16772	56	24	409	409	NUM
bjp-16772	56	25	(	(	PUNCT
bjp-16772	56	26	figure	figure	NOUN
bjp-16772	56	27	1	1	NUM
bjp-16772	56	28	)	)	PUNCT
bjp-16772	56	29	.	.	PUNCT
bjp-16772	57	1	this	this	DET
bjp-16772	57	2	changes	change	NOUN
bjp-16772	57	3	in	in	ADP
bjp-16772	57	4	the	the	DET
bjp-16772	57	5	prevalence	prevalence	NOUN
bjp-16772	57	6	rate	rate	NOUN
bjp-16772	57	7	for	for	ADP
bjp-16772	57	8	the	the	DET
bjp-16772	57	9	above	above	ADJ
bjp-16772	57	10	three	three	NUM
bjp-16772	57	11	prescribed	prescribe	VERB
bjp-16772	57	12	statins	statin	NOUN
bjp-16772	57	13	was	be	AUX
bjp-16772	57	14	significantly	significantly	ADV
bjp-16772	57	15	higher	high	ADJ
bjp-16772	57	16	(	(	PUNCT
bjp-16772	57	17	p<0.05	p<0.05	NOUN
bjp-16772	57	18	)	)	PUNCT
bjp-16772	57	19	at	at	ADP
bjp-16772	57	20	all	all	DET
bjp-16772	57	21	the	the	DET
bjp-16772	57	22	time	time	NOUN
bjp-16772	57	23	points	point	NOUN
bjp-16772	57	24	over	over	ADP
bjp-16772	57	25	the	the	DET
bjp-16772	57	26	five	five	NUM
bjp-16772	57	27	year	year	NOUN
bjp-16772	57	28	study	study	NOUN
bjp-16772	57	29	period	period	NOUN
bjp-16772	57	30	,	,	PUNCT
bjp-16772	57	31	while	while	SCONJ
bjp-16772	57	32	the	the	DET
bjp-16772	57	33	prevalence	prevalence	NOUN
bjp-16772	57	34	rate	rate	NOUN
bjp-16772	57	35	of	of	ADP
bjp-16772	57	36	pravastatin	pravastatin	NOUN
bjp-16772	57	37	and	and	CCONJ
bjp-16772	57	38	fluvastatin	fluvastatin	NOUN
bjp-16772	57	39	prescriptions	prescription	NOUN
bjp-16772	57	40	significantly	significantly	ADV
bjp-16772	57	41	dropped	drop	VERB
bjp-16772	57	42	(	(	PUNCT
bjp-16772	57	43	p<0.05	p<0.05	NOUN
bjp-16772	57	44	)	)	PUNCT
bjp-16772	57	45	.	.	PUNCT
bjp-16772	58	1	however	however	ADV
bjp-16772	58	2	,	,	PUNCT
bjp-16772	58	3	the	the	DET
bjp-16772	58	4	cumulative	cumulative	ADJ
bjp-16772	58	5	changes	change	NOUN
bjp-16772	58	6	in	in	ADP
bjp-16772	58	7	the	the	DET
bjp-16772	58	8	prevalence	prevalence	NOUN
bjp-16772	58	9	rate	rate	NOUN
bjp-16772	58	10	for	for	ADP
bjp-16772	58	11	all	all	DET
bjp-16772	58	12	the	the	DET
bjp-16772	58	13	statin	statin	PROPN
bjp-16772	58	14	prescriptions	prescription	NOUN
bjp-16772	58	15	was	be	AUX
bjp-16772	58	16	significantly	significantly	ADV
bjp-16772	58	17	higher	high	ADJ
bjp-16772	58	18	(	(	PUNCT
bjp-16772	58	19	p<0.05	p<0.05	NOUN
bjp-16772	58	20	)	)	PUNCT
bjp-16772	58	21	in	in	ADP
bjp-16772	58	22	the	the	DET
bjp-16772	58	23	observed	observed	ADJ
bjp-16772	58	24	period	period	NOUN
bjp-16772	58	25	.	.	PUNCT
bjp-16772	59	1	(	(	PUNCT
bjp-16772	59	2	figure	figure	NOUN
bjp-16772	59	3	1	1	NUM
bjp-16772	59	4	)	)	PUNCT
bjp-16772	59	5	.	.	PUNCT
bjp-16772	60	1	new	new	ADJ
bjp-16772	60	2	prescriptions	prescription	NOUN
bjp-16772	60	3	for	for	ADP
bjp-16772	60	4	individual	individual	ADJ
bjp-16772	60	5	statin	statin	PROPN
bjp-16772	60	6	reduced	reduce	VERB
bjp-16772	60	7	over	over	ADP
bjp-16772	60	8	the	the	DET
bjp-16772	60	9	study	study	NOUN
bjp-16772	60	10	period	period	NOUN
bjp-16772	60	11	.	.	PUNCT
bjp-16772	61	1	this	this	PRON
bjp-16772	61	2	shifting	shift	VERB
bjp-16772	61	3	in	in	ADP
bjp-16772	61	4	the	the	DET
bjp-16772	61	5	incidence	incidence	NOUN
bjp-16772	61	6	rate	rate	NOUN
bjp-16772	61	7	for	for	ADP
bjp-16772	61	8	the	the	DET
bjp-16772	61	9	individual	individual	ADJ
bjp-16772	61	10	statin	statin	PROPN
bjp-16772	61	11	except	except	SCONJ
bjp-16772	61	12	rosuvastatin	rosuvastatin	NOUN
bjp-16772	61	13	was	be	AUX
bjp-16772	61	14	significant	significant	ADJ
bjp-16772	61	15	-ly	-ly	NOUN
bjp-16772	61	16	lower	low	ADJ
bjp-16772	61	17	(	(	PUNCT
bjp-16772	61	18	p<0.05	p<0.05	NOUN
bjp-16772	61	19	)	)	PUNCT
bjp-16772	61	20	at	at	ADP
bjp-16772	61	21	all	all	DET
bjp-16772	61	22	the	the	DET
bjp-16772	61	23	time	time	NOUN
bjp-16772	61	24	points	point	NOUN
bjp-16772	61	25	in	in	ADP
bjp-16772	61	26	the	the	DET
bjp-16772	61	27	study	study	NOUN
bjp-16772	61	28	frame	frame	NOUN
bjp-16772	61	29	.	.	PUNCT
bjp-16772	62	1	however	however	ADV
bjp-16772	62	2	,	,	PUNCT
bjp-16772	62	3	the	the	DET
bjp-16772	62	4	cumulative	cumulative	ADJ
bjp-16772	62	5	changes	change	NOUN
bjp-16772	62	6	in	in	ADP
bjp-16772	62	7	the	the	DET
bjp-16772	62	8	incidence	incidence	NOUN
bjp-16772	62	9	rate	rate	NOUN
bjp-16772	62	10	for	for	ADP
bjp-16772	62	11	all	all	DET
bjp-16772	62	12	the	the	DET
bjp-16772	62	13	statin	statin	PROPN
bjp-16772	62	14	prescriptions	prescription	NOUN
bjp-16772	62	15	was	be	AUX
bjp-16772	62	16	significantly	significantly	ADV
bjp-16772	62	17	lower	low	ADJ
bjp-16772	62	18	(	(	PUNCT
bjp-16772	62	19	p<0.05	p<0.05	NOUN
bjp-16772	62	20	)	)	PUNCT
bjp-16772	62	21	in	in	ADP
bjp-16772	62	22	our	our	PRON
bjp-16772	62	23	study	study	NOUN
bjp-16772	62	24	period	period	NOUN
bjp-16772	62	25	(	(	PUNCT
bjp-16772	62	26	figure	figure	NOUN
bjp-16772	62	27	2	2	NUM
bjp-16772	62	28	)	)	PUNCT
bjp-16772	62	29	.	.	PUNCT
bjp-16772	63	1	an	an	DET
bjp-16772	63	2	overall	overall	ADJ
bjp-16772	63	3	decrease	decrease	NOUN
bjp-16772	63	4	in	in	ADP
bjp-16772	63	5	the	the	DET
bjp-16772	63	6	percentages	percentage	NOUN
bjp-16772	63	7	of	of	ADP
bjp-16772	63	8	patients	patient	NOUN
bjp-16772	63	9	prescribed	prescribe	VERB
bjp-16772	63	10	high	high	ADJ
bjp-16772	63	11	dose	dose	PROPN
bjp-16772	63	12	(	(	PUNCT
bjp-16772	63	13	80	80	NUM
bjp-16772	63	14	mg	mg	NOUN
bjp-16772	63	15	)	)	PUNCT
bjp-16772	63	16	simvastatin	simvastatin	NOUN
bjp-16772	63	17	is	be	AUX
bjp-16772	63	18	visible	visible	ADJ
bjp-16772	63	19	.	.	PUNCT
bjp-16772	64	1	however	however	ADV
bjp-16772	64	2	,	,	PUNCT
bjp-16772	64	3	this	this	DET
bjp-16772	64	4	downward	downward	ADJ
bjp-16772	64	5	trend	trend	NOUN
bjp-16772	64	6	in	in	ADP
bjp-16772	64	7	the	the	DET
bjp-16772	64	8	percentages	percentage	NOUN
bjp-16772	64	9	of	of	ADP
bjp-16772	64	10	the	the	DET
bjp-16772	64	11	patients	patient	NOUN
bjp-16772	64	12	was	be	AUX
bjp-16772	64	13	not	not	PART
bjp-16772	64	14	significant	significant	ADJ
bjp-16772	64	15	(	(	PUNCT
bjp-16772	64	16	p>0.05	p>0.05	NOUN
bjp-16772	64	17	)	)	PUNCT
bjp-16772	64	18	in	in	ADP
bjp-16772	64	19	our	our	PRON
bjp-16772	64	20	study	study	NOUN
bjp-16772	64	21	period	period	NOUN
bjp-16772	64	22	(	(	PUNCT
bjp-16772	64	23	figure	figure	NOUN
bjp-16772	64	24	3	3	NUM
bjp-16772	64	25	)	)	PUNCT
bjp-16772	64	26	.	.	PUNCT
bjp-16772	65	1	among	among	ADP
bjp-16772	65	2	3712	3712	NUM
bjp-16772	65	3	patients	patient	NOUN
bjp-16772	65	4	prescribed	prescribe	VERB
bjp-16772	65	5	high	high	ADJ
bjp-16772	65	6	dose	dose	PROPN
bjp-16772	65	7	(	(	PUNCT
bjp-16772	65	8	80	80	NUM
bjp-16772	65	9	mg	mg	NOUN
bjp-16772	65	10	)	)	PUNCT
bjp-16772	65	11	simvastatin	simvastatin	NOUN
bjp-16772	65	12	,	,	PUNCT
bjp-16772	65	13	30	30	NUM
bjp-16772	65	14	%	%	NOUN
bjp-16772	65	15	(	(	PUNCT
bjp-16772	65	16	1097	1097	NUM
bjp-16772	65	17	)	)	PUNCT
bjp-16772	65	18	switched	switch	VERB
bjp-16772	65	19	to	to	ADP
bjp-16772	65	20	other	other	ADJ
bjp-16772	65	21	statin	statin	NOUN
bjp-16772	65	22	and	and	CCONJ
bjp-16772	65	23	of	of	ADP
bjp-16772	65	24	them	they	PRON
bjp-16772	65	25	maximum	maximum	ADJ
bjp-16772	65	26	number	number	NOUN
bjp-16772	65	27	884	884	NUM
bjp-16772	65	28	(	(	PUNCT
bjp-16772	65	29	24	24	NUM
bjp-16772	65	30	%	%	NOUN
bjp-16772	65	31	)	)	PUNCT
bjp-16772	65	32	switched	switch	VERB
bjp-16772	65	33	to	to	ADP
bjp-16772	65	34	atorvastatin	atorvastatin	NOUN
bjp-16772	65	35	(	(	PUNCT
bjp-16772	65	36	table	table	NOUN
bjp-16772	65	37	ii	ii	PROPN
bjp-16772	65	38	)	)	PUNCT
bjp-16772	65	39	.	.	PUNCT
bjp-16772	66	1	female	female	ADJ
bjp-16772	66	2	patients	patient	NOUN
bjp-16772	66	3	and	and	CCONJ
bjp-16772	66	4	particularly	particularly	ADV
bjp-16772	66	5	61	61	NUM
bjp-16772	66	6	-	-	SYM
bjp-16772	66	7	70	70	NUM
bjp-16772	66	8	years	year	NOUN
bjp-16772	66	9	age	age	NOUN
bjp-16772	66	10	band	band	NOUN
bjp-16772	66	11	were	be	AUX
bjp-16772	66	12	significantly	significantly	ADV
bjp-16772	66	13	more	more	ADV
bjp-16772	66	14	prescribed	prescribed	ADJ
bjp-16772	66	15	high	high	ADJ
bjp-16772	66	16	dose	dose	NOUN
bjp-16772	66	17	simvastatin	simvastatin	NOUN
bjp-16772	66	18	than	than	ADP
bjp-16772	66	19	males	male	NOUN
bjp-16772	66	20	(	(	PUNCT
bjp-16772	66	21	p<0.05	p<0.05	NOUN
bjp-16772	66	22	)	)	PUNCT
bjp-16772	66	23	(	(	PUNCT
bjp-16772	66	24	table	table	NOUN
bjp-16772	66	25	iii	iii	NOUN
bjp-16772	66	26	)	)	PUNCT
bjp-16772	66	27	.	.	PUNCT
bjp-16772	67	1	greater	great	ADJ
bjp-16772	67	2	portion	portion	NOUN
bjp-16772	67	3	(	(	PUNCT
bjp-16772	67	4	52	52	NUM
bjp-16772	67	5	%	%	NOUN
bjp-16772	67	6	)	)	PUNCT
bjp-16772	67	7	of	of	ADP
bjp-16772	67	8	the	the	DET
bjp-16772	67	9	patients	patient	NOUN
bjp-16772	67	10	switched	switch	VERB
bjp-16772	67	11	from	from	ADP
bjp-16772	67	12	high	high	ADJ
bjp-16772	67	13	dose	dose	NOUN
bjp-16772	67	14	were	be	AUX
bjp-16772	67	15	female	female	ADJ
bjp-16772	67	16	(	(	PUNCT
bjp-16772	67	17	p>0.05	p>0.05	PROPN
bjp-16772	67	18	)	)	PUNCT
bjp-16772	67	19	.	.	PUNCT
bjp-16772	68	1	patients	patient	NOUN
bjp-16772	68	2	in	in	ADP
bjp-16772	68	3	the	the	DET
bjp-16772	68	4	age	age	NOUN
bjp-16772	68	5	group	group	NOUN
bjp-16772	68	6	of	of	ADP
bjp-16772	68	7	61	61	NUM
bjp-16772	68	8	-	-	SYM
bjp-16772	68	9	70	70	NUM
bjp-16772	68	10	years	year	NOUN
bjp-16772	68	11	,	,	PUNCT
bjp-16772	68	12	significantly	significantly	ADV
bjp-16772	68	13	more	more	ADV
bjp-16772	68	14	switched	switch	VERB
bjp-16772	68	15	to	to	ADP
bjp-16772	68	16	low	low	ADJ
bjp-16772	68	17	dose	dose	PROPN
bjp-16772	68	18	(	(	PUNCT
bjp-16772	68	19	p<0.05	p<0.05	PROPN
bjp-16772	68	20	)	)	PUNCT
bjp-16772	68	21	(	(	PUNCT
bjp-16772	68	22	table	table	NOUN
bjp-16772	68	23	iv	iv	NUM
bjp-16772	68	24	)	)	PUNCT
bjp-16772	68	25	.	.	PUNCT
bjp-16772	69	1	discussion	discussion	NOUN
bjp-16772	69	2	cvd	cvd	PROPN
bjp-16772	69	3	is	be	AUX
bjp-16772	69	4	a	a	DET
bjp-16772	69	5	major	major	ADJ
bjp-16772	69	6	cause	cause	NOUN
bjp-16772	69	7	of	of	ADP
bjp-16772	69	8	mortality	mortality	NOUN
bjp-16772	69	9	and	and	CCONJ
bjp-16772	69	10	morbidity	morbidity	NOUN
bjp-16772	69	11	worldwide	worldwide	ADV
bjp-16772	69	12	as	as	ADV
bjp-16772	69	13	well	well	ADV
bjp-16772	69	14	as	as	ADP
bjp-16772	69	15	in	in	ADP
bjp-16772	69	16	the	the	DET
bjp-16772	69	17	uk	uk	PROPN
bjp-16772	69	18	.	.	PROPN
bjp-16772	70	1	in	in	ADP
bjp-16772	70	2	the	the	DET
bjp-16772	70	3	year	year	NOUN
bjp-16772	70	4	2000	2000	NUM
bjp-16772	70	5	,	,	PUNCT
bjp-16772	70	6	death	death	NOUN
bjp-16772	70	7	from	from	ADP
bjp-16772	70	8	cvd	cvd	PROPN
bjp-16772	70	9	accounted	account	VERB
bjp-16772	70	10	for	for	ADP
bjp-16772	70	11	approximately	approximately	ADV
bjp-16772	70	12	125000	125000	NUM
bjp-16772	70	13	in	in	ADP
bjp-16772	70	14	the	the	DET
bjp-16772	70	15	uk	uk	PROPN
bjp-16772	70	16	(	(	PUNCT
bjp-16772	70	17	wilson	wilson	PROPN
bjp-16772	70	18	et	et	PROPN
bjp-16772	70	19	al	al	PROPN
bjp-16772	70	20	.	.	PROPN
bjp-16772	70	21	,	,	PUNCT
bjp-16772	70	22	2003	2003	NUM
bjp-16772	70	23	)	)	PUNCT
bjp-16772	70	24	.	.	PUNCT
bjp-16772	71	1	although	although	SCONJ
bjp-16772	71	2	coronary	coronary	ADJ
bjp-16772	71	3	heart	heart	NOUN
bjp-16772	71	4	disease	disease	NOUN
bjp-16772	71	5	mortality	mortality	NOUN
bjp-16772	71	6	rates	rate	NOUN
bjp-16772	71	7	have	have	AUX
bjp-16772	71	8	dropped	drop	VERB
bjp-16772	71	9	in	in	ADP
bjp-16772	71	10	recent	recent	ADJ
bjp-16772	71	11	years	year	NOUN
bjp-16772	71	12	in	in	ADP
bjp-16772	71	13	the	the	DET
bjp-16772	71	14	uk	uk	PROPN
bjp-16772	71	15	,	,	PUNCT
bjp-16772	71	16	they	they	PRON
bjp-16772	71	17	remain	remain	VERB
bjp-16772	71	18	still	still	ADV
bjp-16772	71	19	higher	high	ADJ
bjp-16772	71	20	than	than	ADP
bjp-16772	71	21	the	the	DET
bjp-16772	71	22	rest	rest	NOUN
bjp-16772	71	23	of	of	ADP
bjp-16772	71	24	the	the	DET
bjp-16772	71	25	world	world	NOUN
bjp-16772	71	26	.	.	PUNCT
bjp-16772	72	1	incidence	incidence	NOUN
bjp-16772	72	2	of	of	ADP
bjp-16772	72	3	cvd	cvd	PROPN
bjp-16772	72	4	events	event	NOUN
bjp-16772	72	5	is	be	AUX
bjp-16772	72	6	more	more	ADV
bjp-16772	72	7	frequent	frequent	ADJ
bjp-16772	72	8	in	in	ADP
bjp-16772	72	9	younger	young	ADJ
bjp-16772	72	10	male	male	NOUN
bjp-16772	72	11	than	than	ADP
bjp-16772	72	12	female	female	ADJ
bjp-16772	72	13	due	due	ADJ
bjp-16772	72	14	to	to	ADP
bjp-16772	72	15	total	total	ADJ
bjp-16772	72	16	cholesterol	cholesterol	NOUN
bjp-16772	72	17	level	level	NOUN
bjp-16772	72	18	increases	increase	VERB
bjp-16772	72	19	steadily	steadily	ADV
bjp-16772	72	20	in	in	ADP
bjp-16772	72	21	males	male	NOUN
bjp-16772	72	22	after	after	ADP
bjp-16772	72	23	the	the	DET
bjp-16772	72	24	onset	onset	NOUN
bjp-16772	72	25	of	of	ADP
bjp-16772	72	26	puberty	puberty	NOUN
bjp-16772	72	27	till	till	SCONJ
bjp-16772	72	28	the	the	DET
bjp-16772	72	29	age	age	NOUN
bjp-16772	72	30	of	of	ADP
bjp-16772	72	31	50	50	NUM
bjp-16772	72	32	,	,	PUNCT
bjp-16772	72	33	then	then	ADV
bjp-16772	72	34	remains	remain	VERB
bjp-16772	72	35	static	static	ADJ
bjp-16772	72	36	until	until	ADP
bjp-16772	72	37	70	70	NUM
bjp-16772	72	38	years	year	NOUN
bjp-16772	72	39	(	(	PUNCT
bjp-16772	72	40	arnlov	arnlov	PROPN
bjp-16772	72	41	et	et	PROPN
bjp-16772	72	42	al	al	PROPN
bjp-16772	72	43	.	.	PROPN
bjp-16772	72	44	,	,	PUNCT
bjp-16772	72	45	2006	2006	NUM
bjp-16772	72	46	)	)	PUNCT
bjp-16772	72	47	.	.	PUNCT
bjp-16772	73	1	indeed	indeed	ADV
bjp-16772	73	2	,	,	PUNCT
bjp-16772	73	3	sex	sex	NOUN
bjp-16772	73	4	hormones	hormone	NOUN
bjp-16772	73	5	accompanied	accompany	VERB
bjp-16772	73	6	with	with	ADP
bjp-16772	73	7	hypercholesterolemia	hypercholesterolemia	NOUN
bjp-16772	73	8	and	and	CCONJ
bjp-16772	73	9	the	the	DET
bjp-16772	73	10	genetic	genetic	ADJ
bjp-16772	73	11	deficiency	deficiency	NOUN
bjp-16772	73	12	of	of	ADP
bjp-16772	73	13	bangladesh	bangladesh	PROPN
bjp-16772	73	14	j	j	PROPN
bjp-16772	73	15	pharmacol	pharmacol	PROPN
bjp-16772	73	16	2013	2013	NUM
bjp-16772	73	17	;	;	PUNCT
bjp-16772	73	18	8	8	NUM
bjp-16772	73	19	:	:	SYM
bjp-16772	73	20	401	401	NUM
bjp-16772	73	21	-	-	SYM
bjp-16772	73	22	409	409	NUM
bjp-16772	73	23	403	403	NUM
bjp-16772	73	24	table	table	NOUN
bjp-16772	73	25	i	i	PRON
bjp-16772	73	26	proportion	proportion	NOUN
bjp-16772	73	27	and	and	CCONJ
bjp-16772	73	28	mean	mean	ADJ
bjp-16772	73	29	/	/	SYM
bjp-16772	73	30	median	median	ADJ
bjp-16772	73	31	age	age	NOUN
bjp-16772	73	32	of	of	ADP
bjp-16772	73	33	female	female	ADJ
bjp-16772	73	34	and	and	CCONJ
bjp-16772	73	35	male	male	ADJ
bjp-16772	73	36	patients	patient	NOUN
bjp-16772	73	37	prescribed	prescribe	VERB
bjp-16772	73	38	five	five	NUM
bjp-16772	73	39	statins	statin	NOUN
bjp-16772	73	40	in	in	ADP
bjp-16772	73	41	different	different	ADJ
bjp-16772	73	42	age	age	NOUN
bjp-16772	73	43	group	group	NOUN
bjp-16772	73	44	from	from	ADP
bjp-16772	73	45	march	march	PROPN
bjp-16772	73	46	2005	2005	NUM
bjp-16772	73	47	to	to	ADP
bjp-16772	73	48	february	february	PROPN
bjp-16772	73	49	2010	2010	NUM
bjp-16772	73	50	drug	drug	NOUN
bjp-16772	73	51	mean/	mean/	NUM
bjp-16772	73	52	median	median	NOUN
bjp-16772	73	53	age	age	NOUN
bjp-16772	73	54	age	age	NOUN
bjp-16772	73	55	category	category	NOUN
bjp-16772	73	56	<	<	X
bjp-16772	73	57	=	=	ADJ
bjp-16772	73	58	40	40	NUM
bjp-16772	73	59	41	41	NUM
bjp-16772	73	60	-	-	SYM
bjp-16772	73	61	50	50	NUM
bjp-16772	73	62	51	51	NUM
bjp-16772	73	63	-	-	SYM
bjp-16772	73	64	60	60	NUM
bjp-16772	73	65	61	61	NUM
bjp-16772	73	66	-	-	SYM
bjp-16772	73	67	70	70	NUM
bjp-16772	73	68	71	71	NUM
bjp-16772	73	69	-	-	SYM
bjp-16772	73	70	80	80	NUM
bjp-16772	73	71	>	>	SYM
bjp-16772	73	72	80	80	NUM
bjp-16772	73	73	simvastatin	simvastatin	ADJ
bjp-16772	73	74	female	female	ADJ
bjp-16772	73	75	810	810	NUM
bjp-16772	73	76	(	(	PUNCT
bjp-16772	73	77	0.7	0.7	NUM
bjp-16772	73	78	)	)	PUNCT
bjp-16772	73	79	3,347	3,347	NUM
bjp-16772	73	80	(	(	PUNCT
bjp-16772	73	81	2.8	2.8	NUM
bjp-16772	73	82	)	)	PUNCT
bjp-16772	73	83	9,239	9,239	NUM
bjp-16772	73	84	(	(	PUNCT
bjp-16772	73	85	7.7	7.7	NUM
bjp-16772	73	86	)	)	PUNCT
bjp-16772	73	87	15,767	15,767	NUM
bjp-16772	73	88	(	(	PUNCT
bjp-16772	73	89	13.1	13.1	NUM
bjp-16772	73	90	)	)	PUNCT
bjp-16772	73	91	16,893	16,893	NUM
bjp-16772	73	92	(	(	PUNCT
bjp-16772	73	93	14.0	14.0	NUM
bjp-16772	73	94	)	)	PUNCT
bjp-16772	73	95	11,664	11,664	NUM
bjp-16772	73	96	(	(	PUNCT
bjp-16772	73	97	9.7	9.7	NUM
bjp-16772	73	98	)	)	PUNCT
bjp-16772	73	99	69.4	69.4	NUM
bjp-16772	73	100	(	(	PUNCT
bjp-16772	73	101	12.3	12.3	NUM
bjp-16772	73	102	)	)	PUNCT
bjp-16772	73	103	male	male	NOUN
bjp-16772	73	104	1416	1416	NUM
bjp-16772	73	105	(	(	PUNCT
bjp-16772	73	106	1.2	1.2	NUM
bjp-16772	73	107	)	)	PUNCT
bjp-16772	73	108	5710	5710	NUM
bjp-16772	73	109	(	(	PUNCT
bjp-16772	73	110	4.7	4.7	NUM
bjp-16772	73	111	)	)	PUNCT
bjp-16772	73	112	13259	13259	NUM
bjp-16772	73	113	(	(	PUNCT
bjp-16772	73	114	11.0	11.0	NUM
bjp-16772	73	115	)	)	PUNCT
bjp-16772	73	116	18981	18981	NUM
bjp-16772	73	117	(	(	PUNCT
bjp-16772	73	118	15.8	15.8	NUM
bjp-16772	73	119	)	)	PUNCT
bjp-16772	73	120	15858	15858	NUM
bjp-16772	73	121	(	(	PUNCT
bjp-16772	73	122	13.2	13.2	NUM
bjp-16772	73	123	)	)	PUNCT
bjp-16772	73	124	7334	7334	NUM
bjp-16772	73	125	(	(	PUNCT
bjp-16772	73	126	6.1	6.1	NUM
bjp-16772	73	127	)	)	PUNCT
bjp-16772	73	128	65.8	65.8	NUM
bjp-16772	73	129	(	(	PUNCT
bjp-16772	73	130	12.2	12.2	NUM
bjp-16772	73	131	)	)	PUNCT
bjp-16772	73	132	atorvastatin	atorvastatin	NOUN
bjp-16772	73	133	female	female	ADJ
bjp-16772	73	134	320	320	NUM
bjp-16772	73	135	(	(	PUNCT
bjp-16772	73	136	0.6	0.6	NUM
bjp-16772	73	137	)	)	PUNCT
bjp-16772	73	138	1424	1424	NUM
bjp-16772	73	139	(	(	PUNCT
bjp-16772	73	140	2.7	2.7	NUM
bjp-16772	73	141	)	)	PUNCT
bjp-16772	73	142	4234	4234	NUM
bjp-16772	73	143	(	(	PUNCT
bjp-16772	73	144	8.1	8.1	NUM
bjp-16772	73	145	)	)	PUNCT
bjp-16772	73	146	7672	7672	NUM
bjp-16772	73	147	(	(	PUNCT
bjp-16772	73	148	14.7	14.7	NUM
bjp-16772	73	149	)	)	PUNCT
bjp-16772	73	150	7880	7880	NUM
bjp-16772	73	151	(	(	PUNCT
bjp-16772	73	152	15.1	15.1	NUM
bjp-16772	73	153	)	)	PUNCT
bjp-16772	73	154	4122	4122	NUM
bjp-16772	73	155	(	(	PUNCT
bjp-16772	73	156	7.9	7.9	NUM
bjp-16772	73	157	)	)	PUNCT
bjp-16772	73	158	70.0	70.0	NUM
bjp-16772	73	159	male	male	NOUN
bjp-16772	73	160	613	613	NUM
bjp-16772	73	161	(	(	PUNCT
bjp-16772	73	162	1.2	1.2	NUM
bjp-16772	73	163	)	)	PUNCT
bjp-16772	73	164	2548	2548	NUM
bjp-16772	73	165	(	(	PUNCT
bjp-16772	73	166	4.9	4.9	NUM
bjp-16772	73	167	)	)	PUNCT
bjp-16772	73	168	6155	6155	NUM
bjp-16772	73	169	(	(	PUNCT
bjp-16772	73	170	11.8	11.8	NUM
bjp-16772	73	171	)	)	PUNCT
bjp-16772	73	172	8485	8485	NUM
bjp-16772	73	173	(	(	PUNCT
bjp-16772	73	174	16.3	16.3	NUM
bjp-16772	73	175	)	)	PUNCT
bjp-16772	73	176	6458	6458	NUM
bjp-16772	73	177	(	(	PUNCT
bjp-16772	73	178	12.4	12.4	NUM
bjp-16772	73	179	)	)	PUNCT
bjp-16772	73	180	2214	2214	NUM
bjp-16772	73	181	(	(	PUNCT
bjp-16772	73	182	4.2	4.2	NUM
bjp-16772	73	183	)	)	PUNCT
bjp-16772	73	184	65.0	65.0	NUM
bjp-16772	73	185	rosuvastatin	rosuvastatin	ADJ
bjp-16772	73	186	female	female	NOUN
bjp-16772	73	187	60	60	NUM
bjp-16772	73	188	(	(	PUNCT
bjp-16772	73	189	0.7	0.7	NUM
bjp-16772	73	190	)	)	PUNCT
bjp-16772	73	191	253	253	NUM
bjp-16772	73	192	(	(	PUNCT
bjp-16772	73	193	3.2	3.2	NUM
bjp-16772	73	194	)	)	PUNCT
bjp-16772	73	195	754	754	NUM
bjp-16772	73	196	(	(	PUNCT
bjp-16772	73	197	9.4	9.4	NUM
bjp-16772	73	198	)	)	PUNCT
bjp-16772	73	199	754	754	NUM
bjp-16772	73	200	(	(	PUNCT
bjp-16772	73	201	9.4	9.4	NUM
bjp-16772	73	202	)	)	PUNCT
bjp-16772	73	203	1341	1341	NUM
bjp-16772	73	204	(	(	PUNCT
bjp-16772	73	205	16.8	16.8	NUM
bjp-16772	73	206	)	)	PUNCT
bjp-16772	73	207	429	429	NUM
bjp-16772	73	208	(	(	PUNCT
bjp-16772	73	209	5.4	5.4	NUM
bjp-16772	73	210	)	)	PUNCT
bjp-16772	73	211	66.8	66.8	NUM
bjp-16772	73	212	(	(	PUNCT
bjp-16772	73	213	11.2	11.2	NUM
bjp-16772	73	214	)	)	PUNCT
bjp-16772	73	215	male	male	NOUN
bjp-16772	73	216	124	124	NUM
bjp-16772	73	217	(	(	PUNCT
bjp-16772	73	218	1.5	1.5	NUM
bjp-16772	73	219	)	)	PUNCT
bjp-16772	73	220	485	485	NUM
bjp-16772	73	221	(	(	PUNCT
bjp-16772	73	222	6.1	6.1	NUM
bjp-16772	73	223	)	)	PUNCT
bjp-16772	73	224	1121	1121	NUM
bjp-16772	73	225	(	(	PUNCT
bjp-16772	73	226	14.0	14.0	NUM
bjp-16772	73	227	)	)	PUNCT
bjp-16772	73	228	1121	1121	NUM
bjp-16772	73	229	(	(	PUNCT
bjp-16772	73	230	14.0	14.0	NUM
bjp-16772	73	231	)	)	PUNCT
bjp-16772	73	232	1290	1290	NUM
bjp-16772	73	233	(	(	PUNCT
bjp-16772	73	234	16.1	16.1	NUM
bjp-16772	73	235	)	)	PUNCT
bjp-16772	73	236	208	208	NUM
bjp-16772	73	237	(	(	PUNCT
bjp-16772	73	238	2.6	2.6	NUM
bjp-16772	73	239	)	)	PUNCT
bjp-16772	73	240	62.4	62.4	NUM
bjp-16772	73	241	(	(	PUNCT
bjp-16772	73	242	11.4	11.4	NUM
bjp-16772	73	243	)	)	PUNCT
bjp-16772	73	244	pravastatin	pravastatin	NOUN
bjp-16772	73	245	female	female	NOUN
bjp-16772	73	246	40	40	NUM
bjp-16772	73	247	(	(	PUNCT
bjp-16772	73	248	0.4	0.4	NUM
bjp-16772	73	249	)	)	PUNCT
bjp-16772	73	250	170	170	NUM
bjp-16772	73	251	(	(	PUNCT
bjp-16772	73	252	1.7	1.7	NUM
bjp-16772	73	253	)	)	PUNCT
bjp-16772	73	254	623	623	NUM
bjp-16772	73	255	(	(	PUNCT
bjp-16772	73	256	6.1	6.1	NUM
bjp-16772	73	257	)	)	PUNCT
bjp-16772	73	258	623	623	NUM
bjp-16772	73	259	(	(	PUNCT
bjp-16772	73	260	6.1	6.1	NUM
bjp-16772	73	261	)	)	PUNCT
bjp-16772	73	262	1331	1331	NUM
bjp-16772	73	263	(	(	PUNCT
bjp-16772	73	264	13.0	13.0	NUM
bjp-16772	73	265	)	)	PUNCT
bjp-16772	73	266	1142	1142	NUM
bjp-16772	73	267	(	(	PUNCT
bjp-16772	73	268	11.1	11.1	NUM
bjp-16772	73	269	)	)	PUNCT
bjp-16772	73	270	73.0	73.0	NUM
bjp-16772	73	271	male	male	NOUN
bjp-16772	73	272	71	71	NUM
bjp-16772	73	273	(	(	PUNCT
bjp-16772	73	274	0.7	0.7	NUM
bjp-16772	73	275	)	)	PUNCT
bjp-16772	73	276	312	312	NUM
bjp-16772	73	277	(	(	PUNCT
bjp-16772	73	278	3.0	3.0	NUM
bjp-16772	73	279	)	)	PUNCT
bjp-16772	73	280	849	849	NUM
bjp-16772	73	281	(	(	PUNCT
bjp-16772	73	282	8.3	8.3	NUM
bjp-16772	73	283	)	)	PUNCT
bjp-16772	73	284	849	849	NUM
bjp-16772	73	285	(	(	PUNCT
bjp-16772	73	286	8.3	8.3	NUM
bjp-16772	73	287	)	)	PUNCT
bjp-16772	73	288	1568	1568	NUM
bjp-16772	73	289	(	(	PUNCT
bjp-16772	73	290	15.3	15.3	NUM
bjp-16772	73	291	)	)	PUNCT
bjp-16772	73	292	740	740	NUM
bjp-16772	73	293	(	(	PUNCT
bjp-16772	73	294	7.2	7.2	NUM
bjp-16772	73	295	)	)	PUNCT
bjp-16772	73	296	71.0	71.0	NUM
bjp-16772	73	297	fluvastatin	fluvastatin	NOUN
bjp-16772	73	298	female	female	NOUN
bjp-16772	73	299	4	4	NUM
bjp-16772	73	300	(	(	PUNCT
bjp-16772	73	301	0.6	0.6	NUM
bjp-16772	73	302	)	)	PUNCT
bjp-16772	73	303	17	17	NUM
bjp-16772	73	304	(	(	PUNCT
bjp-16772	73	305	2.4	2.4	NUM
bjp-16772	73	306	)	)	PUNCT
bjp-16772	73	307	45	45	NUM
bjp-16772	73	308	(	(	PUNCT
bjp-16772	73	309	6.3	6.3	NUM
bjp-16772	73	310	)	)	PUNCT
bjp-16772	73	311	45	45	NUM
bjp-16772	73	312	(	(	PUNCT
bjp-16772	73	313	6.3	6.3	NUM
bjp-16772	73	314	)	)	SYM
bjp-16772	73	315	105	105	NUM
bjp-16772	73	316	(	(	PUNCT
bjp-16772	73	317	14.7	14.7	NUM
bjp-16772	73	318	)	)	PUNCT
bjp-16772	73	319	61	61	NUM
bjp-16772	73	320	(	(	PUNCT
bjp-16772	73	321	8.5	8.5	NUM
bjp-16772	73	322	)	)	PUNCT
bjp-16772	73	323	71.0	71.0	NUM
bjp-16772	73	324	male	male	NOUN
bjp-16772	73	325	6	6	NUM
bjp-16772	73	326	(	(	PUNCT
bjp-16772	73	327	0.8	0.8	NUM
bjp-16772	73	328	)	)	PUNCT
bjp-16772	73	329	32	32	NUM
bjp-16772	73	330	(	(	PUNCT
bjp-16772	73	331	4.5	4.5	NUM
bjp-16772	73	332	)	)	PUNCT
bjp-16772	73	333	60	60	NUM
bjp-16772	73	334	(	(	PUNCT
bjp-16772	73	335	8.4	8.4	NUM
bjp-16772	73	336	)	)	SYM
bjp-16772	73	337	60	60	NUM
bjp-16772	73	338	(	(	PUNCT
bjp-16772	73	339	8.4	8.4	NUM
bjp-16772	73	340	)	)	SYM
bjp-16772	73	341	113	113	NUM
bjp-16772	73	342	(	(	PUNCT
bjp-16772	73	343	15.8	15.8	NUM
bjp-16772	73	344	)	)	PUNCT
bjp-16772	73	345	50	50	NUM
bjp-16772	73	346	(	(	PUNCT
bjp-16772	73	347	7.0	7.0	NUM
bjp-16772	73	348	)	)	PUNCT
bjp-16772	73	349	69.0	69.0	NUM
bjp-16772	73	350	data	datum	NOUN
bjp-16772	73	351	within	within	ADP
bjp-16772	73	352	parenthesis	parenthesis	NOUN
bjp-16772	73	353	is	be	AUX
bjp-16772	73	354	percentage	percentage	NOUN
bjp-16772	73	355	404	404	NUM
bjp-16772	73	356	bangladesh	bangladesh	NOUN
bjp-16772	73	357	j	j	PROPN
bjp-16772	73	358	pharmacol	pharmacol	PROPN
bjp-16772	73	359	2013	2013	NUM
bjp-16772	73	360	;	;	PUNCT
bjp-16772	73	361	8	8	NUM
bjp-16772	73	362	:	:	SYM
bjp-16772	73	363	401	401	NUM
bjp-16772	73	364	-	-	SYM
bjp-16772	73	365	409	409	NUM
bjp-16772	73	366	figure	figure	NOUN
bjp-16772	73	367	1	1	NUM
bjp-16772	73	368	:	:	PUNCT
bjp-16772	73	369	prevalence	prevalence	NOUN
bjp-16772	73	370	rate	rate	NOUN
bjp-16772	73	371	per	per	ADP
bjp-16772	73	372	thousand	thousand	NUM
bjp-16772	73	373	statin	statin	ADJ
bjp-16772	73	374	prescriptions	prescription	NOUN
bjp-16772	73	375	in	in	ADP
bjp-16772	73	376	scotland	scotland	PROPN
bjp-16772	73	377	from	from	ADP
bjp-16772	73	378	2005	2005	NUM
bjp-16772	73	379	to	to	ADP
bjp-16772	73	380	2010	2010	NUM
bjp-16772	73	381	figure	figure	NOUN
bjp-16772	73	382	2	2	NUM
bjp-16772	73	383	:	:	PUNCT
bjp-16772	73	384	incidence	incidence	NOUN
bjp-16772	73	385	rate	rate	NOUN
bjp-16772	73	386	per	per	ADP
bjp-16772	73	387	thousand	thousand	NUM
bjp-16772	73	388	statin	statin	ADJ
bjp-16772	73	389	prescriptions	prescription	NOUN
bjp-16772	73	390	in	in	ADP
bjp-16772	73	391	scotland	scotland	PROPN
bjp-16772	73	392	from	from	ADP
bjp-16772	73	393	2005	2005	NUM
bjp-16772	73	394	to	to	ADP
bjp-16772	73	395	2010	2010	NUM
bjp-16772	73	396	estrogens	estrogen	NOUN
bjp-16772	73	397	synthesis	synthesis	NOUN
bjp-16772	73	398	in	in	ADP
bjp-16772	73	399	male	male	NOUN
bjp-16772	73	400	is	be	AUX
bjp-16772	73	401	substantially	substantially	ADV
bjp-16772	73	402	associated	associate	VERB
bjp-16772	73	403	with	with	ADP
bjp-16772	73	404	the	the	DET
bjp-16772	73	405	premature	premature	ADJ
bjp-16772	73	406	development	development	NOUN
bjp-16772	73	407	of	of	ADP
bjp-16772	73	408	atherosclerosis	atherosclerosis	NOUN
bjp-16772	73	409	and	and	CCONJ
bjp-16772	73	410	eventually	eventually	ADV
bjp-16772	73	411	cvd	cvd	PROPN
bjp-16772	73	412	(	(	PUNCT
bjp-16772	73	413	arnlov	arnlov	PROPN
bjp-16772	73	414	et	et	PROPN
bjp-16772	73	415	al	al	PROPN
bjp-16772	73	416	.	.	PROPN
bjp-16772	73	417	,	,	PUNCT
bjp-16772	73	418	2006	2006	NUM
bjp-16772	73	419	;	;	PUNCT
bjp-16772	73	420	connor	connor	PROPN
bjp-16772	73	421	et	et	PROPN
bjp-16772	73	422	al	al	PROPN
bjp-16772	73	423	.	.	PROPN
bjp-16772	73	424	,	,	PUNCT
bjp-16772	73	425	1990	1990	NUM
bjp-16772	73	426	;	;	PUNCT
bjp-16772	73	427	millias	millias	PROPN
bjp-16772	73	428	et	et	PROPN
bjp-16772	73	429	al	al	PROPN
bjp-16772	73	430	.	.	PROPN
bjp-16772	73	431	,	,	PUNCT
bjp-16772	73	432	2006	2006	NUM
bjp-16772	73	433	;	;	PUNCT
bjp-16772	73	434	toth	toth	PROPN
bjp-16772	73	435	et	et	PROPN
bjp-16772	73	436	al	al	PROPN
bjp-16772	73	437	.	.	PROPN
bjp-16772	73	438	,	,	PUNCT
bjp-16772	73	439	2007	2007	NUM
bjp-16772	73	440	)	)	PUNCT
bjp-16772	73	441	.	.	PUNCT
bjp-16772	74	1	in	in	ADP
bjp-16772	74	2	our	our	PRON
bjp-16772	74	3	study	study	NOUN
bjp-16772	74	4	male	male	ADJ
bjp-16772	74	5	patients	patient	NOUN
bjp-16772	74	6	were	be	AUX
bjp-16772	74	7	more	more	ADV
bjp-16772	74	8	prescribed	prescribed	ADJ
bjp-16772	74	9	statins	statin	NOUN
bjp-16772	74	10	than	than	ADP
bjp-16772	74	11	female	female	ADJ
bjp-16772	74	12	(	(	PUNCT
bjp-16772	74	13	52	52	NUM
bjp-16772	74	14	and	and	CCONJ
bjp-16772	74	15	48	48	NUM
bjp-16772	74	16	%	%	NOUN
bjp-16772	74	17	respectively	respectively	ADV
bjp-16772	74	18	)	)	PUNCT
bjp-16772	74	19	which	which	PRON
bjp-16772	74	20	can	can	AUX
bjp-16772	74	21	be	be	AUX
bjp-16772	74	22	explained	explain	VERB
bjp-16772	74	23	by	by	ADP
bjp-16772	74	24	the	the	DET
bjp-16772	74	25	above	above	ADJ
bjp-16772	74	26	findings	finding	NOUN
bjp-16772	74	27	.	.	PUNCT
bjp-16772	75	1	a	a	DET
bjp-16772	75	2	similar	similar	ADJ
bjp-16772	75	3	trend	trend	NOUN
bjp-16772	75	4	in	in	ADP
bjp-16772	75	5	the	the	DET
bjp-16772	75	6	uk	uk	PROPN
bjp-16772	75	7	and	and	CCONJ
bjp-16772	75	8	in	in	ADP
bjp-16772	75	9	scotland	scotland	PROPN
bjp-16772	75	10	being	be	AUX
bjp-16772	75	11	also	also	ADV
bjp-16772	75	12	observed	observe	VERB
bjp-16772	75	13	by	by	ADP
bjp-16772	75	14	cappuccio	cappuccio	PROPN
bjp-16772	75	15	et	et	PROPN
bjp-16772	75	16	al	al	PROPN
bjp-16772	75	17	.	.	PROPN
bjp-16772	75	18	(	(	PUNCT
bjp-16772	75	19	2005	2005	NUM
bjp-16772	75	20	)	)	PUNCT
bjp-16772	75	21	and	and	CCONJ
bjp-16772	75	22	simpson	simpson	PROPN
bjp-16772	75	23	et	et	PROPN
bjp-16772	75	24	al	al	PROPN
bjp-16772	75	25	.	.	PROPN
bjp-16772	76	1	(	(	PUNCT
bjp-16772	76	2	2005	2005	NUM
bjp-16772	76	3	)	)	PUNCT
bjp-16772	76	4	.	.	PUNCT
bjp-16772	77	1	the	the	DET
bjp-16772	77	2	patent	patent	NOUN
bjp-16772	77	3	for	for	ADP
bjp-16772	77	4	simvastatin	simvastatin	NOUN
bjp-16772	77	5	and	and	CCONJ
bjp-16772	77	6	pravastatin	pravastatin	NOUN
bjp-16772	77	7	expired	expire	VERB
bjp-16772	77	8	in	in	ADP
bjp-16772	77	9	2003	2003	NUM
bjp-16772	77	10	and	and	CCONJ
bjp-16772	77	11	2004	2004	NUM
bjp-16772	77	12	respectively	respectively	ADV
bjp-16772	77	13	in	in	ADP
bjp-16772	77	14	the	the	DET
bjp-16772	77	15	uk	uk	PROPN
bjp-16772	77	16	and	and	CCONJ
bjp-16772	77	17	rest	rest	NOUN
bjp-16772	77	18	of	of	ADP
bjp-16772	77	19	the	the	DET
bjp-16772	77	20	statins	statin	NOUN
bjp-16772	77	21	is	be	AUX
bjp-16772	77	22	only	only	ADV
bjp-16772	77	23	available	available	ADJ
bjp-16772	77	24	as	as	ADP
bjp-16772	77	25	the	the	DET
bjp-16772	77	26	branded	brand	VERB
bjp-16772	77	27	version	version	NOUN
bjp-16772	77	28	(	(	PUNCT
bjp-16772	77	29	petty	petty	ADJ
bjp-16772	77	30	et	et	PROPN
bjp-16772	77	31	al	al	PROPN
bjp-16772	77	32	.	.	PROPN
bjp-16772	77	33	,	,	PUNCT
bjp-16772	77	34	2008	2008	NUM
bjp-16772	77	35	)	)	PUNCT
bjp-16772	77	36	.	.	PUNCT
bjp-16772	78	1	consequently	consequently	ADV
bjp-16772	78	2	,	,	PUNCT
bjp-16772	78	3	simvastatin	simvastatin	NOUN
bjp-16772	78	4	and	and	CCONJ
bjp-16772	78	5	pravastatin	pravastatin	NOUN
bjp-16772	78	6	are	be	AUX
bjp-16772	78	7	relatively	relatively	ADV
bjp-16772	78	8	inexpensive	inexpensive	ADJ
bjp-16772	78	9	compared	compare	VERB
bjp-16772	78	10	to	to	ADP
bjp-16772	78	11	other	other	ADJ
bjp-16772	78	12	statins	statin	NOUN
bjp-16772	78	13	.	.	PUNCT
bjp-16772	79	1	nice	nice	ADJ
bjp-16772	79	2	recommended	recommend	VERB
bjp-16772	79	3	physicians	physician	NOUN
bjp-16772	79	4	to	to	PART
bjp-16772	79	5	prescribe	prescribe	VERB
bjp-16772	79	6	these	these	DET
bjp-16772	79	7	drugs	drug	NOUN
bjp-16772	79	8	due	due	ADJ
bjp-16772	79	9	to	to	PART
bjp-16772	79	10	have	have	VERB
bjp-16772	79	11	similar	similar	ADJ
bjp-16772	79	12	efficacy	efficacy	NOUN
bjp-16772	79	13	as	as	ADP
bjp-16772	79	14	more	more	ADV
bjp-16772	79	15	expensive	expensive	ADJ
bjp-16772	79	16	alternatives	alternative	NOUN
bjp-16772	79	17	in	in	ADP
bjp-16772	79	18	achieving	achieve	VERB
bjp-16772	79	19	national	national	ADJ
bjp-16772	79	20	cholesterol	cholesterol	NOUN
bjp-16772	79	21	targets	target	NOUN
bjp-16772	79	22	.	.	PUNCT
bjp-16772	80	1	the	the	DET
bjp-16772	80	2	uk	uk	PROPN
bjp-16772	80	3	government	government	NOUN
bjp-16772	80	4	has	have	AUX
bjp-16772	80	5	also	also	ADV
bjp-16772	80	6	provided	provide	VERB
bjp-16772	80	7	strong	strong	ADJ
bjp-16772	80	8	inducement	inducement	NOUN
bjp-16772	80	9	for	for	ADP
bjp-16772	80	10	generic	generic	ADJ
bjp-16772	80	11	prescribing	prescribing	NOUN
bjp-16772	80	12	and	and	CCONJ
bjp-16772	80	13	usage	usage	NOUN
bjp-16772	80	14	through	through	ADP
bjp-16772	80	15	guidance	guidance	NOUN
bjp-16772	80	16	(	(	PUNCT
bjp-16772	80	17	kanavos	kanavos	NOUN
bjp-16772	80	18	et	et	PROPN
bjp-16772	80	19	al	al	PROPN
bjp-16772	80	20	.	.	PROPN
bjp-16772	80	21	,	,	PUNCT
bjp-16772	80	22	2007	2007	NUM
bjp-16772	80	23	)	)	PUNCT
bjp-16772	80	24	.	.	PUNCT
bjp-16772	81	1	in	in	ADP
bjp-16772	81	2	the	the	DET
bjp-16772	81	3	current	current	ADJ
bjp-16772	81	4	study	study	NOUN
bjp-16772	81	5	,	,	PUNCT
bjp-16772	81	6	in	in	ADP
bjp-16772	81	7	a	a	DET
bjp-16772	81	8	total	total	NOUN
bjp-16772	81	9	of	of	ADP
bjp-16772	81	10	191,370	191,370	NUM
bjp-16772	81	11	starting	start	VERB
bjp-16772	81	12	prescription	prescription	NOUN
bjp-16772	81	13	,	,	PUNCT
bjp-16772	81	14	simvastatin	simvastatin	NOUN
bjp-16772	81	15	stands	stand	VERB
bjp-16772	81	16	for	for	ADP
bjp-16772	81	17	63	63	NUM
bjp-16772	81	18	%	%	NOUN
bjp-16772	81	19	,	,	PUNCT
bjp-16772	81	20	followed	follow	VERB
bjp-16772	81	21	by	by	ADP
bjp-16772	81	22	atorvastatin	atorvastatin	PROPN
bjp-16772	81	23	27	27	NUM
bjp-16772	81	24	%	%	NOUN
bjp-16772	81	25	,	,	PUNCT
bjp-16772	81	26	pravastatin	pravastatin	NOUN
bjp-16772	81	27	5	5	NUM
bjp-16772	81	28	%	%	NOUN
bjp-16772	81	29	,	,	PUNCT
bjp-16772	81	30	rosuvastatin	rosuvastatin	ADJ
bjp-16772	81	31	4	4	NUM
bjp-16772	81	32	%	%	NOUN
bjp-16772	81	33	and	and	CCONJ
bjp-16772	81	34	fluvastatin	fluvastatin	NOUN
bjp-16772	81	35	is	be	AUX
bjp-16772	81	36	the	the	DET
bjp-16772	81	37	least	least	ADJ
bjp-16772	81	38	1	1	NUM
bjp-16772	81	39	%	%	NOUN
bjp-16772	81	40	only	only	ADV
bjp-16772	81	41	.	.	PUNCT
bjp-16772	82	1	these	these	DET
bjp-16772	82	2	observations	observation	NOUN
bjp-16772	82	3	are	be	AUX
bjp-16772	82	4	in	in	ADP
bjp-16772	82	5	line	line	NOUN
bjp-16772	82	6	with	with	ADP
bjp-16772	82	7	the	the	DET
bjp-16772	82	8	recommendation	recommendation	NOUN
bjp-16772	82	9	of	of	ADP
bjp-16772	82	10	department	department	NOUN
bjp-16772	82	11	of	of	ADP
bjp-16772	82	12	health	health	PROPN
bjp-16772	82	13	in	in	ADP
bjp-16772	82	14	england	england	PROPN
bjp-16772	82	15	and	and	CCONJ
bjp-16772	82	16	the	the	DET
bjp-16772	82	17	nice	nice	ADJ
bjp-16772	82	18	guideline	guideline	NOUN
bjp-16772	82	19	67	67	NUM
bjp-16772	82	20	,	,	PUNCT
bjp-16772	82	21	(	(	PUNCT
bjp-16772	82	22	2008	2008	NUM
bjp-16772	82	23	)	)	PUNCT
bjp-16772	82	24	for	for	ADP
bjp-16772	82	25	statin	statin	ADJ
bjp-16772	82	26	usage	usage	NOUN
bjp-16772	82	27	in	in	ADP
bjp-16772	82	28	primary	primary	ADJ
bjp-16772	82	29	care	care	NOUN
bjp-16772	82	30	(	(	PUNCT
bjp-16772	82	31	petty	petty	NOUN
bjp-16772	82	32	et	et	PROPN
bjp-16772	82	33	al	al	PROPN
bjp-16772	82	34	.	.	PROPN
bjp-16772	82	35	,	,	PUNCT
bjp-16772	82	36	2008	2008	NUM
bjp-16772	82	37	)	)	PUNCT
bjp-16772	82	38	.	.	PUNCT
bjp-16772	83	1	however	however	ADV
bjp-16772	83	2	,	,	PUNCT
bjp-16772	83	3	the	the	DET
bjp-16772	83	4	superior	superior	ADJ
bjp-16772	83	5	efficacy	efficacy	NOUN
bjp-16772	83	6	in	in	ADP
bjp-16772	83	7	low	low	ADJ
bjp-16772	83	8	dose	dose	PROPN
bjp-16772	83	9	(	(	PUNCT
bjp-16772	83	10	stein	stein	PROPN
bjp-16772	83	11	et	et	PROPN
bjp-16772	83	12	al	al	PROPN
bjp-16772	83	13	.	.	PROPN
bjp-16772	83	14	,	,	PUNCT
bjp-16772	83	15	1998	1998	NUM
bjp-16772	83	16	)	)	PUNCT
bjp-16772	83	17	and	and	CCONJ
bjp-16772	83	18	also	also	ADV
bjp-16772	83	19	for	for	ADP
bjp-16772	83	20	the	the	DET
bjp-16772	83	21	cost	cost	NOUN
bjp-16772	83	22	effectiveness	effectiveness	NOUN
bjp-16772	83	23	compared	compare	VERB
bjp-16772	83	24	to	to	ADP
bjp-16772	83	25	the	the	DET
bjp-16772	83	26	other	other	ADJ
bjp-16772	83	27	branded	brand	VERB
bjp-16772	83	28	ver	ver	NOUN
bjp-16772	83	29	-	-	PUNCT
bjp-16772	83	30	sion	sion	NOUN
bjp-16772	83	31	,	,	PUNCT
bjp-16772	83	32	atorvastatin	atorvastatin	PROPN
bjp-16772	83	33	may	may	AUX
bjp-16772	83	34	be	be	AUX
bjp-16772	83	35	the	the	DET
bjp-16772	83	36	second	second	ADJ
bjp-16772	83	37	most	most	ADV
bjp-16772	83	38	prescribed	prescribe	VERB
bjp-16772	83	39	statin	statin	NOUN
bjp-16772	83	40	by	by	ADP
bjp-16772	83	41	the	the	DET
bjp-16772	83	42	uk	uk	PROPN
bjp-16772	83	43	bangladesh	bangladesh	PROPN
bjp-16772	83	44	j	j	PROPN
bjp-16772	83	45	pharmacol	pharmacol	PROPN
bjp-16772	83	46	2013	2013	NUM
bjp-16772	83	47	;	;	PUNCT
bjp-16772	83	48	8	8	NUM
bjp-16772	83	49	:	:	SYM
bjp-16772	83	50	401	401	NUM
bjp-16772	83	51	-	-	SYM
bjp-16772	83	52	409	409	NUM
bjp-16772	83	53	405	405	NUM
bjp-16772	83	54	figure	figure	NOUN
bjp-16772	83	55	3	3	NUM
bjp-16772	83	56	:	:	PUNCT
bjp-16772	83	57	percentages	percentage	NOUN
bjp-16772	83	58	of	of	ADP
bjp-16772	83	59	high	high	ADJ
bjp-16772	83	60	dose	dose	NOUN
bjp-16772	83	61	(	(	PUNCT
bjp-16772	83	62	80	80	NUM
bjp-16772	83	63	mg	mg	NOUN
bjp-16772	83	64	)	)	PUNCT
bjp-16772	83	65	simvastatin	simvastatin	NOUN
bjp-16772	83	66	prescriptions	prescription	NOUN
bjp-16772	83	67	in	in	ADP
bjp-16772	83	68	scotland	scotland	PROPN
bjp-16772	83	69	on	on	ADP
bjp-16772	83	70	different	different	ADJ
bjp-16772	83	71	time	time	NOUN
bjp-16772	83	72	point	point	NOUN
bjp-16772	83	73	table	table	NOUN
bjp-16772	83	74	ii	ii	NOUN
bjp-16772	83	75	frequency	frequency	NOUN
bjp-16772	83	76	and	and	CCONJ
bjp-16772	83	77	percentage	percentage	NOUN
bjp-16772	83	78	of	of	ADP
bjp-16772	83	79	patients	patient	NOUN
bjp-16772	83	80	switched	switch	VERB
bjp-16772	83	81	to	to	ADP
bjp-16772	83	82	low	low	ADJ
bjp-16772	83	83	dose	dose	NOUN
bjp-16772	83	84	statin	statin	PROPN
bjp-16772	83	85	from	from	ADP
bjp-16772	83	86	high	high	ADJ
bjp-16772	83	87	dose	dose	PROPN
bjp-16772	83	88	(	(	PUNCT
bjp-16772	83	89	80	80	NUM
bjp-16772	83	90	mg	mg	NOUN
bjp-16772	83	91	)	)	PUNCT
bjp-16772	83	92	simvastatin	simvastatin	NOUN
bjp-16772	83	93	time	time	NOUN
bjp-16772	83	94	period	period	NOUN
bjp-16772	83	95	patients	patient	NOUN
bjp-16772	83	96	prescribed	prescribe	VERB
bjp-16772	83	97	high	high	ADJ
bjp-16772	83	98	dose	dose	PROPN
bjp-16772	83	99	(	(	PUNCT
bjp-16772	83	100	80	80	NUM
bjp-16772	83	101	mg	mg	NOUN
bjp-16772	83	102	)	)	PUNCT
bjp-16772	83	103	simvastatin	simvastatin	NOUN
bjp-16772	83	104	patients	patient	NOUN
bjp-16772	83	105	switched	switch	VERB
bjp-16772	83	106	to	to	ADP
bjp-16772	83	107	low	low	ADJ
bjp-16772	83	108	dose	dose	NOUN
bjp-16772	83	109	statin	statin	PROPN
bjp-16772	83	110	from	from	ADP
bjp-16772	83	111	high	high	ADJ
bjp-16772	83	112	dose	dose	NOUN
bjp-16772	83	113	simvastatin	simvastatin	NOUN
bjp-16772	83	114	(	(	PUNCT
bjp-16772	83	115	80	80	NUM
bjp-16772	83	116	mg	mg	NOUN
bjp-16772	83	117	)	)	PUNCT
bjp-16772	83	118	atorvastatin	atorvastatin	PROPN
bjp-16772	83	119	rosuvastatin	rosuvastatin	ADJ
bjp-16772	83	120	pravastatin	pravastatin	PROPN
bjp-16772	83	121	fluvastatin	fluvastatin	NOUN
bjp-16772	83	122	frequency	frequency	NOUN
bjp-16772	83	123	%	%	NOUN
bjp-16772	83	124	frequency	frequency	NOUN
bjp-16772	83	125	%	%	NOUN
bjp-16772	83	126	frequency	frequency	NOUN
bjp-16772	83	127	%	%	NOUN
bjp-16772	83	128	frequency	frequency	NOUN
bjp-16772	83	129	%	%	NOUN
bjp-16772	83	130	(	(	PUNCT
bjp-16772	83	131	01/09/2005	01/09/2005	NOUN
bjp-16772	83	132	31/08/2006	31/08/2006	NUM
bjp-16772	83	133	)	)	PUNCT
bjp-16772	83	134	2170	2170	NUM
bjp-16772	83	135	249	249	NUM
bjp-16772	83	136	11	11	NUM
bjp-16772	83	137	23	23	NUM
bjp-16772	83	138	1	1	NUM
bjp-16772	83	139	9	9	NUM
bjp-16772	83	140	0.4	0.4	NUM
bjp-16772	83	141	(	(	PUNCT
bjp-16772	83	142	01/09/200631/08/2007	01/09/200631/08/2007	PROPN
bjp-16772	83	143	)	)	PUNCT
bjp-16772	83	144	561	561	NUM
bjp-16772	83	145	269	269	NUM
bjp-16772	83	146	48	48	NUM
bjp-16772	83	147	44	44	NUM
bjp-16772	83	148	8	8	NUM
bjp-16772	83	149	3	3	NUM
bjp-16772	83	150	0.5	0.5	NUM
bjp-16772	83	151	2	2	NUM
bjp-16772	83	152	0.4	0.4	NUM
bjp-16772	83	153	(	(	PUNCT
bjp-16772	83	154	01/09/200731/08/2008	01/09/200731/08/2008	NOUN
bjp-16772	83	155	)	)	PUNCT
bjp-16772	83	156	493	493	NUM
bjp-16772	83	157	197	197	NUM
bjp-16772	83	158	40	40	NUM
bjp-16772	83	159	41	41	NUM
bjp-16772	83	160	8	8	NUM
bjp-16772	83	161	2	2	NUM
bjp-16772	83	162	0.4	0.4	NUM
bjp-16772	83	163	(	(	PUNCT
bjp-16772	83	164	1/09/2008	1/09/2008	NUM
bjp-16772	83	165	31/08/2009	31/08/2009	NUM
bjp-16772	83	166	)	)	PUNCT
bjp-16772	83	167	488	488	NUM
bjp-16772	83	168	169	169	NUM
bjp-16772	83	169	35	35	NUM
bjp-16772	83	170	42	42	NUM
bjp-16772	83	171	9	9	NUM
bjp-16772	83	172	3	3	NUM
bjp-16772	83	173	0.6	0.6	NUM
bjp-16772	83	174	total	total	ADJ
bjp-16772	83	175	patients	patient	NOUN
bjp-16772	83	176	(	(	PUNCT
bjp-16772	83	177	01/09/2005	01/09/2005	NOUN
bjp-16772	83	178	31/08/2009	31/08/2009	NUM
bjp-16772	83	179	)	)	PUNCT
bjp-16772	83	180	3712	3712	NUM
bjp-16772	83	181	884	884	NUM
bjp-16772	83	182	24	24	NUM
bjp-16772	83	183	150	150	NUM
bjp-16772	83	184	4	4	NUM
bjp-16772	83	185	17	17	NUM
bjp-16772	83	186	0.5	0.5	NUM
bjp-16772	83	187	2	2	NUM
bjp-16772	83	188	0.05	0.05	NUM
bjp-16772	83	189	general	general	ADJ
bjp-16772	83	190	practitioners	practitioner	NOUN
bjp-16772	83	191	.	.	PUNCT
bjp-16772	84	1	fluvastatin	fluvastatin	PROPN
bjp-16772	84	2	was	be	AUX
bjp-16772	84	3	the	the	DET
bjp-16772	84	4	least	least	ADV
bjp-16772	84	5	preferred	preferred	ADJ
bjp-16772	84	6	due	due	ADP
bjp-16772	84	7	to	to	ADP
bjp-16772	84	8	its	its	PRON
bjp-16772	84	9	lower	low	ADJ
bjp-16772	84	10	efficacy	efficacy	NOUN
bjp-16772	84	11	and	and	CCONJ
bjp-16772	84	12	more	more	ADV
bjp-16772	84	13	costly	costly	ADJ
bjp-16772	84	14	than	than	ADP
bjp-16772	84	15	other	other	ADJ
bjp-16772	84	16	(	(	PUNCT
bjp-16772	84	17	mcdonald	mcdonald	PROPN
bjp-16772	84	18	et	et	PROPN
bjp-16772	84	19	al	al	PROPN
bjp-16772	84	20	.	.	PROPN
bjp-16772	84	21	,	,	PUNCT
bjp-16772	84	22	2008	2008	NUM
bjp-16772	84	23	)	)	PUNCT
bjp-16772	84	24	.	.	PUNCT
bjp-16772	85	1	30	30	NUM
bjp-16772	85	2	and	and	CCONJ
bjp-16772	85	3	28	28	NUM
bjp-16772	85	4	%	%	NOUN
bjp-16772	85	5	of	of	ADP
bjp-16772	85	6	the	the	DET
bjp-16772	85	7	patients	patient	NOUN
bjp-16772	85	8	prescribed	prescribe	VERB
bjp-16772	85	9	statins	statin	NOUN
bjp-16772	85	10	were	be	AUX
bjp-16772	85	11	in	in	ADP
bjp-16772	85	12	the	the	DET
bjp-16772	85	13	61	61	NUM
bjp-16772	85	14	-	-	SYM
bjp-16772	85	15	70	70	NUM
bjp-16772	85	16	and	and	CCONJ
bjp-16772	85	17	71	71	NUM
bjp-16772	85	18	-	-	SYM
bjp-16772	85	19	80	80	NUM
bjp-16772	85	20	years	year	NOUN
bjp-16772	85	21	age	age	NOUN
bjp-16772	85	22	group	group	NOUN
bjp-16772	85	23	;	;	PUNCT
bjp-16772	85	24	figures	figure	NOUN
bjp-16772	85	25	similar	similar	ADJ
bjp-16772	85	26	to	to	ADP
bjp-16772	85	27	the	the	DET
bjp-16772	85	28	previously	previously	ADV
bjp-16772	85	29	reported	report	VERB
bjp-16772	85	30	study	study	NOUN
bjp-16772	85	31	by	by	ADP
bjp-16772	85	32	maycock	maycock	NOUN
bjp-16772	85	33	et	et	PROPN
bjp-16772	85	34	al	al	PROPN
bjp-16772	85	35	.	.	PROPN
bjp-16772	86	1	(	(	PUNCT
bjp-16772	86	2	2002	2002	NUM
bjp-16772	86	3	)	)	PUNCT
bjp-16772	86	4	.	.	PUNCT
bjp-16772	87	1	patients	patient	NOUN
bjp-16772	87	2	'	'	PART
bjp-16772	87	3	mean	mean	ADJ
bjp-16772	87	4	ages	age	NOUN
bjp-16772	87	5	were	be	AUX
bjp-16772	87	6	65	65	NUM
bjp-16772	87	7	±	±	NUM
bjp-16772	87	8	12	12	NUM
bjp-16772	87	9	years	year	NOUN
bjp-16772	87	10	,	,	PUNCT
bjp-16772	87	11	a	a	DET
bjp-16772	87	12	figure	figure	NOUN
bjp-16772	87	13	similar	similar	ADJ
bjp-16772	87	14	to	to	ADP
bjp-16772	87	15	previously	previously	ADV
bjp-16772	87	16	published	publish	VERB
bjp-16772	87	17	data	datum	NOUN
bjp-16772	87	18	where	where	SCONJ
bjp-16772	87	19	adults	adult	NOUN
bjp-16772	87	20	aged	age	VERB
bjp-16772	87	21	≥	≥	NUM
bjp-16772	87	22	65	65	NUM
bjp-16772	87	23	are	be	AUX
bjp-16772	87	24	the	the	DET
bjp-16772	87	25	most	most	ADV
bjp-16772	87	26	susceptible	susceptible	ADJ
bjp-16772	87	27	for	for	ADP
bjp-16772	87	28	cvd	cvd	PROPN
bjp-16772	87	29	;	;	PUNCT
bjp-16772	87	30	about	about	ADV
bjp-16772	87	31	80	80	NUM
bjp-16772	87	32	%	%	NOUN
bjp-16772	87	33	of	of	ADP
bjp-16772	87	34	cardiovascular	cardiovascular	ADJ
bjp-16772	87	35	deaths	death	NOUN
bjp-16772	87	36	occur	occur	VERB
bjp-16772	87	37	in	in	ADP
bjp-16772	87	38	these	these	DET
bjp-16772	87	39	age	age	NOUN
bjp-16772	87	40	groups	group	NOUN
bjp-16772	87	41	and	and	CCONJ
bjp-16772	87	42	statin	statin	PROPN
bjp-16772	87	43	therapy	therapy	NOUN
bjp-16772	87	44	effectively	effectively	ADV
bjp-16772	87	45	decreased	decrease	VERB
bjp-16772	87	46	cvd	cvd	PROPN
bjp-16772	87	47	risk	risk	NOUN
bjp-16772	87	48	in	in	ADP
bjp-16772	87	49	this	this	DET
bjp-16772	87	50	age	age	NOUN
bjp-16772	87	51	group	group	NOUN
bjp-16772	87	52	(	(	PUNCT
bjp-16772	87	53	shepherd	shepherd	NOUN
bjp-16772	87	54	et	et	PROPN
bjp-16772	87	55	al	al	PROPN
bjp-16772	87	56	.	.	PROPN
bjp-16772	87	57	,	,	PUNCT
bjp-16772	87	58	2002	2002	NUM
bjp-16772	87	59	;	;	PUNCT
bjp-16772	87	60	deedwania	deedwania	PROPN
bjp-16772	87	61	et	et	PROPN
bjp-16772	87	62	al	al	PROPN
bjp-16772	87	63	.	.	PROPN
bjp-16772	87	64	,	,	PUNCT
bjp-16772	87	65	2007	2007	NUM
bjp-16772	87	66	;	;	PUNCT
bjp-16772	87	67	4s	4s	NUM
bjp-16772	87	68	study	study	NOUN
bjp-16772	87	69	group	group	NOUN
bjp-16772	87	70	,	,	PUNCT
bjp-16772	87	71	1994	1994	NUM
bjp-16772	87	72	)	)	PUNCT
bjp-16772	87	73	.	.	PUNCT
bjp-16772	88	1	patients	patient	NOUN
bjp-16772	88	2	aged	age	VERB
bjp-16772	88	3	>	>	SYM
bjp-16772	88	4	80	80	NUM
bjp-16772	88	5	years	year	NOUN
bjp-16772	88	6	were	be	AUX
bjp-16772	88	7	prescribed	prescribe	VERB
bjp-16772	88	8	pravastatin	pravastatin	NOUN
bjp-16772	88	9	more	more	ADV
bjp-16772	88	10	frequently	frequently	ADV
bjp-16772	88	11	close	close	ADJ
bjp-16772	88	12	to	to	ADP
bjp-16772	88	13	the	the	DET
bjp-16772	88	14	prosper	prosper	NOUN
bjp-16772	88	15	trial	trial	NOUN
bjp-16772	88	16	(	(	PUNCT
bjp-16772	88	17	shepherd	shepherd	NOUN
bjp-16772	88	18	et	et	PROPN
bjp-16772	88	19	al	al	PROPN
bjp-16772	88	20	.	.	PROPN
bjp-16772	88	21	,	,	PUNCT
bjp-16772	88	22	2002	2002	NUM
bjp-16772	88	23	)	)	PUNCT
bjp-16772	88	24	.	.	PUNCT
bjp-16772	89	1	the	the	DET
bjp-16772	89	2	rate	rate	NOUN
bjp-16772	89	3	for	for	ADP
bjp-16772	89	4	prevalence	prevalence	NOUN
bjp-16772	89	5	of	of	ADP
bjp-16772	89	6	simvastatin	simvastatin	ADJ
bjp-16772	89	7	prescription	prescription	NOUN
bjp-16772	89	8	increased	increase	VERB
bjp-16772	89	9	and	and	CCONJ
bjp-16772	89	10	at	at	ADP
bjp-16772	89	11	the	the	DET
bjp-16772	89	12	same	same	ADJ
bjp-16772	89	13	time	time	NOUN
bjp-16772	89	14	incidence	incidence	NOUN
bjp-16772	89	15	declined	decline	VERB
bjp-16772	89	16	.	.	PUNCT
bjp-16772	90	1	both	both	DET
bjp-16772	90	2	these	these	DET
bjp-16772	90	3	changes	change	NOUN
bjp-16772	90	4	were	be	AUX
bjp-16772	90	5	significant	significant	ADJ
bjp-16772	90	6	(	(	PUNCT
bjp-16772	90	7	p<0.05	p<0.05	NOUN
bjp-16772	90	8	)	)	PUNCT
bjp-16772	90	9	at	at	ADP
bjp-16772	90	10	all	all	DET
bjp-16772	90	11	the	the	DET
bjp-16772	90	12	time	time	NOUN
bjp-16772	90	13	points	point	NOUN
bjp-16772	90	14	over	over	ADP
bjp-16772	90	15	the	the	DET
bjp-16772	90	16	study	study	NOUN
bjp-16772	90	17	period	period	NOUN
bjp-16772	90	18	.	.	PUNCT
bjp-16772	91	1	the	the	DET
bjp-16772	91	2	overall	overall	ADJ
bjp-16772	91	3	prevalence	prevalence	NOUN
bjp-16772	91	4	for	for	ADP
bjp-16772	91	5	patients	patient	NOUN
bjp-16772	91	6	prescribed	prescribe	VERB
bjp-16772	91	7	simvastatin	simvastatin	PROPN
bjp-16772	91	8	increased	increase	VERB
bjp-16772	91	9	irrespective	irrespective	ADV
bjp-16772	91	10	of	of	ADP
bjp-16772	91	11	declining	decline	VERB
bjp-16772	91	12	in	in	ADP
bjp-16772	91	13	incidence	incidence	NOUN
bjp-16772	91	14	,	,	PUNCT
bjp-16772	91	15	reflecting	reflect	VERB
bjp-16772	91	16	that	that	SCONJ
bjp-16772	91	17	a	a	DET
bjp-16772	91	18	reduction	reduction	NOUN
bjp-16772	91	19	in	in	ADP
bjp-16772	91	20	new	new	ADJ
bjp-16772	91	21	prescription	prescription	NOUN
bjp-16772	91	22	of	of	ADP
bjp-16772	91	23	simvastatin	simvastatin	NOUN
bjp-16772	91	24	as	as	ADP
bjp-16772	91	25	other	other	ADJ
bjp-16772	91	26	statins	statin	NOUN
bjp-16772	91	27	are	be	AUX
bjp-16772	91	28	being	be	AUX
bjp-16772	91	29	increasingly	increasingly	ADV
bjp-16772	91	30	favoured	favour	VERB
bjp-16772	91	31	.	.	PUNCT
bjp-16772	92	1	however	however	ADV
bjp-16772	92	2	,	,	PUNCT
bjp-16772	92	3	due	due	ADP
bjp-16772	92	4	to	to	ADP
bjp-16772	92	5	the	the	DET
bjp-16772	92	6	large	large	ADJ
bjp-16772	92	7	number	number	NOUN
bjp-16772	92	8	of	of	ADP
bjp-16772	92	9	patients	patient	NOUN
bjp-16772	92	10	are	be	AUX
bjp-16772	92	11	already	already	ADV
bjp-16772	92	12	on	on	ADP
bjp-16772	92	13	simvastatin	simvastatin	NOUN
bjp-16772	92	14	and	and	CCONJ
bjp-16772	92	15	also	also	ADV
bjp-16772	92	16	for	for	ADP
bjp-16772	92	17	its	its	PRON
bjp-16772	92	18	cost	cost	NOUN
bjp-16772	92	19	effectiveness	effectiveness	NOUN
bjp-16772	92	20	,	,	PUNCT
bjp-16772	92	21	excellent	excellent	ADJ
bjp-16772	92	22	safety	safety	NOUN
bjp-16772	92	23	and	and	CCONJ
bjp-16772	92	24	efficacy	efficacy	NOUN
bjp-16772	92	25	profile	profile	NOUN
bjp-16772	92	26	in	in	ADP
bjp-16772	92	27	lowering	lower	VERB
bjp-16772	92	28	ldl	ldl	NOUN
bjp-16772	92	29	-	-	PUNCT
bjp-16772	92	30	c	c	PROPN
bjp-16772	92	31	and	and	CCONJ
bjp-16772	92	32	the	the	DET
bjp-16772	92	33	influence	influence	NOUN
bjp-16772	92	34	of	of	ADP
bjp-16772	92	35	nice	nice	ADJ
bjp-16772	92	36	guidelines	guideline	NOUN
bjp-16772	92	37	,	,	PUNCT
bjp-16772	92	38	prevalence	prevalence	NOUN
bjp-16772	92	39	continues	continue	VERB
bjp-16772	92	40	to	to	PART
bjp-16772	92	41	increase	increase	VERB
bjp-16772	92	42	and	and	CCONJ
bjp-16772	92	43	it	it	PRON
bjp-16772	92	44	is	be	AUX
bjp-16772	92	45	the	the	DET
bjp-16772	92	46	preferred	prefer	VERB
bjp-16772	92	47	statin	statin	NOUN
bjp-16772	92	48	to	to	PART
bjp-16772	92	49	be	be	AUX
bjp-16772	92	50	prescribed	prescribe	VERB
bjp-16772	92	51	by	by	ADP
bjp-16772	92	52	gps	gps	PROPN
bjp-16772	92	53	in	in	ADP
bjp-16772	92	54	scotland	scotland	PROPN
bjp-16772	92	55	.	.	PUNCT
bjp-16772	93	1	the	the	DET
bjp-16772	93	2	prevalence	prevalence	NOUN
bjp-16772	93	3	rate	rate	NOUN
bjp-16772	93	4	increased	increase	VERB
bjp-16772	93	5	(	(	PUNCT
bjp-16772	93	6	p=	p=	NOUN
bjp-16772	93	7	0.02	0.02	NUM
bjp-16772	93	8	)	)	PUNCT
bjp-16772	93	9	whereas	whereas	SCONJ
bjp-16772	93	10	incidence	incidence	NOUN
bjp-16772	93	11	declined	decline	VERB
bjp-16772	93	12	significantly	significantly	ADV
bjp-16772	93	13	(	(	PUNCT
bjp-16772	93	14	p=	p=	NOUN
bjp-16772	93	15	0.003	0.003	NUM
bjp-16772	93	16	)	)	PUNCT
bjp-16772	93	17	of	of	ADP
bjp-16772	93	18	atorvastatin	atorvastatin	PROPN
bjp-16772	93	19	prescription	prescription	NOUN
bjp-16772	93	20	.	.	PUNCT
bjp-16772	94	1	in	in	ADP
bjp-16772	94	2	the	the	DET
bjp-16772	94	3	uk	uk	PROPN
bjp-16772	94	4	,	,	PUNCT
bjp-16772	94	5	atorvastatin	atorvastatin	PROPN
bjp-16772	94	6	is	be	AUX
bjp-16772	94	7	available	available	ADJ
bjp-16772	94	8	as	as	ADP
bjp-16772	94	9	a	a	DET
bjp-16772	94	10	branded	brand	VERB
bjp-16772	94	11	name	name	NOUN
bjp-16772	94	12	in	in	ADP
bjp-16772	94	13	the	the	DET
bjp-16772	94	14	market	market	NOUN
bjp-16772	94	15	for	for	ADP
bjp-16772	94	16	its	its	PRON
bjp-16772	94	17	patent	patent	NOUN
bjp-16772	94	18	protection	protection	NOUN
bjp-16772	94	19	.	.	PUNCT
bjp-16772	95	1	the	the	DET
bjp-16772	95	2	high	high	ADJ
bjp-16772	95	3	cost	cost	NOUN
bjp-16772	95	4	compared	compare	VERB
bjp-16772	95	5	to	to	ADP
bjp-16772	95	6	generic	generic	ADJ
bjp-16772	95	7	simvastatin	simvastatin	NOUN
bjp-16772	95	8	and	and	CCONJ
bjp-16772	95	9	for	for	ADP
bjp-16772	95	10	the	the	DET
bjp-16772	95	11	nice	nice	ADJ
bjp-16772	95	12	recommendations	recommendation	NOUN
bjp-16772	95	13	,	,	PUNCT
bjp-16772	95	14	patients	patient	NOUN
bjp-16772	95	15	to	to	PART
bjp-16772	95	16	be	be	AUX
bjp-16772	95	17	started	start	VERB
bjp-16772	95	18	on	on	ADP
bjp-16772	95	19	statin	statin	PROPN
bjp-16772	95	20	therapy	therapy	NOUN
bjp-16772	95	21	are	be	AUX
bjp-16772	95	22	usually	usually	ADV
bjp-16772	95	23	not	not	PART
bjp-16772	95	24	prescribed	prescribe	VERB
bjp-16772	95	25	atorvastatin	atorvastatin	NOUN
bjp-16772	95	26	by	by	ADP
bjp-16772	95	27	gps	gps	PROPN
bjp-16772	95	28	.	.	PUNCT
bjp-16772	96	1	the	the	DET
bjp-16772	96	2	better	well	ADJ
bjp-16772	96	3	efficacy	efficacy	NOUN
bjp-16772	96	4	of	of	ADP
bjp-16772	96	5	10/20	10/20	NUM
bjp-16772	96	6	mg	mg	PROPN
bjp-16772	96	7	atorvastatin	atorvastatin	NOUN
bjp-16772	96	8	than	than	ADP
bjp-16772	96	9	20/40	20/40	NUM
bjp-16772	96	10	mg	mg	NOUN
bjp-16772	96	11	of	of	ADP
bjp-16772	96	12	simvastatin	simvastatin	PROPN
bjp-16772	96	13	,	,	PUNCT
bjp-16772	96	14	in	in	ADP
bjp-16772	96	15	the	the	DET
bjp-16772	96	16	primary	primary	ADJ
bjp-16772	96	17	prevention	prevention	NOUN
bjp-16772	96	18	of	of	ADP
bjp-16772	96	19	cvd	cvd	PROPN
bjp-16772	96	20	(	(	PUNCT
bjp-16772	96	21	weng	weng	PROPN
bjp-16772	96	22	et	et	PROPN
bjp-16772	96	23	al	al	PROPN
bjp-16772	96	24	.	.	PROPN
bjp-16772	96	25	,	,	PUNCT
bjp-16772	96	26	2010	2010	NUM
bjp-16772	96	27	)	)	PUNCT
bjp-16772	96	28	might	might	AUX
bjp-16772	96	29	be	be	AUX
bjp-16772	96	30	the	the	DET
bjp-16772	96	31	reason	reason	NOUN
bjp-16772	96	32	for	for	ADP
bjp-16772	96	33	the	the	DET
bjp-16772	96	34	second	second	ADJ
bjp-16772	96	35	most	most	ADV
bjp-16772	96	36	common	common	ADJ
bjp-16772	96	37	prescribed	prescribed	ADJ
bjp-16772	96	38	statin	statin	NOUN
bjp-16772	96	39	in	in	ADP
bjp-16772	96	40	scotland	scotland	PROPN
bjp-16772	96	41	.	.	PUNCT
bjp-16772	97	1	furthermore	furthermore	ADV
bjp-16772	97	2	,	,	PUNCT
bjp-16772	97	3	it	it	PRON
bjp-16772	97	4	can	can	AUX
bjp-16772	97	5	be	be	AUX
bjp-16772	97	6	assumed	assume	VERB
bjp-16772	97	7	that	that	SCONJ
bjp-16772	97	8	with	with	ADP
bjp-16772	97	9	the	the	DET
bjp-16772	97	10	expiry	expiry	NOUN
bjp-16772	97	11	of	of	ADP
bjp-16772	97	12	the	the	DET
bjp-16772	97	13	patent	patent	NOUN
bjp-16772	97	14	,	,	PUNCT
bjp-16772	97	15	prescribing	prescribing	NOUN
bjp-16772	97	16	of	of	ADP
bjp-16772	97	17	atorvastatin	atorvastatin	NOUN
bjp-16772	97	18	may	may	AUX
bjp-16772	97	19	sharply	sharply	ADV
bjp-16772	97	20	increase	increase	VERB
bjp-16772	97	21	.	.	PUNCT
bjp-16772	98	1	incidence	incidence	NOUN
bjp-16772	98	2	rate	rate	NOUN
bjp-16772	98	3	of	of	ADP
bjp-16772	98	4	rosuvastatin	rosuvastatin	ADJ
bjp-16772	98	5	prescription	prescription	NOUN
bjp-16772	98	6	increased	increase	VERB
bjp-16772	98	7	markedly	markedly	ADV
bjp-16772	98	8	(	(	PUNCT
bjp-16772	98	9	p=	p=	NOUN
bjp-16772	98	10	0.001	0.001	NUM
bjp-16772	98	11	)	)	PUNCT
bjp-16772	98	12	.	.	PUNCT
bjp-16772	99	1	rosuvastatin	rosuvastatin	PROPN
bjp-16772	99	2	is	be	AUX
bjp-16772	99	3	the	the	DET
bjp-16772	99	4	third	third	ADJ
bjp-16772	99	5	generation	generation	NOUN
bjp-16772	99	6	statin	statin	PROPN
bjp-16772	99	7	that	that	PRON
bjp-16772	99	8	got	get	VERB
bjp-16772	99	9	406	406	NUM
bjp-16772	99	10	bangladesh	bangladesh	NOUN
bjp-16772	99	11	j	j	PROPN
bjp-16772	99	12	pharmacol	pharmacol	PROPN
bjp-16772	99	13	2013	2013	NUM
bjp-16772	99	14	;	;	PUNCT
bjp-16772	99	15	8	8	NUM
bjp-16772	99	16	:	:	SYM
bjp-16772	99	17	401	401	NUM
bjp-16772	99	18	-	-	SYM
bjp-16772	99	19	409	409	NUM
bjp-16772	99	20	table	table	NOUN
bjp-16772	99	21	iii	iii	NOUN
bjp-16772	99	22	proportion	proportion	NOUN
bjp-16772	99	23	of	of	ADP
bjp-16772	99	24	female	female	ADJ
bjp-16772	99	25	and	and	CCONJ
bjp-16772	99	26	male	male	ADJ
bjp-16772	99	27	patients	patient	NOUN
bjp-16772	99	28	and	and	CCONJ
bjp-16772	99	29	their	their	PRON
bjp-16772	99	30	age	age	NOUN
bjp-16772	99	31	group	group	NOUN
bjp-16772	99	32	in	in	ADP
bjp-16772	99	33	scotland	scotland	PROPN
bjp-16772	99	34	those	those	PRON
bjp-16772	99	35	were	be	AUX
bjp-16772	99	36	prescribed	prescribe	VERB
bjp-16772	99	37	simvastatin	simvastatin	NOUN
bjp-16772	99	38	from	from	ADP
bjp-16772	99	39	01/03/2005	01/03/2005	NUM
bjp-16772	99	40	to	to	ADP
bjp-16772	99	41	28/02/2010	28/02/2010	NUM
bjp-16772	99	42	80	80	NUM
bjp-16772	99	43	mg	mg	PROPN
bjp-16772	99	44	simvastatin	simvastatin	NOUN
bjp-16772	99	45	(	(	PUNCT
bjp-16772	99	46	n	n	NOUN
bjp-16772	99	47	=	=	SYM
bjp-16772	99	48	4,128	4,128	NUM
bjp-16772	99	49	)	)	PUNCT
bjp-16772	99	50	frequency	frequency	NOUN
bjp-16772	99	51	(	(	PUNCT
bjp-16772	99	52	%	%	INTJ
bjp-16772	99	53	)	)	PUNCT
bjp-16772	99	54	age	age	NOUN
bjp-16772	99	55	group	group	NOUN
bjp-16772	99	56	<	<	X
bjp-16772	99	57	=	=	NOUN
bjp-16772	99	58	40	40	NUM
bjp-16772	99	59	years	year	NOUN
bjp-16772	99	60	46	46	NUM
bjp-16772	99	61	(	(	PUNCT
bjp-16772	99	62	1	1	NUM
bjp-16772	99	63	)	)	PUNCT
bjp-16772	99	64	41	41	NUM
bjp-16772	99	65	-	-	SYM
bjp-16772	99	66	50	50	NUM
bjp-16772	99	67	years	year	NOUN
bjp-16772	99	68	327	327	NUM
bjp-16772	99	69	(	(	PUNCT
bjp-16772	99	70	8)	8)	NUM
bjp-16772	99	71	51	51	NUM
bjp-16772	99	72	-	-	SYM
bjp-16772	99	73	60	60	NUM
bjp-16772	99	74	years	year	NOUN
bjp-16772	99	75	929	929	NUM
bjp-16772	99	76	(	(	PUNCT
bjp-16772	99	77	23	23	NUM
bjp-16772	99	78	)	)	PUNCT
bjp-16772	99	79	61	61	NUM
bjp-16772	99	80	-	-	SYM
bjp-16772	99	81	70	70	NUM
bjp-16772	99	82	years	year	NOUN
bjp-16772	99	83	1,405	1,405	NUM
bjp-16772	99	84	(	(	PUNCT
bjp-16772	99	85	34	34	NUM
bjp-16772	99	86	)	)	PUNCT
bjp-16772	99	87	71	71	NUM
bjp-16772	99	88	-	-	SYM
bjp-16772	99	89	80	80	NUM
bjp-16772	99	90	years	year	NOUN
bjp-16772	99	91	1,054	1,054	NUM
bjp-16772	99	92	(	(	PUNCT
bjp-16772	99	93	26	26	NUM
bjp-16772	99	94	)	)	PUNCT
bjp-16772	99	95	>	>	SYM
bjp-16772	99	96	80	80	NUM
bjp-16772	99	97	years	year	NOUN
bjp-16772	99	98	367	367	NUM
bjp-16772	99	99	(	(	PUNCT
bjp-16772	99	100	9	9	NUM
bjp-16772	99	101	)	)	PUNCT
bjp-16772	99	102	gender	gender	NOUN
bjp-16772	99	103	male	male	NOUN
bjp-16772	99	104	2,011	2,011	NUM
bjp-16772	99	105	(	(	PUNCT
bjp-16772	99	106	49	49	NUM
bjp-16772	99	107	)	)	PUNCT
bjp-16772	99	108	female	female	NOUN
bjp-16772	99	109	2,117	2,117	NUM
bjp-16772	99	110	(	(	PUNCT
bjp-16772	99	111	51	51	NUM
bjp-16772	99	112	)	)	PUNCT
bjp-16772	99	113	low	low	ADJ
bjp-16772	99	114	dose	dose	NOUN
bjp-16772	99	115	simvastatin	simvastatin	NOUN
bjp-16772	99	116	(	(	PUNCT
bjp-16772	99	117	n	n	NOUN
bjp-16772	99	118	=	=	SYM
bjp-16772	99	119	116,150	116,150	NUM
bjp-16772	99	120	)	)	PUNCT
bjp-16772	99	121	age	age	NOUN
bjp-16772	99	122	group	group	NOUN
bjp-16772	99	123	<	<	X
bjp-16772	99	124	=	=	NOUN
bjp-16772	99	125	40	40	NUM
bjp-16772	99	126	years	year	NOUN
bjp-16772	99	127	2,180	2,180	NUM
bjp-16772	99	128	(	(	PUNCT
bjp-16772	99	129	2	2	NUM
bjp-16772	99	130	)	)	PUNCT
bjp-16772	99	131	41	41	NUM
bjp-16772	99	132	-	-	SYM
bjp-16772	99	133	50	50	NUM
bjp-16772	99	134	years	year	NOUN
bjp-16772	99	135	8,730	8,730	NUM
bjp-16772	99	136	(	(	PUNCT
bjp-16772	99	137	8)	8)	NUM
bjp-16772	99	138	51	51	NUM
bjp-16772	99	139	-	-	SYM
bjp-16772	99	140	60	60	NUM
bjp-16772	99	141	years	year	NOUN
bjp-16772	99	142	21,569	21,569	NUM
bjp-16772	99	143	(	(	PUNCT
bjp-16772	99	144	19	19	NUM
bjp-16772	99	145	)	)	PUNCT
bjp-16772	99	146	61	61	NUM
bjp-16772	99	147	-	-	SYM
bjp-16772	99	148	70	70	NUM
bjp-16772	99	149	years	year	NOUN
bjp-16772	99	150	33,343	33,343	NUM
bjp-16772	99	151	(	(	PUNCT
bjp-16772	99	152	29	29	NUM
bjp-16772	99	153	)	)	SYM
bjp-16772	99	154	71	71	NUM
bjp-16772	99	155	-	-	SYM
bjp-16772	99	156	80	80	NUM
bjp-16772	99	157	years	year	NOUN
bjp-16772	99	158	31,697	31,697	NUM
bjp-16772	99	159	(	(	PUNCT
bjp-16772	99	160	27	27	NUM
bjp-16772	99	161	)	)	PUNCT
bjp-16772	99	162	>	>	SYM
bjp-16772	99	163	80	80	NUM
bjp-16772	99	164	years	year	NOUN
bjp-16772	99	165	18,631	18,631	NUM
bjp-16772	99	166	(	(	PUNCT
bjp-16772	99	167	16	16	NUM
bjp-16772	99	168	)	)	PUNCT
bjp-16772	99	169	gender	gender	NOUN
bjp-16772	99	170	male	male	NOUN
bjp-16772	99	171	60,547	60,547	NUM
bjp-16772	99	172	(	(	PUNCT
bjp-16772	99	173	52	52	NUM
bjp-16772	99	174	)	)	PUNCT
bjp-16772	99	175	female	female	NOUN
bjp-16772	99	176	55,603	55,603	NUM
bjp-16772	99	177	(	(	PUNCT
bjp-16772	99	178	48	48	NUM
bjp-16772	99	179	)	)	PUNCT
bjp-16772	99	180	table	table	NOUN
bjp-16772	99	181	iv	iv	NUM
bjp-16772	99	182	proportion	proportion	NOUN
bjp-16772	99	183	of	of	ADP
bjp-16772	99	184	female	female	ADJ
bjp-16772	99	185	and	and	CCONJ
bjp-16772	99	186	male	male	ADJ
bjp-16772	99	187	patients	patient	NOUN
bjp-16772	99	188	and	and	CCONJ
bjp-16772	99	189	their	their	PRON
bjp-16772	99	190	age	age	NOUN
bjp-16772	99	191	group	group	NOUN
bjp-16772	99	192	in	in	ADP
bjp-16772	99	193	scotland	scotland	PROPN
bjp-16772	99	194	those	those	PRON
bjp-16772	99	195	were	be	AUX
bjp-16772	99	196	switched	switch	VERB
bjp-16772	99	197	to	to	ADP
bjp-16772	99	198	other	other	ADJ
bjp-16772	99	199	statins	statin	NOUN
bjp-16772	99	200	from	from	ADP
bjp-16772	99	201	high	high	ADJ
bjp-16772	99	202	dose	dose	NOUN
bjp-16772	99	203	simvastatin	simvastatin	NOUN
bjp-16772	99	204	from	from	ADP
bjp-16772	99	205	01/03/2005	01/03/2005	NUM
bjp-16772	99	206	to	to	ADP
bjp-16772	99	207	28/02/2009	28/02/2009	NUM
bjp-16772	99	208	patients	patient	NOUN
bjp-16772	99	209	switched	switch	VERB
bjp-16772	99	210	from	from	ADP
bjp-16772	99	211	80	80	NUM
bjp-16772	99	212	mg	mg	NOUN
bjp-16772	99	213	simvastatin	simvastatin	NOUN
bjp-16772	99	214	(	(	PUNCT
bjp-16772	99	215	n	n	NOUN
bjp-16772	99	216	=	=	SYM
bjp-16772	99	217	1053	1053	NUM
bjp-16772	99	218	)	)	PUNCT
bjp-16772	99	219	frequency	frequency	NOUN
bjp-16772	99	220	(	(	PUNCT
bjp-16772	99	221	%	%	INTJ
bjp-16772	99	222	)	)	PUNCT
bjp-16772	99	223	age	age	NOUN
bjp-16772	99	224	group	group	NOUN
bjp-16772	99	225	<	<	X
bjp-16772	99	226	=	=	SYM
bjp-16772	99	227	40	40	NUM
bjp-16772	99	228	years	year	NOUN
bjp-16772	99	229	15	15	NUM
bjp-16772	99	230	(	(	PUNCT
bjp-16772	99	231	1	1	NUM
bjp-16772	99	232	)	)	PUNCT
bjp-16772	99	233	41	41	NUM
bjp-16772	99	234	-	-	SYM
bjp-16772	99	235	50	50	NUM
bjp-16772	99	236	years	year	NOUN
bjp-16772	99	237	107	107	NUM
bjp-16772	99	238	(	(	PUNCT
bjp-16772	99	239	10	10	NUM
bjp-16772	99	240	)	)	PUNCT
bjp-16772	99	241	51	51	NUM
bjp-16772	99	242	-	-	SYM
bjp-16772	99	243	60	60	NUM
bjp-16772	99	244	years	year	NOUN
bjp-16772	99	245	270	270	NUM
bjp-16772	99	246	(	(	PUNCT
bjp-16772	99	247	26	26	NUM
bjp-16772	99	248	)	)	PUNCT
bjp-16772	99	249	61	61	NUM
bjp-16772	99	250	-	-	SYM
bjp-16772	99	251	70	70	NUM
bjp-16772	99	252	years	year	NOUN
bjp-16772	99	253	364	364	NUM
bjp-16772	99	254	(	(	PUNCT
bjp-16772	99	255	35	35	NUM
bjp-16772	99	256	)	)	PUNCT
bjp-16772	99	257	71	71	NUM
bjp-16772	99	258	-	-	SYM
bjp-16772	99	259	80	80	NUM
bjp-16772	99	260	years	year	NOUN
bjp-16772	99	261	250	250	NUM
bjp-16772	99	262	(	(	PUNCT
bjp-16772	99	263	24	24	NUM
bjp-16772	99	264	)	)	PUNCT
bjp-16772	99	265	>	>	SYM
bjp-16772	99	266	80	80	NUM
bjp-16772	99	267	years	year	NOUN
bjp-16772	99	268	47	47	NUM
bjp-16772	99	269	(	(	PUNCT
bjp-16772	99	270	5	5	NUM
bjp-16772	99	271	)	)	PUNCT
bjp-16772	99	272	gender	gender	NOUN
bjp-16772	99	273	male	male	NOUN
bjp-16772	99	274	500	500	NUM
bjp-16772	99	275	(	(	PUNCT
bjp-16772	99	276	48	48	NUM
bjp-16772	99	277	)	)	PUNCT
bjp-16772	99	278	female	female	NOUN
bjp-16772	99	279	553	553	NUM
bjp-16772	99	280	(	(	PUNCT
bjp-16772	99	281	52	52	NUM
bjp-16772	99	282	)	)	PUNCT
bjp-16772	99	283	patients	patient	NOUN
bjp-16772	99	284	continued	continue	VERB
bjp-16772	99	285	80	80	NUM
bjp-16772	99	286	mg	mg	PROPN
bjp-16772	99	287	simvastatin	simvastatin	NOUN
bjp-16772	99	288	(	(	PUNCT
bjp-16772	99	289	n	n	NOUN
bjp-16772	99	290	=	=	NOUN
bjp-16772	99	291	2,659	2,659	NUM
bjp-16772	99	292	)	)	PUNCT
bjp-16772	99	293	age	age	NOUN
bjp-16772	99	294	group	group	NOUN
bjp-16772	99	295	<	<	X
bjp-16772	99	296	=	=	SYM
bjp-16772	99	297	40	40	NUM
bjp-16772	99	298	years	year	NOUN
bjp-16772	99	299	23	23	NUM
bjp-16772	99	300	(	(	PUNCT
bjp-16772	99	301	1	1	NUM
bjp-16772	99	302	)	)	PUNCT
bjp-16772	99	303	41	41	NUM
bjp-16772	99	304	-	-	SYM
bjp-16772	99	305	50	50	NUM
bjp-16772	99	306	years	year	NOUN
bjp-16772	99	307	164	164	NUM
bjp-16772	99	308	(	(	PUNCT
bjp-16772	99	309	6	6	NUM
bjp-16772	99	310	)	)	SYM
bjp-16772	99	311	51	51	NUM
bjp-16772	99	312	-	-	SYM
bjp-16772	99	313	60	60	NUM
bjp-16772	99	314	years	year	NOUN
bjp-16772	99	315	543	543	NUM
bjp-16772	99	316	(	(	PUNCT
bjp-16772	99	317	20	20	NUM
bjp-16772	99	318	)	)	PUNCT
bjp-16772	99	319	61	61	NUM
bjp-16772	99	320	-	-	SYM
bjp-16772	99	321	70	70	NUM
bjp-16772	99	322	years	year	NOUN
bjp-16772	99	323	912	912	NUM
bjp-16772	99	324	(	(	PUNCT
bjp-16772	99	325	34	34	NUM
bjp-16772	99	326	)	)	PUNCT
bjp-16772	99	327	71	71	NUM
bjp-16772	99	328	-	-	SYM
bjp-16772	99	329	80	80	NUM
bjp-16772	99	330	years	year	NOUN
bjp-16772	99	331	727	727	NUM
bjp-16772	99	332	(	(	PUNCT
bjp-16772	99	333	27	27	NUM
bjp-16772	99	334	)	)	PUNCT
bjp-16772	99	335	>	>	SYM
bjp-16772	99	336	80	80	NUM
bjp-16772	99	337	years	year	NOUN
bjp-16772	99	338	290	290	NUM
bjp-16772	99	339	(	(	PUNCT
bjp-16772	99	340	11	11	NUM
bjp-16772	99	341	)	)	PUNCT
bjp-16772	99	342	gender	gender	NOUN
bjp-16772	99	343	male	male	NOUN
bjp-16772	99	344	1,310	1,310	NUM
bjp-16772	99	345	(	(	PUNCT
bjp-16772	99	346	49	49	NUM
bjp-16772	99	347	)	)	PUNCT
bjp-16772	99	348	female	female	NOUN
bjp-16772	99	349	1,349	1,349	NUM
bjp-16772	99	350	(	(	PUNCT
bjp-16772	99	351	51	51	NUM
bjp-16772	99	352	)	)	PUNCT
bjp-16772	99	353	approval	approval	NOUN
bjp-16772	99	354	from	from	ADP
bjp-16772	99	355	the	the	DET
bjp-16772	99	356	fda	fda	PROPN
bjp-16772	99	357	in	in	ADP
bjp-16772	99	358	2003	2003	NUM
bjp-16772	99	359	and	and	CCONJ
bjp-16772	99	360	till	till	SCONJ
bjp-16772	99	361	date	date	NOUN
bjp-16772	99	362	it	it	PRON
bjp-16772	99	363	is	be	AUX
bjp-16772	99	364	the	the	DET
bjp-16772	99	365	most	most	ADV
bjp-16772	99	366	potent	potent	NOUN
bjp-16772	99	367	of	of	ADP
bjp-16772	99	368	the	the	DET
bjp-16772	99	369	approved	approve	VERB
bjp-16772	99	370	statins	statin	NOUN
bjp-16772	99	371	(	(	PUNCT
bjp-16772	99	372	crouse	crouse	PROPN
bjp-16772	99	373	,	,	PUNCT
bjp-16772	99	374	2008	2008	NUM
bjp-16772	99	375	)	)	PUNCT
bjp-16772	99	376	.	.	PUNCT
bjp-16772	100	1	regarding	regard	VERB
bjp-16772	100	2	the	the	DET
bjp-16772	100	3	efficacy	efficacy	NOUN
bjp-16772	100	4	,	,	PUNCT
bjp-16772	100	5	several	several	ADJ
bjp-16772	100	6	clinical	clinical	ADJ
bjp-16772	100	7	trials	trial	NOUN
bjp-16772	100	8	and	and	CCONJ
bjp-16772	100	9	metaanalysis	metaanalysis	NOUN
bjp-16772	100	10	demonstrated	demonstrate	VERB
bjp-16772	100	11	the	the	DET
bjp-16772	100	12	superior	superior	ADJ
bjp-16772	100	13	efficacy	efficacy	NOUN
bjp-16772	100	14	of	of	ADP
bjp-16772	100	15	rosuvastatin	rosuvastatin	ADJ
bjp-16772	100	16	10	10	NUM
bjp-16772	100	17	mg	mg	NOUN
bjp-16772	100	18	as	as	ADP
bjp-16772	100	19	starting	starting	AUX
bjp-16772	100	20	dose	dose	NOUN
bjp-16772	100	21	than	than	ADP
bjp-16772	100	22	doses	dose	NOUN
bjp-16772	100	23	of	of	ADP
bjp-16772	100	24	atorvastatin	atorvastatin	PROPN
bjp-16772	100	25	,	,	PUNCT
bjp-16772	100	26	simvastatin	simvastatin	NOUN
bjp-16772	100	27	and	and	CCONJ
bjp-16772	100	28	pravastatin	pravastatin	NOUN
bjp-16772	100	29	in	in	ADP
bjp-16772	100	30	reducing	reduce	VERB
bjp-16772	100	31	ldl	ldl	NOUN
bjp-16772	100	32	-	-	PUNCT
bjp-16772	100	33	c	c	NOUN
bjp-16772	100	34	in	in	ADP
bjp-16772	100	35	hypercholesterolaemia	hypercholesterolaemia	NOUN
bjp-16772	100	36	(	(	PUNCT
bjp-16772	100	37	hobbs	hobbs	PROPN
bjp-16772	100	38	et	et	PROPN
bjp-16772	100	39	al	al	PROPN
bjp-16772	100	40	.	.	PROPN
bjp-16772	100	41	,	,	PUNCT
bjp-16772	100	42	2005	2005	NUM
bjp-16772	100	43	)	)	PUNCT
bjp-16772	100	44	.	.	PUNCT
bjp-16772	101	1	literally	literally	ADV
bjp-16772	101	2	,	,	PUNCT
bjp-16772	101	3	rosuvastatin	rosuvastatin	NOUN
bjp-16772	101	4	is	be	AUX
bjp-16772	101	5	the	the	DET
bjp-16772	101	6	only	only	ADJ
bjp-16772	101	7	current	current	ADJ
bjp-16772	101	8	statin	statin	NOUN
bjp-16772	101	9	that	that	PRON
bjp-16772	101	10	can	can	AUX
bjp-16772	101	11	reduce	reduce	VERB
bjp-16772	101	12	ldl	ldl	NOUN
bjp-16772	101	13	-	-	PUNCT
bjp-16772	101	14	c	c	NOUN
bjp-16772	101	15	>	>	PUNCT
bjp-16772	101	16	50	50	NUM
bjp-16772	101	17	%	%	NOUN
bjp-16772	101	18	at	at	ADP
bjp-16772	101	19	such	such	DET
bjp-16772	101	20	a	a	DET
bjp-16772	101	21	dose	dose	NOUN
bjp-16772	101	22	as	as	ADP
bjp-16772	101	23	20	20	NUM
bjp-16772	101	24	mg	mg	NOUN
bjp-16772	101	25	(	(	PUNCT
bjp-16772	101	26	catapano	catapano	PROPN
bjp-16772	101	27	et	et	PROPN
bjp-16772	101	28	al	al	PROPN
bjp-16772	101	29	.	.	PROPN
bjp-16772	101	30	,	,	PUNCT
bjp-16772	101	31	2005	2005	NUM
bjp-16772	101	32	)	)	PUNCT
bjp-16772	101	33	.	.	PUNCT
bjp-16772	102	1	in	in	ADP
bjp-16772	102	2	spite	spite	NOUN
bjp-16772	102	3	of	of	ADP
bjp-16772	102	4	increasing	increase	VERB
bjp-16772	102	5	evidences	evidence	NOUN
bjp-16772	102	6	of	of	ADP
bjp-16772	102	7	rosuvastatin	rosuvastatin	ADJ
bjp-16772	102	8	efficacy	efficacy	NOUN
bjp-16772	102	9	than	than	ADP
bjp-16772	102	10	other	other	ADJ
bjp-16772	102	11	available	available	ADJ
bjp-16772	102	12	statins	statin	NOUN
bjp-16772	102	13	,	,	PUNCT
bjp-16772	102	14	fewer	few	ADJ
bjp-16772	102	15	patients	patient	NOUN
bjp-16772	102	16	were	be	AUX
bjp-16772	102	17	prescribed	prescribe	VERB
bjp-16772	102	18	rosuvastatin	rosuvastatin	NOUN
bjp-16772	102	19	in	in	ADP
bjp-16772	102	20	scotland	scotland	PROPN
bjp-16772	102	21	.	.	PUNCT
bjp-16772	103	1	this	this	PRON
bjp-16772	103	2	under	under	ADP
bjp-16772	103	3	prescription	prescription	NOUN
bjp-16772	103	4	could	could	AUX
bjp-16772	103	5	be	be	AUX
bjp-16772	103	6	due	due	ADJ
bjp-16772	103	7	to	to	ADP
bjp-16772	103	8	the	the	DET
bjp-16772	103	9	lack	lack	NOUN
bjp-16772	103	10	of	of	ADP
bjp-16772	103	11	long	long	ADJ
bjp-16772	103	12	-	-	PUNCT
bjp-16772	103	13	term	term	NOUN
bjp-16772	103	14	safety	safety	NOUN
bjp-16772	103	15	data	datum	NOUN
bjp-16772	103	16	and	and	CCONJ
bjp-16772	103	17	is	be	AUX
bjp-16772	103	18	licensed	license	VERB
bjp-16772	103	19	for	for	ADP
bjp-16772	103	20	using	use	VERB
bjp-16772	103	21	in	in	ADP
bjp-16772	103	22	primary	primary	ADJ
bjp-16772	103	23	hypercholesterolemia	hypercholesterolemia	NOUN
bjp-16772	103	24	only	only	ADV
bjp-16772	103	25	in	in	ADP
bjp-16772	103	26	the	the	DET
bjp-16772	103	27	uk	uk	PROPN
bjp-16772	103	28	.	.	PUNCT
bjp-16772	104	1	meanwhile	meanwhile	ADV
bjp-16772	104	2	,	,	PUNCT
bjp-16772	104	3	other	other	ADJ
bjp-16772	104	4	available	available	ADJ
bjp-16772	104	5	statins	statin	NOUN
bjp-16772	104	6	have	have	VERB
bjp-16772	104	7	long	long	ADJ
bjp-16772	104	8	-	-	PUNCT
bjp-16772	104	9	term	term	NOUN
bjp-16772	104	10	mortality	mortality	NOUN
bjp-16772	104	11	and	and	CCONJ
bjp-16772	104	12	morbidity	morbidity	NOUN
bjp-16772	104	13	data	datum	NOUN
bjp-16772	104	14	and	and	CCONJ
bjp-16772	104	15	permitted	permit	VERB
bjp-16772	104	16	to	to	PART
bjp-16772	104	17	use	use	VERB
bjp-16772	104	18	both	both	PRON
bjp-16772	104	19	in	in	ADP
bjp-16772	104	20	primary	primary	ADJ
bjp-16772	104	21	and	and	CCONJ
bjp-16772	104	22	secondary	secondary	ADJ
bjp-16772	104	23	cvd	cvd	PROPN
bjp-16772	104	24	events	event	VERB
bjp-16772	104	25	prevention	prevention	NOUN
bjp-16772	104	26	.	.	PUNCT
bjp-16772	105	1	nice	nice	ADJ
bjp-16772	105	2	(	(	PUNCT
bjp-16772	105	3	2010	2010	NUM
bjp-16772	105	4	)	)	PUNCT
bjp-16772	105	5	recommended	recommend	VERB
bjp-16772	105	6	that	that	SCONJ
bjp-16772	105	7	statin	statin	PROPN
bjp-16772	105	8	therapy	therapy	NOUN
bjp-16772	105	9	should	should	AUX
bjp-16772	105	10	usually	usually	ADV
bjp-16772	105	11	be	be	AUX
bjp-16772	105	12	started	start	VERB
bjp-16772	105	13	with	with	ADP
bjp-16772	105	14	a	a	DET
bjp-16772	105	15	drug	drug	NOUN
bjp-16772	105	16	with	with	ADP
bjp-16772	105	17	a	a	DET
bjp-16772	105	18	low	low	ADJ
bjp-16772	105	19	acquisition	acquisition	NOUN
bjp-16772	105	20	cost	cost	NOUN
bjp-16772	105	21	;	;	PUNCT
bjp-16772	105	22	the	the	DET
bjp-16772	105	23	expenditure	expenditure	NOUN
bjp-16772	105	24	for	for	ADP
bjp-16772	105	25	5	5	NUM
bjp-16772	105	26	mg	mg	PROPN
bjp-16772	105	27	rosuvastatin	rosuvastatin	NOUN
bjp-16772	105	28	is	be	AUX
bjp-16772	105	29	£	£	SYM
bjp-16772	105	30	18.03	18.03	NUM
bjp-16772	105	31	for	for	ADP
bjp-16772	105	32	28	28	NUM
bjp-16772	105	33	days	day	NOUN
bjp-16772	105	34	,	,	PUNCT
bjp-16772	105	35	13	13	NUM
bjp-16772	105	36	times	time	NOUN
bjp-16772	105	37	more	more	ADV
bjp-16772	105	38	costly	costly	ADJ
bjp-16772	105	39	than	than	ADP
bjp-16772	105	40	40	40	NUM
bjp-16772	105	41	mg	mg	PROPN
bjp-16772	105	42	simvastatin	simvastatin	NOUN
bjp-16772	105	43	and	and	CCONJ
bjp-16772	105	44	£	£	SYM
bjp-16772	105	45	5	5	NUM
bjp-16772	105	46	more	more	ADV
bjp-16772	105	47	costly	costly	ADJ
bjp-16772	105	48	than	than	ADP
bjp-16772	105	49	10	10	NUM
bjp-16772	105	50	mg	mg	PROPN
bjp-16772	105	51	atorvastatin	atorvastatin	NOUN
bjp-16772	105	52	for	for	ADP
bjp-16772	105	53	the	the	DET
bjp-16772	105	54	same	same	ADJ
bjp-16772	105	55	duration	duration	NOUN
bjp-16772	105	56	(	(	PUNCT
bjp-16772	105	57	prescribing	prescribing	NOUN
bjp-16772	105	58	indicators	indicator	NOUN
bjp-16772	105	59	,	,	PUNCT
bjp-16772	105	60	2010	2010	NUM
bjp-16772	105	61	)	)	PUNCT
bjp-16772	105	62	.	.	PUNCT
bjp-16772	106	1	henceforth	henceforth	ADV
bjp-16772	106	2	,	,	PUNCT
bjp-16772	106	3	gps	gps	PROPN
bjp-16772	106	4	will	will	AUX
bjp-16772	106	5	be	be	AUX
bjp-16772	106	6	less	less	ADV
bjp-16772	106	7	inclined	inclined	ADJ
bjp-16772	106	8	to	to	PART
bjp-16772	106	9	prescribe	prescribe	VERB
bjp-16772	106	10	rosuvastatin	rosuvastatin	NOUN
bjp-16772	106	11	except	except	SCONJ
bjp-16772	106	12	when	when	SCONJ
bjp-16772	106	13	other	other	ADJ
bjp-16772	106	14	statins	statin	NOUN
bjp-16772	106	15	are	be	AUX
bjp-16772	106	16	not	not	PART
bjp-16772	106	17	well	well	ADV
bjp-16772	106	18	tolerated	tolerate	VERB
bjp-16772	106	19	by	by	ADP
bjp-16772	106	20	patients	patient	NOUN
bjp-16772	106	21	.	.	PUNCT
bjp-16772	107	1	both	both	CCONJ
bjp-16772	107	2	the	the	DET
bjp-16772	107	3	prevalence	prevalence	NOUN
bjp-16772	107	4	and	and	CCONJ
bjp-16772	107	5	incidence	incidence	NOUN
bjp-16772	107	6	rate	rate	NOUN
bjp-16772	107	7	of	of	ADP
bjp-16772	107	8	pravastatin	pravastatin	NOUN
bjp-16772	107	9	prescriptions	prescription	NOUN
bjp-16772	107	10	decreased	decrease	VERB
bjp-16772	107	11	in	in	ADP
bjp-16772	107	12	the	the	DET
bjp-16772	107	13	study	study	NOUN
bjp-16772	107	14	period	period	NOUN
bjp-16772	107	15	(	(	PUNCT
bjp-16772	107	16	p=	p=	NOUN
bjp-16772	107	17	0.001	0.001	NUM
bjp-16772	107	18	and	and	CCONJ
bjp-16772	107	19	p=	p=	NOUN
bjp-16772	107	20	0.004	0.004	NUM
bjp-16772	107	21	respectively	respectively	ADV
bjp-16772	107	22	)	)	PUNCT
bjp-16772	107	23	.	.	PUNCT
bjp-16772	108	1	pravastatin	pravastatin	PROPN
bjp-16772	108	2	represents	represent	VERB
bjp-16772	108	3	the	the	DET
bjp-16772	108	4	lowest	low	ADJ
bjp-16772	108	5	potency	potency	NOUN
bjp-16772	108	6	statin	statin	PROPN
bjp-16772	108	7	.	.	PUNCT
bjp-16772	109	1	ideally	ideally	ADV
bjp-16772	109	2	it	it	PRON
bjp-16772	109	3	needs	need	VERB
bjp-16772	109	4	to	to	PART
bjp-16772	109	5	be	be	AUX
bjp-16772	109	6	taken	take	VERB
bjp-16772	109	7	40	40	NUM
bjp-16772	109	8	mg	mg	NOUN
bjp-16772	109	9	daily	daily	ADV
bjp-16772	109	10	to	to	PART
bjp-16772	109	11	achieve	achieve	VERB
bjp-16772	109	12	a	a	DET
bjp-16772	109	13	30	30	NUM
bjp-16772	109	14	%	%	NOUN
bjp-16772	109	15	decrease	decrease	NOUN
bjp-16772	109	16	in	in	ADP
bjp-16772	109	17	ldl	ldl	NOUN
bjp-16772	109	18	-	-	PUNCT
bjp-16772	109	19	c	c	NOUN
bjp-16772	109	20	level	level	NOUN
bjp-16772	109	21	(	(	PUNCT
bjp-16772	109	22	shepherd	shepherd	NOUN
bjp-16772	109	23	et	et	PROPN
bjp-16772	109	24	al	al	PROPN
bjp-16772	109	25	.	.	PROPN
bjp-16772	109	26	,	,	PUNCT
bjp-16772	109	27	2002	2002	NUM
bjp-16772	109	28	;	;	PUNCT
bjp-16772	109	29	shepherd	shepherd	NOUN
bjp-16772	109	30	et	et	PROPN
bjp-16772	109	31	al	al	PROPN
bjp-16772	109	32	.	.	PROPN
bjp-16772	109	33	,	,	PUNCT
bjp-16772	109	34	1995	1995	NUM
bjp-16772	109	35	)	)	PUNCT
bjp-16772	109	36	whereas	whereas	SCONJ
bjp-16772	109	37	simvastatin	simvastatin	PROPN
bjp-16772	109	38	,	,	PUNCT
bjp-16772	109	39	atorvastatin	atorvastatin	NOUN
bjp-16772	109	40	and	and	CCONJ
bjp-16772	109	41	rosuvastatin	rosuvastatin	NOUN
bjp-16772	109	42	at	at	ADP
bjp-16772	109	43	40	40	NUM
bjp-16772	109	44	mg	mg	NOUN
bjp-16772	109	45	dose	dose	NOUN
bjp-16772	109	46	lowers	lower	VERB
bjp-16772	109	47	the	the	DET
bjp-16772	109	48	ldl	ldl	NOUN
bjp-16772	109	49	by	by	ADP
bjp-16772	109	50	37	37	NUM
bjp-16772	109	51	,	,	PUNCT
bjp-16772	109	52	49	49	NUM
bjp-16772	109	53	and	and	CCONJ
bjp-16772	109	54	59	59	NUM
bjp-16772	109	55	%	%	NOUN
bjp-16772	109	56	respectively	respectively	ADV
bjp-16772	109	57	(	(	PUNCT
bjp-16772	109	58	davidson	davidson	NOUN
bjp-16772	109	59	et	et	PROPN
bjp-16772	109	60	al	al	PROPN
bjp-16772	109	61	.	.	PROPN
bjp-16772	109	62	,	,	PUNCT
bjp-16772	109	63	2007	2007	NUM
bjp-16772	109	64	)	)	PUNCT
bjp-16772	109	65	.	.	PUNCT
bjp-16772	110	1	ohsfeldt	ohsfeldt	PROPN
bjp-16772	110	2	et	et	PROPN
bjp-16772	110	3	al	al	PROPN
bjp-16772	110	4	.	.	PROPN
bjp-16772	110	5	,	,	PUNCT
bjp-16772	110	6	2008	2008	NUM
bjp-16772	110	7	pointed	point	VERB
bjp-16772	110	8	out	out	ADP
bjp-16772	110	9	the	the	DET
bjp-16772	110	10	7	7	NUM
bjp-16772	110	11	%	%	NOUN
bjp-16772	110	12	more	more	ADJ
bjp-16772	110	13	efficacy	efficacy	NOUN
bjp-16772	110	14	of	of	ADP
bjp-16772	110	15	generic	generic	ADJ
bjp-16772	110	16	simvastatin	simvastatin	NOUN
bjp-16772	110	17	than	than	ADP
bjp-16772	110	18	pravastatin	pravastatin	NOUN
bjp-16772	110	19	in	in	ADP
bjp-16772	110	20	lowering	lower	VERB
bjp-16772	110	21	ldlc	ldlc	NOUN
bjp-16772	110	22	.	.	PUNCT
bjp-16772	111	1	hence	hence	ADV
bjp-16772	111	2	,	,	PUNCT
bjp-16772	111	3	pravastatin	pravastatin	NOUN
bjp-16772	111	4	will	will	AUX
bjp-16772	111	5	be	be	AUX
bjp-16772	111	6	the	the	DET
bjp-16772	111	7	less	less	ADV
bjp-16772	111	8	preferred	preferred	ADJ
bjp-16772	111	9	statin	statin	NOUN
bjp-16772	111	10	as	as	ADP
bjp-16772	111	11	a	a	DET
bjp-16772	111	12	first	first	ADJ
bjp-16772	111	13	line	line	NOUN
bjp-16772	111	14	drug	drug	NOUN
bjp-16772	111	15	for	for	ADP
bjp-16772	111	16	preventing	prevent	VERB
bjp-16772	111	17	primary	primary	ADJ
bjp-16772	111	18	or	or	CCONJ
bjp-16772	111	19	secondary	secondary	ADJ
bjp-16772	111	20	cvd	cvd	PROPN
bjp-16772	111	21	events	event	NOUN
bjp-16772	111	22	.	.	PUNCT
bjp-16772	112	1	a	a	DET
bjp-16772	112	2	downward	downward	ADJ
bjp-16772	112	3	trend	trend	NOUN
bjp-16772	112	4	was	be	AUX
bjp-16772	112	5	noted	note	VERB
bjp-16772	112	6	both	both	CCONJ
bjp-16772	112	7	in	in	ADP
bjp-16772	112	8	the	the	DET
bjp-16772	112	9	prevalence	prevalence	NOUN
bjp-16772	112	10	(	(	PUNCT
bjp-16772	112	11	p=	p=	NOUN
bjp-16772	112	12	0.001	0.001	NUM
bjp-16772	112	13	)	)	PUNCT
bjp-16772	112	14	and	and	CCONJ
bjp-16772	112	15	incidence	incidence	NOUN
bjp-16772	112	16	(	(	PUNCT
bjp-16772	112	17	p=	p=	NOUN
bjp-16772	112	18	0.02	0.02	NUM
bjp-16772	112	19	)	)	PUNCT
bjp-16772	112	20	rate	rate	NOUN
bjp-16772	112	21	of	of	ADP
bjp-16772	112	22	fluvastatin	fluvastatin	NOUN
bjp-16772	112	23	prescriptions	prescription	NOUN
bjp-16772	112	24	.	.	PUNCT
bjp-16772	113	1	although	although	SCONJ
bjp-16772	113	2	fluvastatin	fluvastatin	NOUN
bjp-16772	113	3	is	be	AUX
bjp-16772	113	4	one	one	NUM
bjp-16772	113	5	of	of	ADP
bjp-16772	113	6	the	the	DET
bjp-16772	113	7	first	first	ADJ
bjp-16772	113	8	marketed	market	VERB
bjp-16772	113	9	statins	statin	NOUN
bjp-16772	113	10	in	in	ADP
bjp-16772	113	11	the	the	DET
bjp-16772	113	12	world	world	NOUN
bjp-16772	113	13	,	,	PUNCT
bjp-16772	113	14	its	its	PRON
bjp-16772	113	15	effective	effective	ADJ
bjp-16772	113	16	dose	dose	NOUN
bjp-16772	113	17	range	range	NOUN
bjp-16772	113	18	is	be	AUX
bjp-16772	113	19	still	still	ADV
bjp-16772	113	20	not	not	PART
bjp-16772	113	21	fully	fully	ADV
bjp-16772	113	22	explored	explore	VERB
bjp-16772	113	23	;	;	PUNCT
bjp-16772	113	24	thereby	thereby	ADV
bjp-16772	113	25	making	make	VERB
bjp-16772	113	26	it	it	PRON
bjp-16772	113	27	as	as	ADP
bjp-16772	113	28	the	the	DET
bjp-16772	113	29	lowest	low	ADJ
bjp-16772	113	30	potency	potency	NOUN
bjp-16772	113	31	statin	statin	PROPN
bjp-16772	113	32	(	(	PUNCT
bjp-16772	113	33	mcdonald	mcdonald	PROPN
bjp-16772	113	34	et	et	PROPN
bjp-16772	113	35	al	al	PROPN
bjp-16772	113	36	.	.	PROPN
bjp-16772	113	37	,	,	PUNCT
bjp-16772	113	38	2008	2008	NUM
bjp-16772	113	39	)	)	PUNCT
bjp-16772	113	40	.	.	PUNCT
bjp-16772	114	1	a	a	DET
bjp-16772	114	2	daily	daily	ADJ
bjp-16772	114	3	dose	dose	NOUN
bjp-16772	114	4	of	of	ADP
bjp-16772	114	5	80	80	NUM
bjp-16772	114	6	mg	mg	PROPN
bjp-16772	114	7	fluvastatin	fluvastatin	NOUN
bjp-16772	114	8	can	can	AUX
bjp-16772	114	9	reduce	reduce	VERB
bjp-16772	114	10	30	30	NUM
bjp-16772	114	11	%	%	NOUN
bjp-16772	114	12	ldl	ldl	NOUN
bjp-16772	114	13	-	-	PUNCT
bjp-16772	114	14	c	c	PROPN
bjp-16772	114	15	,	,	PUNCT
bjp-16772	114	16	a	a	DET
bjp-16772	114	17	very	very	ADV
bjp-16772	114	18	high	high	ADJ
bjp-16772	114	19	dose	dose	NOUN
bjp-16772	114	20	compared	compare	VERB
bjp-16772	114	21	to	to	ADP
bjp-16772	114	22	other	other	ADJ
bjp-16772	114	23	marketed	market	VERB
bjp-16772	114	24	statins	statin	NOUN
bjp-16772	114	25	(	(	PUNCT
bjp-16772	114	26	weng	weng	PROPN
bjp-16772	114	27	et	et	PROPN
bjp-16772	114	28	al	al	PROPN
bjp-16772	114	29	.	.	PROPN
bjp-16772	114	30	,	,	PUNCT
bjp-16772	114	31	2010	2010	NUM
bjp-16772	114	32	)	)	PUNCT
bjp-16772	114	33	.	.	PUNCT
bjp-16772	115	1	the	the	DET
bjp-16772	115	2	cumulative	cumulative	ADJ
bjp-16772	115	3	prevalence	prevalence	NOUN
bjp-16772	115	4	rate	rate	NOUN
bjp-16772	115	5	for	for	ADP
bjp-16772	115	6	all	all	DET
bjp-16772	115	7	statins	statin	NOUN
bjp-16772	115	8	increased	increase	VERB
bjp-16772	115	9	by	by	ADP
bjp-16772	115	10	28	28	NUM
bjp-16772	115	11	%	%	NOUN
bjp-16772	115	12	(	(	PUNCT
bjp-16772	115	13	p=	p=	NOUN
bjp-16772	115	14	0.001	0.001	NUM
bjp-16772	115	15	)	)	PUNCT
bjp-16772	115	16	.	.	PUNCT
bjp-16772	116	1	while	while	SCONJ
bjp-16772	116	2	,	,	PUNCT
bjp-16772	116	3	the	the	DET
bjp-16772	116	4	incidence	incidence	NOUN
bjp-16772	116	5	rate	rate	NOUN
bjp-16772	116	6	reduced	reduce	VERB
bjp-16772	116	7	by	by	ADP
bjp-16772	116	8	24	24	NUM
bjp-16772	116	9	%	%	NOUN
bjp-16772	116	10	(	(	PUNCT
bjp-16772	116	11	p=	p=	NOUN
bjp-16772	116	12	0.001	0.001	NUM
bjp-16772	116	13	)	)	PUNCT
bjp-16772	116	14	.	.	PUNCT
bjp-16772	117	1	packham	packham	PROPN
bjp-16772	117	2	et	et	PROPN
bjp-16772	117	3	al	al	PROPN
bjp-16772	117	4	.	.	PROPN
bjp-16772	118	1	(	(	PUNCT
bjp-16772	118	2	2000	2000	NUM
bjp-16772	118	3	)	)	PUNCT
bjp-16772	118	4	in	in	ADP
bjp-16772	118	5	nottingham	nottingham	PROPN
bjp-16772	118	6	,	,	PUNCT
bjp-16772	118	7	kucera	kucera	NOUN
bjp-16772	118	8	et	et	PROPN
bjp-16772	118	9	al	al	PROPN
bjp-16772	118	10	.	.	PROPN
bjp-16772	119	1	(	(	PUNCT
bjp-16772	119	2	2005	2005	NUM
bjp-16772	119	3	)	)	PUNCT
bjp-16772	119	4	in	in	ADP
bjp-16772	119	5	the	the	DET
bjp-16772	119	6	czech	czech	ADJ
bjp-16772	119	7	population	population	NOUN
bjp-16772	119	8	,	,	PUNCT
bjp-16772	119	9	magrini	magrini	PROPN
bjp-16772	119	10	et	et	PROPN
bjp-16772	119	11	al	al	PROPN
bjp-16772	119	12	.	.	PROPN
bjp-16772	120	1	(	(	PUNCT
bjp-16772	120	2	1997	1997	NUM
bjp-16772	120	3	)	)	PUNCT
bjp-16772	120	4	in	in	ADP
bjp-16772	120	5	australia	australia	PROPN
bjp-16772	120	6	,	,	PUNCT
bjp-16772	120	7	finland	finland	PROPN
bjp-16772	120	8	,	,	PUNCT
bjp-16772	120	9	italy	italy	PROPN
bjp-16772	120	10	,	,	PUNCT
bjp-16772	120	11	norway	norway	PROPN
bjp-16772	120	12	and	and	CCONJ
bjp-16772	120	13	sweden	sweden	PROPN
bjp-16772	120	14	,	,	PUNCT
bjp-16772	120	15	jackevicious	jackevicious	PROPN
bjp-16772	120	16	et	et	PROPN
bjp-16772	120	17	al	al	PROPN
bjp-16772	120	18	.	.	PROPN
bjp-16772	121	1	(	(	PUNCT
bjp-16772	121	2	2003	2003	NUM
bjp-16772	121	3	)	)	PUNCT
bjp-16772	121	4	in	in	ADP
bjp-16772	121	5	canada	canada	PROPN
bjp-16772	121	6	noted	note	VERB
bjp-16772	121	7	a	a	DET
bjp-16772	121	8	similar	similar	ADJ
bjp-16772	121	9	pattern	pattern	NOUN
bjp-16772	121	10	of	of	ADP
bjp-16772	121	11	increased	increase	VERB
bjp-16772	121	12	prevalent	prevalent	ADJ
bjp-16772	121	13	statin	statin	PROPN
bjp-16772	121	14	use	use	NOUN
bjp-16772	121	15	.	.	PUNCT
bjp-16772	122	1	due	due	ADP
bjp-16772	122	2	to	to	ADP
bjp-16772	122	3	the	the	DET
bjp-16772	122	4	better	well	ADJ
bjp-16772	122	5	survival	survival	NOUN
bjp-16772	122	6	of	of	ADP
bjp-16772	122	7	patients	patient	NOUN
bjp-16772	122	8	with	with	ADP
bjp-16772	122	9	previously	previously	ADV
bjp-16772	122	10	diagnosed	diagnose	VERB
bjp-16772	122	11	chd	chd	NOUN
bjp-16772	122	12	,	,	PUNCT
bjp-16772	122	13	gps	gps	PROPN
bjp-16772	122	14	continued	continue	VERB
bjp-16772	122	15	renewing	renew	VERB
bjp-16772	122	16	the	the	DET
bjp-16772	122	17	treatment	treatment	NOUN
bjp-16772	122	18	resulting	result	VERB
bjp-16772	122	19	cumulative	cumulative	ADJ
bjp-16772	122	20	increase	increase	NOUN
bjp-16772	122	21	in	in	ADP
bjp-16772	122	22	prevalence	prevalence	NOUN
bjp-16772	122	23	rate	rate	NOUN
bjp-16772	122	24	.	.	PUNCT
bjp-16772	123	1	concurrently	concurrently	ADV
bjp-16772	123	2	,	,	PUNCT
bjp-16772	123	3	mortality	mortality	NOUN
bjp-16772	123	4	declined	decline	VERB
bjp-16772	123	5	among	among	ADP
bjp-16772	123	6	people	people	NOUN
bjp-16772	123	7	with	with	ADP
bjp-16772	123	8	chd	chd	PROPN
bjp-16772	123	9	in	in	ADP
bjp-16772	123	10	the	the	DET
bjp-16772	123	11	scottish	scottish	ADJ
bjp-16772	123	12	population	population	NOUN
bjp-16772	123	13	.	.	PUNCT
bjp-16772	124	1	the	the	DET
bjp-16772	124	2	reduction	reduction	NOUN
bjp-16772	124	3	in	in	ADP
bjp-16772	124	4	the	the	DET
bjp-16772	124	5	mortality	mortality	NOUN
bjp-16772	124	6	outweighs	outweigh	VERB
bjp-16772	124	7	the	the	DET
bjp-16772	124	8	newly	newly	ADV
bjp-16772	124	9	diagnosed	diagnose	VERB
bjp-16772	124	10	chd	chd	NOUN
bjp-16772	124	11	and	and	CCONJ
bjp-16772	124	12	the	the	DET
bjp-16772	124	13	combined	combine	VERB
bjp-16772	124	14	effects	effect	NOUN
bjp-16772	124	15	in	in	ADP
bjp-16772	124	16	turn	turn	NOUN
bjp-16772	124	17	declines	decline	VERB
bjp-16772	124	18	the	the	DET
bjp-16772	124	19	incidence	incidence	ADJ
bjp-16772	124	20	rate	rate	NOUN
bjp-16772	124	21	of	of	ADP
bjp-16772	124	22	statin	statin	ADJ
bjp-16772	124	23	prescriptions	prescription	NOUN
bjp-16772	124	24	.	.	PUNCT
bjp-16772	125	1	davies	davy	NOUN
bjp-16772	125	2	et	et	PROPN
bjp-16772	125	3	al	al	PROPN
bjp-16772	125	4	.	.	PUNCT
bjp-16772	126	1	(	(	PUNCT
bjp-16772	126	2	2007	2007	NUM
bjp-16772	126	3	)	)	PUNCT
bjp-16772	126	4	in	in	ADP
bjp-16772	126	5	their	their	PRON
bjp-16772	126	6	study	study	NOUN
bjp-16772	126	7	also	also	ADV
bjp-16772	126	8	documented	document	VERB
bjp-16772	126	9	a	a	DET
bjp-16772	126	10	similar	similar	ADJ
bjp-16772	126	11	trend	trend	NOUN
bjp-16772	126	12	in	in	ADP
bjp-16772	126	13	the	the	DET
bjp-16772	126	14	prevalence	prevalence	NOUN
bjp-16772	126	15	and	and	CCONJ
bjp-16772	126	16	incidence	incidence	NOUN
bjp-16772	126	17	of	of	ADP
bjp-16772	126	18	chd	chd	NOUN
bjp-16772	126	19	in	in	ADP
bjp-16772	126	20	the	the	DET
bjp-16772	126	21	uk	uk	PROPN
bjp-16772	126	22	population	population	NOUN
bjp-16772	126	23	.	.	PUNCT
bjp-16772	127	1	while	while	SCONJ
bjp-16772	127	2	,	,	PUNCT
bjp-16772	127	3	many	many	ADJ
bjp-16772	127	4	clinical	clinical	ADJ
bjp-16772	127	5	trials	trial	NOUN
bjp-16772	127	6	(	(	PUNCT
bjp-16772	127	7	cannon	cannon	NOUN
bjp-16772	127	8	et	et	NOUN
bjp-16772	127	9	al	al	PROPN
bjp-16772	127	10	.	.	PROPN
bjp-16772	127	11	,	,	PUNCT
bjp-16772	127	12	2002	2002	NUM
bjp-16772	127	13	;	;	PUNCT
bjp-16772	127	14	pedersen	pedersen	PROPN
bjp-16772	127	15	et	et	PROPN
bjp-16772	127	16	al	al	PROPN
bjp-16772	127	17	.	.	PROPN
bjp-16772	127	18	,	,	PUNCT
bjp-16772	127	19	2005	2005	NUM
bjp-16772	127	20	;	;	PUNCT
bjp-16772	127	21	rosa	rosa	PROPN
bjp-16772	127	22	et	et	PROPN
bjp-16772	127	23	al	al	PROPN
bjp-16772	127	24	.	.	PROPN
bjp-16772	127	25	,	,	PUNCT
bjp-16772	127	26	2005	2005	NUM
bjp-16772	127	27	)	)	PUNCT
bjp-16772	127	28	evidenced	evidence	VERB
bjp-16772	127	29	the	the	DET
bjp-16772	127	30	incremental	incremental	ADJ
bjp-16772	127	31	benefits	benefit	NOUN
bjp-16772	127	32	of	of	ADP
bjp-16772	127	33	high	high	ADJ
bjp-16772	127	34	dose	dose	NOUN
bjp-16772	127	35	statin	statin	PROPN
bjp-16772	127	36	therapy	therapy	NOUN
bjp-16772	127	37	in	in	ADP
bjp-16772	127	38	lowering	lower	VERB
bjp-16772	127	39	the	the	DET
bjp-16772	127	40	ldl	ldl	NOUN
bjp-16772	127	41	-	-	PUNCT
bjp-16772	127	42	c	c	NOUN
bjp-16772	127	43	level	level	NOUN
bjp-16772	127	44	especially	especially	ADV
bjp-16772	127	45	in	in	ADP
bjp-16772	127	46	patients	patient	NOUN
bjp-16772	127	47	with	with	ADP
bjp-16772	127	48	chd	chd	NOUN
bjp-16772	127	49	or	or	CCONJ
bjp-16772	127	50	diabetes	diabetes	NOUN
bjp-16772	127	51	,	,	PUNCT
bjp-16772	127	52	there	there	PRON
bjp-16772	127	53	is	be	VERB
bjp-16772	127	54	also	also	ADV
bjp-16772	127	55	manifestation	manifestation	NOUN
bjp-16772	127	56	(	(	PUNCT
bjp-16772	127	57	lemos	lemos	PROPN
bjp-16772	127	58	et	et	PROPN
bjp-16772	127	59	al	al	PROPN
bjp-16772	127	60	.	.	PROPN
bjp-16772	127	61	,	,	PUNCT
bjp-16772	127	62	2004	2004	NUM
bjp-16772	127	63	;	;	PUNCT
bjp-16772	127	64	bruckert	bruckert	PROPN
bjp-16772	127	65	et	et	PROPN
bjp-16772	127	66	al	al	PROPN
bjp-16772	127	67	.	.	PROPN
bjp-16772	127	68	,	,	PUNCT
bjp-16772	127	69	2005	2005	NUM
bjp-16772	127	70	;	;	PUNCT
bjp-16772	127	71	search	search	NOUN
bjp-16772	127	72	group	group	NOUN
bjp-16772	127	73	,	,	PUNCT
bjp-16772	127	74	2010	2010	NUM
bjp-16772	127	75	)	)	PUNCT
bjp-16772	127	76	of	of	ADP
bjp-16772	127	77	increased	increase	VERB
bjp-16772	127	78	rate	rate	NOUN
bjp-16772	127	79	of	of	ADP
bjp-16772	127	80	adverse	adverse	ADJ
bjp-16772	127	81	events	event	NOUN
bjp-16772	127	82	such	such	ADJ
bjp-16772	127	83	as	as	ADP
bjp-16772	127	84	myopathy	myopathy	ADJ
bjp-16772	127	85	,	,	PUNCT
bjp-16772	127	86	elevation	elevation	NOUN
bjp-16772	127	87	of	of	ADP
bjp-16772	127	88	hepatic	hepatic	ADJ
bjp-16772	127	89	transaminases	transaminase	NOUN
bjp-16772	127	90	leading	lead	VERB
bjp-16772	127	91	to	to	ADP
bjp-16772	127	92	patients	patient	NOUN
bjp-16772	127	93	non	non	ADJ
bjp-16772	127	94	adherence	adherence	NOUN
bjp-16772	127	95	and	and	CCONJ
bjp-16772	127	96	treatment	treatment	NOUN
bjp-16772	127	97	discontinuation	discontinuation	NOUN
bjp-16772	127	98	.	.	PUNCT
bjp-16772	128	1	recently	recently	ADV
bjp-16772	128	2	,	,	PUNCT
bjp-16772	128	3	fda	fda	PROPN
bjp-16772	128	4	has	have	AUX
bjp-16772	128	5	issued	issue	VERB
bjp-16772	128	6	a	a	DET
bjp-16772	128	7	warning	warning	NOUN
bjp-16772	128	8	for	for	ADP
bjp-16772	128	9	patients	patient	NOUN
bjp-16772	128	10	on	on	ADP
bjp-16772	128	11	80	80	NUM
bjp-16772	128	12	mg	mg	PROPN
bjp-16772	128	13	daily	daily	ADJ
bjp-16772	128	14	dose	dose	NOUN
bjp-16772	128	15	of	of	ADP
bjp-16772	128	16	simvastatin	simvastatin	NOUN
bjp-16772	128	17	for	for	ADP
bjp-16772	128	18	the	the	DET
bjp-16772	128	19	increased	increase	VERB
bjp-16772	128	20	risk	risk	NOUN
bjp-16772	128	21	of	of	ADP
bjp-16772	128	22	myopathy	myopathy	ADJ
bjp-16772	128	23	and	and	CCONJ
bjp-16772	128	24	in	in	ADP
bjp-16772	128	25	the	the	DET
bjp-16772	128	26	uk	uk	PROPN
bjp-16772	128	27	,	,	PUNCT
bjp-16772	128	28	the	the	DET
bjp-16772	128	29	mhra	mhra	NOUN
bjp-16772	128	30	also	also	ADV
bjp-16772	128	31	suggested	suggest	VERB
bjp-16772	128	32	the	the	DET
bjp-16772	128	33	gps	gps	PROPN
bjp-16772	128	34	to	to	PART
bjp-16772	128	35	review	review	VERB
bjp-16772	128	36	their	their	PRON
bjp-16772	128	37	patients	patient	NOUN
bjp-16772	128	38	who	who	PRON
bjp-16772	128	39	are	be	AUX
bjp-16772	128	40	on	on	ADP
bjp-16772	128	41	80	80	NUM
bjp-16772	128	42	mg	mg	PROPN
bjp-16772	128	43	simvastatin	simvastatin	NOUN
bjp-16772	128	44	therapy	therapy	NOUN
bjp-16772	128	45	based	base	VERB
bjp-16772	128	46	on	on	ADP
bjp-16772	128	47	new	new	ADJ
bjp-16772	128	48	safety	safety	NOUN
bjp-16772	128	49	concern	concern	NOUN
bjp-16772	128	50	.	.	PUNCT
bjp-16772	129	1	in	in	ADP
bjp-16772	129	2	the	the	DET
bjp-16772	129	3	current	current	ADJ
bjp-16772	129	4	study	study	NOUN
bjp-16772	129	5	,	,	PUNCT
bjp-16772	129	6	a	a	DET
bjp-16772	129	7	slight	slight	ADJ
bjp-16772	129	8	decreasing	decrease	VERB
bjp-16772	129	9	trend	trend	NOUN
bjp-16772	129	10	,	,	PUNCT
bjp-16772	129	11	1.56	1.56	NUM
bjp-16772	129	12	%	%	NOUN
bjp-16772	129	13	in	in	ADP
bjp-16772	129	14	2005	2005	NUM
bjp-16772	129	15	to	to	ADP
bjp-16772	129	16	1.45	1.45	NUM
bjp-16772	129	17	%	%	NOUN
bjp-16772	129	18	in	in	ADP
bjp-16772	129	19	2009	2009	NUM
bjp-16772	129	20	is	be	AUX
bjp-16772	129	21	visible	visible	ADJ
bjp-16772	129	22	in	in	ADP
bjp-16772	129	23	the	the	DET
bjp-16772	129	24	percentages	percentage	NOUN
bjp-16772	129	25	high	high	ADJ
bjp-16772	129	26	dose	dose	PROPN
bjp-16772	129	27	(	(	PUNCT
bjp-16772	129	28	80	80	NUM
bjp-16772	129	29	mg	mg	NOUN
bjp-16772	129	30	)	)	PUNCT
bjp-16772	129	31	simvastatin	simvastatin	NOUN
bjp-16772	129	32	(	(	PUNCT
bjp-16772	129	33	p=	p=	ADJ
bjp-16772	129	34	0.151	0.151	NUM
bjp-16772	129	35	)	)	PUNCT
bjp-16772	129	36	prescriptions	prescription	NOUN
bjp-16772	129	37	.	.	PUNCT
bjp-16772	130	1	mohamed	mohamed	PROPN
bjp-16772	130	2	et	et	PROPN
bjp-16772	130	3	al	al	PROPN
bjp-16772	130	4	.	.	PROPN
bjp-16772	130	5	(	(	PUNCT
bjp-16772	130	6	2011	2011	NUM
bjp-16772	130	7	)	)	PUNCT
bjp-16772	130	8	,	,	PUNCT
bjp-16772	130	9	in	in	ADP
bjp-16772	130	10	scotland	scotland	NOUN
bjp-16772	130	11	denoted	denote	VERB
bjp-16772	130	12	a	a	DET
bjp-16772	130	13	similar	similar	ADJ
bjp-16772	130	14	trend	trend	NOUN
bjp-16772	130	15	,	,	PUNCT
bjp-16772	130	16	where	where	SCONJ
bjp-16772	130	17	patients	patient	NOUN
bjp-16772	130	18	discontinued	discontinue	VERB
bjp-16772	130	19	simvastatin	simvastatin	NOUN
bjp-16772	130	20	within	within	ADP
bjp-16772	130	21	3	3	NUM
bjp-16772	130	22	to	to	PART
bjp-16772	130	23	6	6	NUM
bjp-16772	130	24	months	month	NOUN
bjp-16772	130	25	of	of	ADP
bjp-16772	130	26	treatment	treatment	NOUN
bjp-16772	130	27	initiation	initiation	NOUN
bjp-16772	130	28	due	due	ADP
bjp-16772	130	29	to	to	ADP
bjp-16772	130	30	adverse	adverse	ADJ
bjp-16772	130	31	drug	drug	NOUN
bjp-16772	130	32	event	event	NOUN
bjp-16772	130	33	.	.	PUNCT
bjp-16772	131	1	as	as	SCONJ
bjp-16772	131	2	there	there	PRON
bjp-16772	131	3	is	be	VERB
bjp-16772	131	4	increased	increase	VERB
bjp-16772	131	5	data	datum	NOUN
bjp-16772	131	6	on	on	ADP
bjp-16772	131	7	association	association	NOUN
bjp-16772	131	8	of	of	ADP
bjp-16772	131	9	high	high	ADJ
bjp-16772	131	10	dose	dose	NOUN
bjp-16772	131	11	simvastatin	simvastatin	NOUN
bjp-16772	131	12	and	and	CCONJ
bjp-16772	131	13	the	the	DET
bjp-16772	131	14	adverse	adverse	ADJ
bjp-16772	131	15	event	event	NOUN
bjp-16772	131	16	,	,	PUNCT
bjp-16772	131	17	it	it	PRON
bjp-16772	131	18	can	can	AUX
bjp-16772	131	19	be	be	AUX
bjp-16772	131	20	anticipated	anticipate	VERB
bjp-16772	131	21	that	that	SCONJ
bjp-16772	131	22	most	most	ADJ
bjp-16772	131	23	of	of	ADP
bjp-16772	131	24	the	the	DET
bjp-16772	131	25	patients	patient	NOUN
bjp-16772	131	26	discontinued	discontinue	VERB
bjp-16772	131	27	were	be	AUX
bjp-16772	131	28	on	on	ADP
bjp-16772	131	29	high	high	ADJ
bjp-16772	131	30	dose	dose	NOUN
bjp-16772	131	31	simvastatin	simvastatin	NOUN
bjp-16772	131	32	.	.	PUNCT
bjp-16772	132	1	however	however	ADV
bjp-16772	132	2	,	,	PUNCT
bjp-16772	132	3	a	a	DET
bjp-16772	132	4	slight	slight	ADJ
bjp-16772	132	5	upward	upward	ADJ
bjp-16772	132	6	trend	trend	NOUN
bjp-16772	132	7	from	from	ADP
bjp-16772	132	8	2008	2008	NUM
bjp-16772	132	9	to	to	ADP
bjp-16772	132	10	2009	2009	NUM
bjp-16772	132	11	in	in	ADP
bjp-16772	132	12	the	the	DET
bjp-16772	132	13	percentage	percentage	NOUN
bjp-16772	132	14	of	of	ADP
bjp-16772	132	15	prescripttions	prescripttion	NOUN
bjp-16772	132	16	might	might	AUX
bjp-16772	132	17	be	be	AUX
bjp-16772	132	18	due	due	ADJ
bjp-16772	132	19	to	to	ADP
bjp-16772	132	20	the	the	DET
bjp-16772	132	21	release	release	NOUN
bjp-16772	132	22	of	of	ADP
bjp-16772	132	23	nice	nice	ADJ
bjp-16772	132	24	clinical	clinical	ADJ
bjp-16772	132	25	guideline	guideline	NOUN
bjp-16772	132	26	,	,	PUNCT
bjp-16772	132	27	67	67	NUM
bjp-16772	132	28	;	;	PUNCT
bjp-16772	132	29	where	where	SCONJ
bjp-16772	132	30	gps	gps	PROPN
bjp-16772	132	31	were	be	AUX
bjp-16772	132	32	suggested	suggest	VERB
bjp-16772	132	33	to	to	PART
bjp-16772	132	34	prescribe	prescribe	VERB
bjp-16772	132	35	patients	patient	NOUN
bjp-16772	132	36	with	with	ADP
bjp-16772	132	37	80	80	NUM
bjp-16772	132	38	mg	mg	NOUN
bjp-16772	132	39	simvastatin	simvastatin	NOUN
bjp-16772	132	40	for	for	ADP
bjp-16772	132	41	secondary	secondary	ADJ
bjp-16772	132	42	prevention	prevention	NOUN
bjp-16772	132	43	of	of	ADP
bjp-16772	132	44	cvd	cvd	PROPN
bjp-16772	132	45	.	.	PUNCT
bjp-16772	133	1	the	the	DET
bjp-16772	133	2	percentages	percentage	NOUN
bjp-16772	133	3	further	far	ADV
bjp-16772	133	4	decreased	decrease	VERB
bjp-16772	133	5	in	in	ADP
bjp-16772	133	6	the	the	DET
bjp-16772	133	7	upcoming	upcoming	ADJ
bjp-16772	133	8	years	year	NOUN
bjp-16772	133	9	suggestive	suggestive	ADJ
bjp-16772	133	10	of	of	ADP
bjp-16772	133	11	raised	raise	VERB
bjp-16772	133	12	awareness	awareness	NOUN
bjp-16772	133	13	from	from	ADP
bjp-16772	133	14	gps	gps	PROPN
bjp-16772	133	15	regarding	regard	VERB
bjp-16772	133	16	the	the	DET
bjp-16772	133	17	issue	issue	NOUN
bjp-16772	133	18	of	of	ADP
bjp-16772	133	19	dose	dose	NOUN
bjp-16772	133	20	related	relate	VERB
bjp-16772	133	21	toxic	toxic	ADJ
bjp-16772	133	22	effect	effect	NOUN
bjp-16772	133	23	of	of	ADP
bjp-16772	133	24	simvastatin	simvastatin	PROPN
bjp-16772	133	25	.	.	PUNCT
bjp-16772	133	26	female	female	ADJ
bjp-16772	133	27	patients	patient	NOUN
bjp-16772	133	28	aged	age	VERB
bjp-16772	133	29	61	61	NUM
bjp-16772	133	30	-	-	SYM
bjp-16772	133	31	70	70	NUM
bjp-16772	133	32	,	,	PUNCT
bjp-16772	133	33	were	be	AUX
bjp-16772	133	34	significantly	significantly	ADV
bjp-16772	133	35	more	more	ADV
bjp-16772	133	36	prescribed	prescribed	ADJ
bjp-16772	133	37	high	high	ADJ
bjp-16772	133	38	dose	dose	NOUN
bjp-16772	133	39	simvastatin	simvastatin	NOUN
bjp-16772	133	40	than	than	ADP
bjp-16772	133	41	male	male	ADJ
bjp-16772	133	42	(	(	PUNCT
bjp-16772	133	43	p<0.001	p<0.001	PROPN
bjp-16772	133	44	)	)	PUNCT
bjp-16772	133	45	.	.	PUNCT
bjp-16772	134	1	this	this	DET
bjp-16772	134	2	finding	finding	NOUN
bjp-16772	134	3	is	be	AUX
bjp-16772	134	4	similar	similar	ADJ
bjp-16772	134	5	to	to	ADP
bjp-16772	134	6	the	the	DET
bjp-16772	134	7	study	study	NOUN
bjp-16772	134	8	population	population	NOUN
bjp-16772	134	9	of	of	ADP
bjp-16772	134	10	other	other	ADJ
bjp-16772	134	11	large	large	ADJ
bjp-16772	134	12	clinical	clinical	ADJ
bjp-16772	134	13	trials	trial	NOUN
bjp-16772	134	14	namely	namely	ADV
bjp-16772	134	15	sage	sage	NOUN
bjp-16772	134	16	(	(	PUNCT
bjp-16772	134	17	deedwania	deedwania	PROPN
bjp-16772	134	18	et	et	PROPN
bjp-16772	134	19	al	al	PROPN
bjp-16772	134	20	.	.	PROPN
bjp-16772	134	21	,	,	PUNCT
bjp-16772	134	22	2007	2007	NUM
bjp-16772	134	23	)	)	PUNCT
bjp-16772	134	24	,	,	PUNCT
bjp-16772	134	25	tnt	tnt	PROPN
bjp-16772	134	26	(	(	PUNCT
bjp-16772	134	27	rosa	rosa	PROPN
bjp-16772	134	28	et	et	PROPN
bjp-16772	134	29	al	al	PROPN
bjp-16772	134	30	.	.	PROPN
bjp-16772	134	31	,	,	PUNCT
bjp-16772	134	32	2005	2005	NUM
bjp-16772	134	33	)	)	PUNCT
bjp-16772	134	34	and	and	CCONJ
bjp-16772	134	35	primo	primo	NOUN
bjp-16772	134	36	(	(	PUNCT
bjp-16772	134	37	bruckert	bruckert	PROPN
bjp-16772	134	38	et	et	PROPN
bjp-16772	134	39	al	al	PROPN
bjp-16772	134	40	.	.	PROPN
bjp-16772	134	41	,	,	PUNCT
bjp-16772	134	42	2005	2005	NUM
bjp-16772	134	43	)	)	PUNCT
bjp-16772	134	44	.	.	PUNCT
bjp-16772	135	1	in	in	ADP
bjp-16772	135	2	all	all	DET
bjp-16772	135	3	these	these	DET
bjp-16772	135	4	trials	trial	NOUN
bjp-16772	135	5	,	,	PUNCT
bjp-16772	135	6	patients	patient	NOUN
bjp-16772	135	7	in	in	ADP
bjp-16772	135	8	this	this	DET
bjp-16772	135	9	age	age	NOUN
bjp-16772	135	10	group	group	NOUN
bjp-16772	135	11	mostly	mostly	ADV
bjp-16772	135	12	benefited	benefit	VERB
bjp-16772	135	13	from	from	ADP
bjp-16772	135	14	intensive	intensive	ADJ
bjp-16772	135	15	statin	statin	PROPN
bjp-16772	135	16	therapy	therapy	NOUN
bjp-16772	135	17	.	.	PUNCT
bjp-16772	136	1	both	both	PRON
bjp-16772	136	2	in	in	ADP
bjp-16772	136	3	cumulative	cumulative	ADJ
bjp-16772	136	4	and	and	CCONJ
bjp-16772	136	5	individual	individual	ADJ
bjp-16772	136	6	year	year	NOUN
bjp-16772	136	7	data	datum	NOUN
bjp-16772	136	8	analysis	analysis	NOUN
bjp-16772	136	9	we	we	PRON
bjp-16772	136	10	found	find	VERB
bjp-16772	136	11	that	that	SCONJ
bjp-16772	136	12	most	most	ADJ
bjp-16772	136	13	of	of	ADP
bjp-16772	136	14	the	the	DET
bjp-16772	136	15	patients	patient	NOUN
bjp-16772	136	16	switched	switch	VERB
bjp-16772	136	17	to	to	ADP
bjp-16772	136	18	atorvastatin	atorvastatin	NOUN
bjp-16772	136	19	from	from	ADP
bjp-16772	136	20	80	80	NUM
bjp-16772	136	21	mg	mg	PROPN
bjp-16772	136	22	simvastatin	simvastatin	PROPN
bjp-16772	136	23	.	.	PUNCT
bjp-16772	137	1	atorvastatin	atorvastatin	PROPN
bjp-16772	137	2	has	have	AUX
bjp-16772	137	3	long	long	ADV
bjp-16772	137	4	standing	stand	VERB
bjp-16772	137	5	excellent	excellent	ADJ
bjp-16772	137	6	safety	safety	NOUN
bjp-16772	137	7	and	and	CCONJ
bjp-16772	137	8	efficacy	efficacy	NOUN
bjp-16772	137	9	profile	profile	NOUN
bjp-16772	137	10	both	both	PRON
bjp-16772	137	11	in	in	ADP
bjp-16772	137	12	moderate	moderate	ADJ
bjp-16772	137	13	to	to	PART
bjp-16772	137	14	high	high	ADJ
bjp-16772	137	15	dose	dose	VERB
bjp-16772	137	16	in	in	ADP
bjp-16772	137	17	all	all	DET
bjp-16772	137	18	age	age	NOUN
bjp-16772	137	19	groups	group	NOUN
bjp-16772	137	20	of	of	ADP
bjp-16772	137	21	patients	patient	NOUN
bjp-16772	137	22	.	.	PUNCT
bjp-16772	138	1	many	many	ADJ
bjp-16772	138	2	clinical	clinical	ADJ
bjp-16772	138	3	trials	trial	NOUN
bjp-16772	138	4	(	(	PUNCT
bjp-16772	138	5	rosa	rosa	PROPN
bjp-16772	138	6	et	et	PROPN
bjp-16772	138	7	al	al	PROPN
bjp-16772	138	8	.	.	PROPN
bjp-16772	138	9	,	,	PUNCT
bjp-16772	138	10	2005	2005	NUM
bjp-16772	138	11	;	;	PUNCT
bjp-16772	138	12	deedwania	deedwania	PROPN
bjp-16772	138	13	et	et	PROPN
bjp-16772	138	14	al	al	PROPN
bjp-16772	138	15	.	.	PROPN
bjp-16772	138	16	,	,	PUNCT
bjp-16772	138	17	2007	2007	NUM
bjp-16772	138	18	)	)	PUNCT
bjp-16772	138	19	and	and	CCONJ
bjp-16772	138	20	meta	meta	VERB
bjp-16772	138	21	-	-	PUNCT
bjp-16772	138	22	analysis	analysis	NOUN
bjp-16772	138	23	noted	note	VERB
bjp-16772	138	24	that	that	SCONJ
bjp-16772	138	25	10	10	NUM
bjp-16772	138	26	-	-	SYM
bjp-16772	138	27	80	80	NUM
bjp-16772	138	28	mg	mg	PROPN
bjp-16772	138	29	bangladesh	bangladesh	PROPN
bjp-16772	138	30	j	j	PROPN
bjp-16772	138	31	pharmacol	pharmacol	PROPN
bjp-16772	138	32	2013	2013	NUM
bjp-16772	138	33	;	;	PUNCT
bjp-16772	138	34	8	8	NUM
bjp-16772	138	35	:	:	SYM
bjp-16772	138	36	401	401	NUM
bjp-16772	138	37	-	-	SYM
bjp-16772	138	38	409	409	NUM
bjp-16772	138	39	407	407	NUM
bjp-16772	138	40	atorvastatin	atorvastatin	NOUN
bjp-16772	138	41	can	can	AUX
bjp-16772	138	42	reduce	reduce	VERB
bjp-16772	138	43	ldl	ldl	NOUN
bjp-16772	138	44	-	-	PUNCT
bjp-16772	138	45	c	c	NOUN
bjp-16772	138	46	by	by	ADP
bjp-16772	138	47	37	37	NUM
bjp-16772	138	48	-	-	SYM
bjp-16772	138	49	55	55	NUM
bjp-16772	138	50	%	%	NOUN
bjp-16772	138	51	while	while	SCONJ
bjp-16772	138	52	40	40	NUM
bjp-16772	138	53	-	-	SYM
bjp-16772	138	54	80	80	NUM
bjp-16772	138	55	mg	mg	PROPN
bjp-16772	138	56	simvastatin	simvastatin	NOUN
bjp-16772	138	57	reduces	reduce	VERB
bjp-16772	138	58	37	37	NUM
bjp-16772	138	59	-	-	SYM
bjp-16772	138	60	42	42	NUM
bjp-16772	138	61	%	%	NOUN
bjp-16772	138	62	ldl	ldl	NOUN
bjp-16772	138	63	-	-	PUNCT
bjp-16772	138	64	c	c	PROPN
bjp-16772	138	65	(	(	PUNCT
bjp-16772	138	66	weng	weng	PROPN
bjp-16772	138	67	et	et	PROPN
bjp-16772	138	68	al	al	PROPN
bjp-16772	138	69	.	.	PROPN
bjp-16772	138	70	,	,	PUNCT
bjp-16772	138	71	2010	2010	NUM
bjp-16772	138	72	)	)	PUNCT
bjp-16772	138	73	.	.	PUNCT
bjp-16772	139	1	accordingly	accordingly	ADV
bjp-16772	139	2	atorvastatin	atorvastatin	PROPN
bjp-16772	139	3	is	be	AUX
bjp-16772	139	4	the	the	DET
bjp-16772	139	5	preferred	prefer	VERB
bjp-16772	139	6	switch	switch	NOUN
bjp-16772	139	7	drug	drug	NOUN
bjp-16772	139	8	for	for	ADP
bjp-16772	139	9	gps	gps	PROPN
bjp-16772	139	10	,	,	PUNCT
bjp-16772	139	11	despite	despite	SCONJ
bjp-16772	139	12	the	the	DET
bjp-16772	139	13	high	high	ADJ
bjp-16772	139	14	cost	cost	NOUN
bjp-16772	139	15	.	.	PUNCT
bjp-16772	140	1	analysing	analyse	VERB
bjp-16772	140	2	the	the	DET
bjp-16772	140	3	switching	switch	VERB
bjp-16772	140	4	data	datum	NOUN
bjp-16772	140	5	from	from	ADP
bjp-16772	140	6	high	high	ADJ
bjp-16772	140	7	dose	dose	NOUN
bjp-16772	140	8	simvastatin	simvastatin	NOUN
bjp-16772	140	9	we	we	PRON
bjp-16772	140	10	found	find	VERB
bjp-16772	140	11	that	that	SCONJ
bjp-16772	140	12	switching	switch	VERB
bjp-16772	140	13	to	to	PART
bjp-16772	140	14	rosuvastatin	rosuvastatin	NOUN
bjp-16772	140	15	slowly	slowly	ADV
bjp-16772	140	16	increased	increase	VERB
bjp-16772	140	17	,	,	PUNCT
bjp-16772	140	18	from	from	ADP
bjp-16772	140	19	1	1	NUM
bjp-16772	140	20	%	%	NOUN
bjp-16772	140	21	patients	patient	NOUN
bjp-16772	140	22	in	in	ADP
bjp-16772	140	23	2006	2006	NUM
bjp-16772	140	24	to	to	ADP
bjp-16772	140	25	9	9	NUM
bjp-16772	140	26	%	%	NOUN
bjp-16772	140	27	in	in	ADP
bjp-16772	140	28	2009	2009	NUM
bjp-16772	140	29	.	.	PUNCT
bjp-16772	141	1	jones	jones	PROPN
bjp-16772	141	2	et	et	PROPN
bjp-16772	141	3	al	al	PROPN
bjp-16772	141	4	.	.	PROPN
bjp-16772	141	5	(	(	PUNCT
bjp-16772	141	6	2003	2003	NUM
bjp-16772	141	7	)	)	PUNCT
bjp-16772	141	8	demonstrated	demonstrate	VERB
bjp-16772	141	9	that	that	SCONJ
bjp-16772	141	10	rosuvastatin	rosuvastatin	NOUN
bjp-16772	141	11	provides	provide	VERB
bjp-16772	141	12	8	8	NUM
bjp-16772	141	13	%	%	NOUN
bjp-16772	141	14	additional	additional	ADJ
bjp-16772	141	15	reduction	reduction	NOUN
bjp-16772	141	16	of	of	ADP
bjp-16772	141	17	ldl	ldl	NOUN
bjp-16772	141	18	-	-	PUNCT
bjp-16772	141	19	c	c	NOUN
bjp-16772	141	20	at	at	ADP
bjp-16772	141	21	the	the	DET
bjp-16772	141	22	same	same	ADJ
bjp-16772	141	23	dose	dose	NOUN
bjp-16772	141	24	of	of	ADP
bjp-16772	141	25	atorvastatin	atorvastatin	PROPN
bjp-16772	141	26	.	.	PUNCT
bjp-16772	142	1	mercury	mercury	NOUN
bjp-16772	142	2	i	i	PROPN
bjp-16772	142	3	and	and	CCONJ
bjp-16772	142	4	ii	ii	PROPN
bjp-16772	142	5	trial	trial	NOUN
bjp-16772	142	6	(	(	PUNCT
bjp-16772	142	7	measuring	measure	VERB
bjp-16772	142	8	effective	effective	ADJ
bjp-16772	142	9	reductions	reduction	NOUN
bjp-16772	142	10	in	in	ADP
bjp-16772	142	11	cholesterol	cholesterol	NOUN
bjp-16772	142	12	using	use	VERB
bjp-16772	142	13	rosuvastatin	rosuvastatin	ADJ
bjp-16772	142	14	therapy	therapy	NOUN
bjp-16772	142	15	)	)	PUNCT
bjp-16772	142	16	(	(	PUNCT
bjp-16772	142	17	schuster	schuster	PROPN
bjp-16772	142	18	et	et	PROPN
bjp-16772	142	19	al	al	PROPN
bjp-16772	142	20	.	.	PROPN
bjp-16772	142	21	,	,	PUNCT
bjp-16772	142	22	2004	2004	NUM
bjp-16772	142	23	;	;	PUNCT
bjp-16772	142	24	izzat	izzat	PROPN
bjp-16772	142	25	et	et	PROPN
bjp-16772	142	26	al	al	PROPN
bjp-16772	142	27	.	.	PROPN
bjp-16772	142	28	,	,	PUNCT
bjp-16772	142	29	2006	2006	NUM
bjp-16772	142	30	)	)	PUNCT
bjp-16772	142	31	illustared	illustare	VERB
bjp-16772	142	32	that	that	SCONJ
bjp-16772	142	33	rosuvastatin	rosuvastatin	NOUN
bjp-16772	142	34	is	be	AUX
bjp-16772	142	35	safe	safe	ADJ
bjp-16772	142	36	and	and	CCONJ
bjp-16772	142	37	effective	effective	ADJ
bjp-16772	142	38	to	to	PART
bjp-16772	142	39	achieve	achieve	VERB
bjp-16772	142	40	the	the	DET
bjp-16772	142	41	ncep	ncep	NOUN
bjp-16772	142	42	/	/	SYM
bjp-16772	142	43	atp	atp	PROPN
bjp-16772	142	44	-	-	PUNCT
bjp-16772	142	45	iii	iii	NOUN
bjp-16772	142	46	ldl	ldl	PROPN
bjp-16772	142	47	-	-	PUNCT
bjp-16772	142	48	c	c	NOUN
bjp-16772	142	49	targets	target	NOUN
bjp-16772	142	50	for	for	ADP
bjp-16772	142	51	high	high	ADJ
bjp-16772	142	52	risk	risk	NOUN
bjp-16772	142	53	patients	patient	NOUN
bjp-16772	142	54	with	with	ADP
bjp-16772	142	55	hypercholesterolemia	hypercholesterolemia	NOUN
bjp-16772	142	56	even	even	ADV
bjp-16772	142	57	though	though	SCONJ
bjp-16772	142	58	switched	switch	VERB
bjp-16772	142	59	from	from	ADP
bjp-16772	142	60	atorvastatin	atorvastatin	NOUN
bjp-16772	142	61	or	or	CCONJ
bjp-16772	142	62	simvastatin	simvastatin	PROPN
bjp-16772	142	63	.	.	PUNCT
bjp-16772	143	1	since	since	SCONJ
bjp-16772	143	2	unavailability	unavailability	NOUN
bjp-16772	143	3	of	of	ADP
bjp-16772	143	4	long	long	ADJ
bjp-16772	143	5	-	-	PUNCT
bjp-16772	143	6	term	term	NOUN
bjp-16772	143	7	safety	safety	NOUN
bjp-16772	143	8	or	or	CCONJ
bjp-16772	143	9	cardiovascular	cardiovascular	ADJ
bjp-16772	143	10	event	event	NOUN
bjp-16772	143	11	data	datum	NOUN
bjp-16772	143	12	and	and	CCONJ
bjp-16772	143	13	the	the	DET
bjp-16772	143	14	higher	high	ADJ
bjp-16772	143	15	acquisition	acquisition	NOUN
bjp-16772	143	16	cost	cost	NOUN
bjp-16772	143	17	,	,	PUNCT
bjp-16772	143	18	made	make	VERB
bjp-16772	143	19	it	it	PRON
bjp-16772	143	20	less	less	ADV
bjp-16772	143	21	preferred	prefer	VERB
bjp-16772	143	22	by	by	ADP
bjp-16772	143	23	the	the	DET
bjp-16772	143	24	gps	gps	PROPN
bjp-16772	143	25	in	in	ADP
bjp-16772	143	26	scotland	scotland	PROPN
bjp-16772	143	27	as	as	ADP
bjp-16772	143	28	an	an	DET
bjp-16772	143	29	alternative	alternative	ADJ
bjp-16772	143	30	statin	statin	NOUN
bjp-16772	143	31	for	for	ADP
bjp-16772	143	32	switching	switch	VERB
bjp-16772	143	33	.	.	PUNCT
bjp-16772	144	1	61	61	NUM
bjp-16772	144	2	-	-	SYM
bjp-16772	144	3	70	70	NUM
bjp-16772	144	4	years	year	NOUN
bjp-16772	144	5	age	age	NOUN
bjp-16772	144	6	group	group	NOUN
bjp-16772	144	7	patient	patient	NOUN
bjp-16772	144	8	mostly	mostly	ADV
bjp-16772	144	9	switched	switch	VERB
bjp-16772	144	10	to	to	ADP
bjp-16772	144	11	other	other	ADJ
bjp-16772	144	12	statin	statin	PROPN
bjp-16772	144	13	(	(	PUNCT
bjp-16772	144	14	p<0.001	p<0.001	PROPN
bjp-16772	144	15	)	)	PUNCT
bjp-16772	144	16	which	which	PRON
bjp-16772	144	17	might	might	AUX
bjp-16772	144	18	be	be	AUX
bjp-16772	144	19	due	due	ADJ
bjp-16772	144	20	to	to	ADP
bjp-16772	144	21	the	the	DET
bjp-16772	144	22	association	association	NOUN
bjp-16772	144	23	of	of	ADP
bjp-16772	144	24	drug	drug	NOUN
bjp-16772	144	25	related	relate	VERB
bjp-16772	144	26	adverse	adverse	ADJ
bjp-16772	144	27	effect	effect	NOUN
bjp-16772	144	28	and	and	CCONJ
bjp-16772	144	29	elderly	elderly	ADJ
bjp-16772	144	30	physiological	physiological	ADJ
bjp-16772	144	31	changes	change	NOUN
bjp-16772	144	32	.	.	PUNCT
bjp-16772	145	1	conclusion	conclusion	NOUN
bjp-16772	145	2	increasing	increase	VERB
bjp-16772	145	3	prevalence	prevalence	NOUN
bjp-16772	145	4	rate	rate	NOUN
bjp-16772	145	5	with	with	ADP
bjp-16772	145	6	the	the	DET
bjp-16772	145	7	simultaneous	simultaneous	ADJ
bjp-16772	145	8	reduction	reduction	NOUN
bjp-16772	145	9	in	in	ADP
bjp-16772	145	10	the	the	DET
bjp-16772	145	11	incidence	incidence	NOUN
bjp-16772	145	12	rate	rate	NOUN
bjp-16772	145	13	for	for	ADP
bjp-16772	145	14	statin	statin	ADJ
bjp-16772	145	15	prescriptions	prescription	NOUN
bjp-16772	145	16	being	be	AUX
bjp-16772	145	17	observed	observe	VERB
bjp-16772	145	18	in	in	ADP
bjp-16772	145	19	scotland	scotland	PROPN
bjp-16772	145	20	,	,	PUNCT
bjp-16772	145	21	likely	likely	ADJ
bjp-16772	145	22	to	to	PART
bjp-16772	145	23	be	be	AUX
bjp-16772	145	24	attributed	attribute	VERB
bjp-16772	145	25	to	to	ADP
bjp-16772	145	26	the	the	DET
bjp-16772	145	27	decline	decline	NOUN
bjp-16772	145	28	in	in	ADP
bjp-16772	145	29	chd	chd	NOUN
bjp-16772	145	30	mortality	mortality	NOUN
bjp-16772	145	31	and	and	CCONJ
bjp-16772	145	32	subsequent	subsequent	ADJ
bjp-16772	145	33	increased	increase	VERB
bjp-16772	145	34	survival	survival	NOUN
bjp-16772	145	35	of	of	ADP
bjp-16772	145	36	patients	patient	NOUN
bjp-16772	145	37	with	with	ADP
bjp-16772	145	38	chd	chd	PROPN
bjp-16772	145	39	as	as	ADV
bjp-16772	145	40	well	well	ADV
bjp-16772	145	41	as	as	ADP
bjp-16772	145	42	the	the	DET
bjp-16772	145	43	high	high	ADJ
bjp-16772	145	44	efficacy	efficacy	NOUN
bjp-16772	145	45	and	and	CCONJ
bjp-16772	145	46	good	good	ADJ
bjp-16772	145	47	safety	safety	NOUN
bjp-16772	145	48	profile	profile	NOUN
bjp-16772	145	49	of	of	ADP
bjp-16772	145	50	statins	statin	NOUN
bjp-16772	145	51	.	.	PUNCT
bjp-16772	146	1	references	reference	NOUN
bjp-16772	146	2	arnlov	arnlov	PROPN
bjp-16772	146	3	j	j	PROPN
bjp-16772	146	4	,	,	PUNCT
bjp-16772	146	5	pencina	pencina	PROPN
bjp-16772	146	6	jm	jm	PROPN
bjp-16772	146	7	,	,	PUNCT
bjp-16772	146	8	amin	amin	PROPN
bjp-16772	146	9	s	s	PROPN
bjp-16772	146	10	,	,	PUNCT
bjp-16772	146	11	nam	nam	PROPN
bjp-16772	146	12	b	b	PROPN
bjp-16772	146	13	,	,	PUNCT
bjp-16772	146	14	benjamin	benjamin	PROPN
bjp-16772	146	15	je	je	PROPN
bjp-16772	146	16	,	,	PUNCT
bjp-16772	146	17	murabito	murabito	PROPN
bjp-16772	146	18	mj	mj	PROPN
bjp-16772	146	19	et	et	PROPN
bjp-16772	146	20	al	al	PROPN
bjp-16772	146	21	.	.	PROPN
bjp-16772	146	22	endogenous	endogenous	ADJ
bjp-16772	146	23	sex	sex	NOUN
bjp-16772	146	24	hormones	hormone	NOUN
bjp-16772	146	25	and	and	CCONJ
bjp-16772	146	26	cardiovascular	cardiovascular	ADJ
bjp-16772	146	27	disease	disease	NOUN
bjp-16772	146	28	incidence	incidence	NOUN
bjp-16772	146	29	in	in	ADP
bjp-16772	146	30	men	man	NOUN
bjp-16772	146	31	.	.	PUNCT
bjp-16772	147	1	ann	ann	PROPN
bjp-16772	147	2	intern	intern	PROPN
bjp-16772	147	3	med	me	VERB
bjp-16772	147	4	.	.	PUNCT
bjp-16772	148	1	2006	2006	NUM
bjp-16772	148	2	;	;	PUNCT
bjp-16772	148	3	145	145	NUM
bjp-16772	148	4	:	:	PUNCT
bjp-16772	148	5	176	176	NUM
bjp-16772	148	6	-	-	SYM
bjp-16772	148	7	84	84	NUM
bjp-16772	148	8	.	.	PUNCT
bjp-16772	149	1	bruckert	bruckert	PROPN
bjp-16772	149	2	e	e	PROPN
bjp-16772	149	3	,	,	PUNCT
bjp-16772	149	4	hayem	hayem	VERB
bjp-16772	149	5	g	g	NOUN
bjp-16772	149	6	,	,	PUNCT
bjp-16772	149	7	dejager	dejager	NOUN
bjp-16772	149	8	s	s	PART
bjp-16772	149	9	,	,	PUNCT
bjp-16772	149	10	yau	yau	PROPN
bjp-16772	149	11	c	c	PROPN
bjp-16772	149	12	,	,	PUNCT
bjp-16772	149	13	begaud	begaud	PROPN
bjp-16772	149	14	b.	b.	PROPN
bjp-16772	149	15	mild	mild	NOUN
bjp-16772	149	16	to	to	AUX
bjp-16772	149	17	moderate	moderate	ADJ
bjp-16772	149	18	muscular	muscular	ADJ
bjp-16772	149	19	symptoms	symptom	NOUN
bjp-16772	149	20	with	with	ADP
bjp-16772	149	21	high	high	ADJ
bjp-16772	149	22	-	-	PUNCT
bjp-16772	149	23	dosage	dosage	NOUN
bjp-16772	149	24	statin	statin	NOUN
bjp-16772	149	25	therapy	therapy	NOUN
bjp-16772	149	26	in	in	ADP
bjp-16772	149	27	hyperlipidemic	hyperlipidemic	ADJ
bjp-16772	149	28	patients	patient	NOUN
bjp-16772	149	29	:	:	PUNCT
bjp-16772	149	30	the	the	DET
bjp-16772	149	31	primo	primo	PROPN
bjp-16772	149	32	study	study	PROPN
bjp-16772	149	33	.	.	PUNCT
bjp-16772	150	1	cardiovasc	cardiovasc	PROPN
bjp-16772	150	2	drugs	drug	VERB
bjp-16772	150	3	ther	ther	ADV
bjp-16772	150	4	.	.	PUNCT
bjp-16772	151	1	2005	2005	NUM
bjp-16772	151	2	;	;	PUNCT
bjp-16772	151	3	19	19	NUM
bjp-16772	151	4	:	:	SYM
bjp-16772	151	5	403	403	NUM
bjp-16772	151	6	-	-	SYM
bjp-16772	151	7	14	14	NUM
bjp-16772	151	8	.	.	PUNCT
bjp-16772	152	1	cannon	cannon	NOUN
bjp-16772	152	2	cp	cp	PROPN
bjp-16772	152	3	,	,	PUNCT
bjp-16772	152	4	mccabe	mccabe	PROPN
bjp-16772	152	5	ch	ch	PROPN
bjp-16772	152	6	,	,	PUNCT
bjp-16772	152	7	belder	belder	NOUN
bjp-16772	152	8	r	r	NOUN
bjp-16772	152	9	,	,	PUNCT
bjp-16772	152	10	breen	breen	PROPN
bjp-16772	152	11	j	j	PROPN
bjp-16772	152	12	,	,	PUNCT
bjp-16772	152	13	braunwald	braunwald	PROPN
bjp-16772	152	14	e.	e.	PROPN
bjp-16772	152	15	design	design	PROPN
bjp-16772	152	16	of	of	ADP
bjp-16772	152	17	the	the	DET
bjp-16772	152	18	pravastatin	pravastatin	NOUN
bjp-16772	152	19	or	or	CCONJ
bjp-16772	152	20	atorvastatin	atorvastatin	NOUN
bjp-16772	152	21	evaluation	evaluation	NOUN
bjp-16772	152	22	and	and	CCONJ
bjp-16772	152	23	infection	infection	NOUN
bjp-16772	152	24	therapy	therapy	NOUN
bjp-16772	152	25	(	(	PUNCT
bjp-16772	152	26	prove	prove	VERB
bjp-16772	152	27	it)–timi	it)–timi	PRON
bjp-16772	152	28	22	22	NUM
bjp-16772	152	29	trial	trial	NOUN
bjp-16772	152	30	.	.	PUNCT
bjp-16772	153	1	am	be	AUX
bjp-16772	153	2	j	j	PROPN
bjp-16772	153	3	cardiol	cardiol	NOUN
bjp-16772	153	4	.	.	PUNCT
bjp-16772	154	1	2002	2002	NUM
bjp-16772	154	2	;	;	PUNCT
bjp-16772	154	3	89	89	NUM
bjp-16772	154	4	:	:	PUNCT
bjp-16772	154	5	860	860	NUM
bjp-16772	154	6	-	-	SYM
bjp-16772	154	7	61	61	NUM
bjp-16772	154	8	.	.	PUNCT
bjp-16772	155	1	cappuccio	cappuccio	PROPN
bjp-16772	155	2	fp	fp	PROPN
bjp-16772	155	3	,	,	PUNCT
bjp-16772	155	4	wilson	wilson	PROPN
bjp-16772	155	5	k	k	PROPN
bjp-16772	155	6	,	,	PUNCT
bjp-16772	155	7	lacey	lacey	PROPN
bjp-16772	155	8	la	la	PROPN
bjp-16772	155	9	,	,	PUNCT
bjp-16772	155	10	marchant	marchant	PROPN
bjp-16772	155	11	n.	n.	PROPN
bjp-16772	155	12	management	management	NOUN
bjp-16772	155	13	of	of	ADP
bjp-16772	155	14	hyperlipidemia	hyperlipidemia	NOUN
bjp-16772	155	15	in	in	ADP
bjp-16772	155	16	the	the	DET
bjp-16772	155	17	uk	uk	PROPN
bjp-16772	155	18	:	:	PUNCT
bjp-16772	155	19	an	an	DET
bjp-16772	155	20	estimation	estimation	NOUN
bjp-16772	155	21	of	of	ADP
bjp-16772	155	22	the	the	DET
bjp-16772	155	23	level	level	NOUN
bjp-16772	155	24	of	of	ADP
bjp-16772	155	25	controlled	control	VERB
bjp-16772	155	26	achieved	achieve	VERB
bjp-16772	155	27	.	.	PUNCT
bjp-16772	156	1	j	j	PROPN
bjp-16772	156	2	outcomes	outcomes	PROPN
bjp-16772	156	3	res	re	NOUN
bjp-16772	156	4	.	.	PUNCT
bjp-16772	156	5	2005	2005	NUM
bjp-16772	156	6	;	;	PUNCT
bjp-16772	156	7	9	9	NUM
bjp-16772	156	8	:	:	SYM
bjp-16772	156	9	1	1	NUM
bjp-16772	156	10	-	-	SYM
bjp-16772	156	11	14	14	NUM
bjp-16772	156	12	.	.	PUNCT
bjp-16772	157	1	catapano	catapano	PROPN
bjp-16772	157	2	a	a	DET
bjp-16772	157	3	,	,	PUNCT
bjp-16772	157	4	brady	brady	PROPN
bjp-16772	157	5	wk	wk	PROPN
bjp-16772	157	6	,	,	PUNCT
bjp-16772	157	7	king	king	NOUN
bjp-16772	157	8	tr	tr	VERB
bjp-16772	157	9	,	,	PUNCT
bjp-16772	157	10	palmisano	palmisano	PROPN
bjp-16772	157	11	j.	j.	PROPN
bjp-16772	157	12	lipid	lipid	PROPN
bjp-16772	157	13	alteringefficacy	alteringefficacy	PROPN
bjp-16772	157	14	of	of	ADP
bjp-16772	157	15	ezetimibe	ezetimibe	NOUN
bjp-16772	157	16	co	co	VERB
bjp-16772	157	17	-	-	VERB
bjp-16772	157	18	administered	administer	VERB
bjp-16772	157	19	with	with	ADP
bjp-16772	157	20	simvstatin	simvstatin	NOUN
bjp-16772	157	21	compared	compare	VERB
bjp-16772	157	22	with	with	ADP
bjp-16772	157	23	rosuvastatin	rosuvastatin	NOUN
bjp-16772	157	24	:	:	PUNCT
bjp-16772	157	25	a	a	DET
bjp-16772	157	26	meta	meta	ADJ
bjp-16772	157	27	-	-	PUNCT
bjp-16772	157	28	analysis	analysis	NOUN
bjp-16772	157	29	of	of	ADP
bjp-16772	157	30	pooled	pool	VERB
bjp-16772	157	31	data	datum	NOUN
bjp-16772	157	32	from	from	ADP
bjp-16772	157	33	14	14	NUM
bjp-16772	157	34	clinical	clinical	ADJ
bjp-16772	157	35	trials	trial	NOUN
bjp-16772	157	36	.	.	PUNCT
bjp-16772	158	1	curr	curr	PROPN
bjp-16772	158	2	med	med	PROPN
bjp-16772	158	3	res	re	NOUN
bjp-16772	158	4	opin	opin	NOUN
bjp-16772	158	5	.	.	PUNCT
bjp-16772	159	1	2005	2005	NUM
bjp-16772	159	2	;	;	PUNCT
bjp-16772	159	3	21	21	NUM
bjp-16772	159	4	:	:	PUNCT
bjp-16772	159	5	1123	1123	NUM
bjp-16772	159	6	-	-	SYM
bjp-16772	159	7	30	30	NUM
bjp-16772	159	8	.	.	PUNCT
bjp-16772	160	1	connor	connor	PROPN
bjp-16772	160	2	p	p	PROPN
bjp-16772	160	3	,	,	PUNCT
bjp-16772	160	4	feely	feely	ADV
bjp-16772	160	5	j	j	PROPN
bjp-16772	160	6	,	,	PUNCT
bjp-16772	160	7	shepherd	shepherd	ADJ
bjp-16772	160	8	j.	j.	PROPN
bjp-16772	160	9	lipid	lipid	PROPN
bjp-16772	160	10	lowering	lower	VERB
bjp-16772	160	11	drugs	drug	NOUN
bjp-16772	160	12	.	.	PUNCT
bjp-16772	161	1	bmj	bmj	PROPN
bjp-16772	161	2	1990	1990	NUM
bjp-16772	161	3	;	;	PUNCT
bjp-16772	161	4	300	300	NUM
bjp-16772	161	5	:	:	SYM
bjp-16772	161	6	667	667	NUM
bjp-16772	161	7	-	-	SYM
bjp-16772	161	8	72	72	NUM
bjp-16772	161	9	.	.	PUNCT
bjp-16772	162	1	crouse	crouse	PROPN
bjp-16772	162	2	jr	jr	PROPN
bjp-16772	162	3	.	.	PUNCT
bjp-16772	163	1	an	an	DET
bjp-16772	163	2	evaluation	evaluation	NOUN
bjp-16772	163	3	of	of	ADP
bjp-16772	163	4	rosuvastatin	rosuvastatin	NOUN
bjp-16772	163	5	:	:	PUNCT
bjp-16772	163	6	pharmacokinetics	pharmacokinetic	NOUN
bjp-16772	163	7	,	,	PUNCT
bjp-16772	163	8	clinical	clinical	ADJ
bjp-16772	163	9	efficacy	efficacy	NOUN
bjp-16772	163	10	and	and	CCONJ
bjp-16772	163	11	tolerability	tolerability	NOUN
bjp-16772	163	12	.	.	PUNCT
bjp-16772	164	1	drug	drug	NOUN
bjp-16772	164	2	metab	metab	PROPN
bjp-16772	164	3	toxicol	toxicol	PROPN
bjp-16772	164	4	.	.	PUNCT
bjp-16772	164	5	2008	2008	NUM
bjp-16772	164	6	;	;	PUNCT
bjp-16772	164	7	4	4	NUM
bjp-16772	164	8	:	:	SYM
bjp-16772	164	9	287	287	NUM
bjp-16772	164	10	-	-	SYM
bjp-16772	164	11	94	94	NUM
bjp-16772	164	12	.	.	PUNCT
bjp-16772	165	1	davidson	davidson	PROPN
bjp-16772	165	2	mh	mh	PROPN
bjp-16772	165	3	,	,	PUNCT
bjp-16772	165	4	robinson	robinson	PROPN
bjp-16772	165	5	jg	jg	PROPN
bjp-16772	165	6	.	.	PUNCT
bjp-16772	166	1	safety	safety	NOUN
bjp-16772	166	2	of	of	ADP
bjp-16772	166	3	aggressive	aggressive	ADJ
bjp-16772	166	4	lipid	lipid	NOUN
bjp-16772	166	5	management	management	NOUN
bjp-16772	166	6	.	.	PUNCT
bjp-16772	167	1	j	j	PROPN
bjp-16772	167	2	am	be	AUX
bjp-16772	167	3	coll	coll	PROPN
bjp-16772	167	4	cardiol	cardiol	NOUN
bjp-16772	167	5	.	.	PUNCT
bjp-16772	168	1	2007	2007	NUM
bjp-16772	168	2	;	;	PUNCT
bjp-16772	168	3	49	49	NUM
bjp-16772	168	4	:	:	PUNCT
bjp-16772	168	5	1753	1753	NUM
bjp-16772	168	6	-	-	SYM
bjp-16772	168	7	62	62	NUM
bjp-16772	168	8	.	.	PUNCT
bjp-16772	169	1	davies	davies	PROPN
bjp-16772	169	2	ar	ar	PROPN
bjp-16772	169	3	,	,	PUNCT
bjp-16772	169	4	smeeth	smeeth	PROPN
bjp-16772	169	5	l	l	PROPN
bjp-16772	169	6	,	,	PUNCT
bjp-16772	169	7	grundy	grundy	PROPN
bjp-16772	169	8	emd	emd	PROPN
bjp-16772	169	9	.	.	PROPN
bjp-16772	169	10	contribution	contribution	NOUN
bjp-16772	169	11	of	of	ADP
bjp-16772	169	12	changes	change	NOUN
bjp-16772	169	13	in	in	ADP
bjp-16772	169	14	incidence	incidence	NOUN
bjp-16772	169	15	and	and	CCONJ
bjp-16772	169	16	mortality	mortality	NOUN
bjp-16772	169	17	to	to	ADP
bjp-16772	169	18	trends	trend	NOUN
bjp-16772	169	19	in	in	ADP
bjp-16772	169	20	the	the	DET
bjp-16772	169	21	prevalence	prevalence	NOUN
bjp-16772	169	22	of	of	ADP
bjp-16772	169	23	coronary	coronary	ADJ
bjp-16772	169	24	heart	heart	NOUN
bjp-16772	169	25	disease	disease	NOUN
bjp-16772	169	26	in	in	ADP
bjp-16772	169	27	the	the	DET
bjp-16772	169	28	uk	uk	PROPN
bjp-16772	169	29	:	:	PUNCT
bjp-16772	169	30	1996–2005	1996–2005	NUM
bjp-16772	169	31	.	.	PUNCT
bjp-16772	170	1	eur	eur	PROPN
bjp-16772	170	2	heart	heart	NOUN
bjp-16772	170	3	j.	j.	PROPN
bjp-16772	170	4	2007	2007	NUM
bjp-16772	170	5	;	;	PUNCT
bjp-16772	170	6	28	28	NUM
bjp-16772	170	7	:	:	SYM
bjp-16772	170	8	2142	2142	NUM
bjp-16772	170	9	-	-	SYM
bjp-16772	170	10	47	47	NUM
bjp-16772	170	11	.	.	PUNCT
bjp-16772	171	1	deedwania	deedwania	PROPN
bjp-16772	171	2	p	p	NOUN
bjp-16772	171	3	,	,	PUNCT
bjp-16772	171	4	stone	stone	NOUN
bjp-16772	171	5	ph	ph	VERB
bjp-16772	171	6	,	,	PUNCT
bjp-16772	171	7	merz	merz	PROPN
bjp-16772	171	8	cn	cn	PROPN
bjp-16772	171	9	,	,	PUNCT
bjp-16772	171	10	cosin	cosin	PROPN
bjp-16772	171	11	-	-	PUNCT
bjp-16772	171	12	aguilar	aguilar	PROPN
bjp-16772	171	13	j	j	PROPN
bjp-16772	171	14	,	,	PUNCT
bjp-16772	171	15	koylan	koylan	PROPN
bjp-16772	171	16	n	n	CCONJ
bjp-16772	171	17	,	,	PUNCT
bjp-16772	171	18	luo	luo	PROPN
bjp-16772	171	19	d	d	X
bjp-16772	171	20	et	et	PROPN
bjp-16772	171	21	al	al	PROPN
bjp-16772	171	22	.	.	PUNCT
bjp-16772	171	23	effects	effect	NOUN
bjp-16772	171	24	of	of	ADP
bjp-16772	171	25	intensive	intensive	ADJ
bjp-16772	171	26	versus	versus	ADP
bjp-16772	171	27	moderate	moderate	ADJ
bjp-16772	171	28	lipidlowering	lipidlowering	NOUN
bjp-16772	171	29	therapy	therapy	NOUN
bjp-16772	171	30	on	on	ADP
bjp-16772	171	31	myocardial	myocardial	ADJ
bjp-16772	171	32	ischemia	ischemia	NOUN
bjp-16772	171	33	in	in	ADP
bjp-16772	171	34	older	old	ADJ
bjp-16772	171	35	patients	patient	NOUN
bjp-16772	171	36	with	with	ADP
bjp-16772	171	37	coronary	coronary	ADJ
bjp-16772	171	38	heart	heart	NOUN
bjp-16772	171	39	disease	disease	NOUN
bjp-16772	171	40	:	:	PUNCT
bjp-16772	171	41	results	result	NOUN
bjp-16772	171	42	of	of	ADP
bjp-16772	171	43	the	the	DET
bjp-16772	171	44	study	study	NOUN
bjp-16772	171	45	assessing	assess	VERB
bjp-16772	171	46	goals	goal	NOUN
bjp-16772	171	47	in	in	ADP
bjp-16772	171	48	the	the	DET
bjp-16772	171	49	elderly	elderly	ADJ
bjp-16772	171	50	(	(	PUNCT
bjp-16772	171	51	sage	sage	NOUN
bjp-16772	171	52	)	)	PUNCT
bjp-16772	171	53	.	.	PUNCT
bjp-16772	172	1	circulation	circulation	NOUN
bjp-16772	172	2	2007	2007	NUM
bjp-16772	172	3	;	;	PUNCT
bjp-16772	172	4	115	115	NUM
bjp-16772	172	5	:	:	SYM
bjp-16772	172	6	700	700	NUM
bjp-16772	172	7	-	-	SYM
bjp-16772	172	8	07	07	NUM
bjp-16772	172	9	.	.	PUNCT
bjp-16772	173	1	grundy	grundy	PROPN
bjp-16772	173	2	sm	sm	PROPN
bjp-16772	173	3	,	,	PUNCT
bjp-16772	173	4	cleeman	cleeman	PROPN
bjp-16772	173	5	ji	ji	PROPN
bjp-16772	173	6	,	,	PUNCT
bjp-16772	173	7	merz	merz	PROPN
bjp-16772	173	8	cn	cn	PROPN
bjp-16772	173	9	,	,	PUNCT
bjp-16772	173	10	brewer	brewer	PROPN
bjp-16772	173	11	b.	b.	PROPN
bjp-16772	173	12	implications	implication	NOUN
bjp-16772	173	13	of	of	ADP
bjp-16772	173	14	recent	recent	ADJ
bjp-16772	173	15	clinical	clinical	ADJ
bjp-16772	173	16	trials	trial	NOUN
bjp-16772	173	17	for	for	ADP
bjp-16772	173	18	the	the	DET
bjp-16772	173	19	national	national	ADJ
bjp-16772	173	20	cholesterol	cholesterol	PROPN
bjp-16772	173	21	education	education	NOUN
bjp-16772	173	22	program	program	NOUN
bjp-16772	173	23	adult	adult	NOUN
bjp-16772	173	24	treatment	treatment	NOUN
bjp-16772	173	25	panel	panel	NOUN
bjp-16772	173	26	iii	iii	NUM
bjp-16772	173	27	guidelines	guideline	NOUN
bjp-16772	173	28	.	.	PUNCT
bjp-16772	174	1	circulation	circulation	NOUN
bjp-16772	174	2	2004	2004	NUM
bjp-16772	174	3	;	;	PUNCT
bjp-16772	174	4	110	110	NUM
bjp-16772	174	5	:	:	PUNCT
bjp-16772	174	6	227	227	NUM
bjp-16772	174	7	-	-	SYM
bjp-16772	174	8	39	39	NUM
bjp-16772	174	9	.	.	PUNCT
bjp-16772	175	1	hobbs	hobbs	PROPN
bjp-16772	175	2	fdr	fdr	PROPN
bjp-16772	175	3	,	,	PUNCT
bjp-16772	175	4	southworth	southworth	PROPN
bjp-16772	175	5	h.	h.	PROPN
bjp-16772	175	6	achievement	achievement	NOUN
bjp-16772	175	7	of	of	ADP
bjp-16772	175	8	english	english	PROPN
bjp-16772	175	9	national	national	PROPN
bjp-16772	175	10	service	service	NOUN
bjp-16772	175	11	framework	framework	NOUN
bjp-16772	175	12	lipid	lipid	NOUN
bjp-16772	175	13	lowering	lower	VERB
bjp-16772	175	14	goals	goal	NOUN
bjp-16772	175	15	:	:	PUNCT
bjp-16772	175	16	pooled	pool	VERB
bjp-16772	175	17	data	datum	NOUN
bjp-16772	175	18	from	from	ADP
bjp-16772	175	19	recent	recent	ADJ
bjp-16772	175	20	comparative	comparative	ADJ
bjp-16772	175	21	treatment	treatment	NOUN
bjp-16772	175	22	trials	trial	NOUN
bjp-16772	175	23	of	of	ADP
bjp-16772	175	24	statins	statin	NOUN
bjp-16772	175	25	at	at	ADP
bjp-16772	175	26	starting	start	VERB
bjp-16772	175	27	doses	dose	NOUN
bjp-16772	175	28	.	.	PUNCT
bjp-16772	176	1	int	int	PROPN
bjp-16772	177	1	j	j	PROPN
bjp-16772	177	2	clin	clin	PROPN
bjp-16772	177	3	pract	pract	PROPN
bjp-16772	177	4	.	.	PUNCT
bjp-16772	178	1	2005	2005	NUM
bjp-16772	178	2	;	;	PUNCT
bjp-16772	178	3	59	59	NUM
bjp-16772	178	4	:	:	SYM
bjp-16772	178	5	1171	1171	NUM
bjp-16772	178	6	-	-	SYM
bjp-16772	178	7	77	77	NUM
bjp-16772	178	8	.	.	PUNCT
bjp-16772	179	1	izzat	izzat	PROPN
bjp-16772	179	2	l.	l.	PROPN
bjp-16772	179	3	the	the	DET
bjp-16772	179	4	mercury	mercury	PROPN
bjp-16772	179	5	ii	ii	PROPN
bjp-16772	179	6	trial	trial	NOUN
bjp-16772	179	7	:	:	PUNCT
bjp-16772	179	8	benefits	benefit	NOUN
bjp-16772	179	9	of	of	ADP
bjp-16772	179	10	rosuvastatin	rosuvastatin	NOUN
bjp-16772	179	11	.	.	PUNCT
bjp-16772	180	1	bjdvd	bjdvd	PROPN
bjp-16772	180	2	.	.	PUNCT
bjp-16772	181	1	2006	2006	NUM
bjp-16772	181	2	;	;	PUNCT
bjp-16772	181	3	6	6	NUM
bjp-16772	181	4	:	:	SYM
bjp-16772	181	5	171	171	NUM
bjp-16772	181	6	-	-	SYM
bjp-16772	181	7	74	74	NUM
bjp-16772	181	8	.	.	PUNCT
bjp-16772	182	1	jackevicius	jackevicius	PROPN
bjp-16772	182	2	ca	ca	PROPN
bjp-16772	182	3	,	,	PUNCT
bjp-16772	182	4	tu	tu	PROPN
bjp-16772	182	5	k	k	PROPN
bjp-16772	182	6	,	,	PUNCT
bjp-16772	182	7	filate	filate	VERB
bjp-16772	182	8	wa	wa	PROPN
bjp-16772	182	9	.	.	PROPN
bjp-16772	182	10	trends	trend	NOUN
bjp-16772	182	11	in	in	ADP
bjp-16772	182	12	cardiovascular	cardiovascular	ADJ
bjp-16772	182	13	drug	drug	NOUN
bjp-16772	182	14	utilization	utilization	NOUN
bjp-16772	182	15	and	and	CCONJ
bjp-16772	182	16	drug	drug	NOUN
bjp-16772	182	17	expenditures	expenditure	NOUN
bjp-16772	182	18	in	in	ADP
bjp-16772	182	19	canada	canada	PROPN
bjp-16772	182	20	between	between	ADP
bjp-16772	182	21	1996	1996	NUM
bjp-16772	182	22	and	and	CCONJ
bjp-16772	182	23	2001	2001	NUM
bjp-16772	182	24	.	.	PUNCT
bjp-16772	183	1	can	can	AUX
bjp-16772	183	2	j	j	PROPN
bjp-16772	183	3	cardiol	cardiol	NOUN
bjp-16772	183	4	.	.	PUNCT
bjp-16772	184	1	2003	2003	NUM
bjp-16772	184	2	;	;	PUNCT
bjp-16772	184	3	19	19	NUM
bjp-16772	184	4	:	:	SYM
bjp-16772	184	5	1359	1359	NUM
bjp-16772	184	6	-	-	SYM
bjp-16772	184	7	66	66	NUM
bjp-16772	184	8	.	.	PUNCT
bjp-16772	185	1	kanavos	kanavos	PROPN
bjp-16772	185	2	p.	p.	PROPN
bjp-16772	185	3	do	do	AUX
bjp-16772	185	4	generics	generic	NOUN
bjp-16772	185	5	offer	offer	VERB
bjp-16772	185	6	significant	significant	ADJ
bjp-16772	185	7	savings	saving	NOUN
bjp-16772	185	8	to	to	ADP
bjp-16772	185	9	the	the	DET
bjp-16772	185	10	uk	uk	PROPN
bjp-16772	185	11	national	national	PROPN
bjp-16772	185	12	health	health	PROPN
bjp-16772	185	13	service	service	PROPN
bjp-16772	185	14	?	?	PUNCT
bjp-16772	186	1	curr	curr	PROPN
bjp-16772	186	2	med	med	PROPN
bjp-16772	186	3	res	re	NOUN
bjp-16772	186	4	opin	opin	NOUN
bjp-16772	186	5	.	.	PUNCT
bjp-16772	187	1	2007	2007	NUM
bjp-16772	187	2	;	;	PUNCT
bjp-16772	187	3	23	23	NUM
bjp-16772	187	4	:	:	SYM
bjp-16772	187	5	10516	10516	NUM
bjp-16772	187	6	.	.	PUNCT
bjp-16772	188	1	kucera	kucera	PROPN
bjp-16772	188	2	z	z	PROPN
bjp-16772	188	3	,	,	PUNCT
bjp-16772	188	4	vlcek	vlcek	PROPN
bjp-16772	188	5	j	j	PROPN
bjp-16772	188	6	,	,	PUNCT
bjp-16772	188	7	hejdova	hejdova	PROPN
bjp-16772	188	8	m.	m.	NOUN
bjp-16772	188	9	theoretical	theoretical	ADJ
bjp-16772	188	10	exposure	exposure	NOUN
bjp-16772	188	11	of	of	ADP
bjp-16772	188	12	chronically	chronically	ADV
bjp-16772	188	13	treated	treat	VERB
bjp-16772	188	14	patients	patient	NOUN
bjp-16772	188	15	to	to	ADP
bjp-16772	188	16	lipid	lipid	NOUN
bjp-16772	188	17	lowering	lower	VERB
bjp-16772	188	18	agents	agent	NOUN
bjp-16772	188	19	.	.	PUNCT
bjp-16772	189	1	pharmacoepidemiol	pharmacoepidemiol	PROPN
bjp-16772	189	2	drug	drug	PROPN
bjp-16772	189	3	saf	saf	PROPN
bjp-16772	189	4	.	.	PROPN
bjp-16772	189	5	2005	2005	NUM
bjp-16772	189	6	;	;	PUNCT
bjp-16772	189	7	14	14	NUM
bjp-16772	189	8	:	:	SYM
bjp-16772	189	9	61	61	NUM
bjp-16772	189	10	-	-	SYM
bjp-16772	189	11	67	67	NUM
bjp-16772	189	12	.	.	PUNCT
bjp-16772	190	1	lemos	lemos	PROPN
bjp-16772	190	2	ja	ja	PROPN
bjp-16772	190	3	,	,	PUNCT
bjp-16772	190	4	blazing	blaze	VERB
bjp-16772	190	5	ma	ma	PROPN
bjp-16772	190	6	,	,	PUNCT
bjp-16772	190	7	wiviott	wiviott	VERB
bjp-16772	190	8	sd	sd	PROPN
bjp-16772	190	9	,	,	PUNCT
bjp-16772	190	10	lewis	lewis	PROPN
bjp-16772	190	11	ef	ef	PROPN
bjp-16772	190	12	,	,	PUNCT
bjp-16772	190	13	fox	fox	PROPN
bjp-16772	190	14	kaa	kaa	PROPN
bjp-16772	190	15	,	,	PUNCT
bjp-16772	190	16	white	white	PROPN
bjp-16772	190	17	hd	hd	PROPN
bjp-16772	190	18	et	et	PROPN
bjp-16772	190	19	al	al	PROPN
bjp-16772	190	20	.	.	PROPN
bjp-16772	191	1	early	early	ADV
bjp-16772	191	2	intensive	intensive	ADJ
bjp-16772	191	3	vs	vs	ADP
bjp-16772	191	4	a	a	DET
bjp-16772	191	5	delayed	delay	VERB
bjp-16772	191	6	conservative	conservative	ADJ
bjp-16772	191	7	simvastatin	simvastatin	ADJ
bjp-16772	191	8	strategy	strategy	NOUN
bjp-16772	191	9	in	in	ADP
bjp-16772	191	10	patients	patient	NOUN
bjp-16772	191	11	with	with	ADP
bjp-16772	191	12	acute	acute	ADJ
bjp-16772	191	13	coronary	coronary	ADJ
bjp-16772	191	14	syndromes	syndrome	NOUN
bjp-16772	191	15	phase	phase	NOUN
bjp-16772	191	16	z	z	NOUN
bjp-16772	191	17	of	of	ADP
bjp-16772	191	18	the	the	DET
bjp-16772	191	19	a	a	DET
bjp-16772	191	20	to	to	ADP
bjp-16772	191	21	z	z	NOUN
bjp-16772	191	22	trial	trial	NOUN
bjp-16772	191	23	.	.	PUNCT
bjp-16772	192	1	jama	jama	PROPN
bjp-16772	192	2	.	.	PUNCT
bjp-16772	193	1	2004	2004	NUM
bjp-16772	193	2	;	;	PUNCT
bjp-16772	193	3	292	292	NUM
bjp-16772	193	4	:	:	SYM
bjp-16772	193	5	1307	1307	NUM
bjp-16772	193	6	-	-	SYM
bjp-16772	193	7	16	16	NUM
bjp-16772	193	8	.	.	PUNCT
bjp-16772	194	1	magrini	magrini	PROPN
bjp-16772	194	2	n	n	CCONJ
bjp-16772	194	3	,	,	PUNCT
bjp-16772	194	4	einarson	einarson	PROPN
bjp-16772	194	5	t	t	PROPN
bjp-16772	194	6	,	,	PUNCT
bjp-16772	194	7	vaccheri	vaccheri	ADJ
bjp-16772	194	8	a.	a.	NOUN
bjp-16772	194	9	use	use	NOUN
bjp-16772	194	10	of	of	ADP
bjp-16772	194	11	lipid	lipid	NOUN
bjp-16772	194	12	-	-	PUNCT
bjp-16772	194	13	lowering	lower	VERB
bjp-16772	194	14	drugs	drug	NOUN
bjp-16772	194	15	from	from	ADP
bjp-16772	194	16	1990	1990	NUM
bjp-16772	194	17	to	to	ADP
bjp-16772	194	18	1994	1994	NUM
bjp-16772	194	19	:	:	PUNCT
bjp-16772	194	20	an	an	DET
bjp-16772	194	21	international	international	ADJ
bjp-16772	194	22	comparison	comparison	NOUN
bjp-16772	194	23	among	among	ADP
bjp-16772	194	24	australia	australia	PROPN
bjp-16772	194	25	,	,	PUNCT
bjp-16772	194	26	finland	finland	PROPN
bjp-16772	194	27	,	,	PUNCT
bjp-16772	194	28	italy	italy	PROPN
bjp-16772	194	29	,	,	PUNCT
bjp-16772	194	30	norway	norway	PROPN
bjp-16772	194	31	and	and	CCONJ
bjp-16772	194	32	sweden	sweden	PROPN
bjp-16772	194	33	.	.	PUNCT
bjp-16772	195	1	eur	eur	PROPN
bjp-16772	195	2	j	j	PROPN
bjp-16772	195	3	clin	clin	PROPN
bjp-16772	195	4	pharmacol	pharmacol	PROPN
bjp-16772	195	5	.	.	PUNCT
bjp-16772	196	1	1997	1997	NUM
bjp-16772	196	2	;	;	PUNCT
bjp-16772	196	3	53	53	NUM
bjp-16772	196	4	:	:	SYM
bjp-16772	196	5	185	185	NUM
bjp-16772	196	6	-	-	SYM
bjp-16772	196	7	89	89	NUM
bjp-16772	196	8	.	.	PUNCT
bjp-16772	197	1	mason	mason	PROPN
bjp-16772	197	2	cm	cm	PROPN
bjp-16772	197	3	.	.	PUNCT
bjp-16772	198	1	preventing	prevent	VERB
bjp-16772	198	2	coronary	coronary	ADJ
bjp-16772	198	3	heart	heart	NOUN
bjp-16772	198	4	disease	disease	NOUN
bjp-16772	198	5	and	and	CCONJ
bjp-16772	198	6	stroke	stroke	NOUN
bjp-16772	198	7	with	with	ADP
bjp-16772	198	8	aggressive	aggressive	ADJ
bjp-16772	198	9	statin	statin	ADJ
bjp-16772	198	10	therapy	therapy	NOUN
bjp-16772	198	11	in	in	ADP
bjp-16772	198	12	older	old	ADJ
bjp-16772	198	13	adults	adult	NOUN
bjp-16772	198	14	using	use	VERB
bjp-16772	198	15	a	a	DET
bjp-16772	198	16	team	team	NOUN
bjp-16772	198	17	management	management	NOUN
bjp-16772	198	18	model	model	NOUN
bjp-16772	198	19	.	.	PUNCT
bjp-16772	199	1	j	j	PROPN
bjp-16772	199	2	am	be	AUX
bjp-16772	199	3	acad	acad	ADJ
bjp-16772	199	4	nurse	nurse	NOUN
bjp-16772	199	5	pract	pract	NOUN
bjp-16772	199	6	.	.	PUNCT
bjp-16772	200	1	2009	2009	NUM
bjp-16772	200	2	;	;	PUNCT
bjp-16772	200	3	21	21	NUM
bjp-16772	200	4	:	:	PUNCT
bjp-16772	200	5	47	47	NUM
bjp-16772	200	6	-	-	SYM
bjp-16772	200	7	53	53	NUM
bjp-16772	200	8	.	.	PUNCT
bjp-16772	201	1	maycock	maycock	PROPN
bjp-16772	201	2	ca	ca	PROPN
bjp-16772	201	3	,	,	PUNCT
bjp-16772	201	4	muhlestein	muhlestein	PROPN
bjp-16772	201	5	jb	jb	PROPN
bjp-16772	201	6	,	,	PUNCT
bjp-16772	201	7	horne	horne	PROPN
bjp-16772	201	8	bd	bd	PROPN
bjp-16772	201	9	,	,	PUNCT
bjp-16772	201	10	carlquist	carlquist	PROPN
bjp-16772	201	11	jf	jf	PROPN
bjp-16772	201	12	,	,	PUNCT
bjp-16772	201	13	bair	bair	PROPN
bjp-16772	201	14	tl	tl	PROPN
bjp-16772	201	15	,	,	PUNCT
bjp-16772	202	1	pearson	pearson	PROPN
bjp-16772	202	2	rr	rr	PROPN
bjp-16772	202	3	et	et	PROPN
bjp-16772	202	4	al	al	PROPN
bjp-16772	202	5	.	.	PROPN
bjp-16772	203	1	statin	statin	PROPN
bjp-16772	203	2	therapy	therapy	NOUN
bjp-16772	203	3	is	be	AUX
bjp-16772	203	4	associated	associate	VERB
bjp-16772	203	5	with	with	ADP
bjp-16772	203	6	reduced	reduce	VERB
bjp-16772	203	7	mortality	mortality	NOUN
bjp-16772	203	8	across	across	ADP
bjp-16772	203	9	all	all	DET
bjp-16772	203	10	age	age	NOUN
bjp-16772	203	11	groups	group	NOUN
bjp-16772	203	12	of	of	ADP
bjp-16772	203	13	individuals	individual	NOUN
bjp-16772	203	14	with	with	ADP
bjp-16772	203	15	significant	significant	ADJ
bjp-16772	203	16	coronary	coronary	ADJ
bjp-16772	203	17	disease	disease	NOUN
bjp-16772	203	18	,	,	PUNCT
bjp-16772	203	19	including	include	VERB
bjp-16772	203	20	very	very	ADV
bjp-16772	203	21	elderly	elderly	ADJ
bjp-16772	203	22	patients	patient	NOUN
bjp-16772	203	23	.	.	PUNCT
bjp-16772	204	1	jacc	jacc	INTJ
bjp-16772	204	2	.	.	PUNCT
bjp-16772	205	1	2002	2002	NUM
bjp-16772	205	2	;	;	PUNCT
bjp-16772	205	3	40	40	NUM
bjp-16772	205	4	:	:	PUNCT
bjp-16772	205	5	1777	1777	NUM
bjp-16772	205	6	-	-	SYM
bjp-16772	205	7	85	85	NUM
bjp-16772	205	8	.	.	PUNCT
bjp-16772	206	1	mcdonald	mcdonald	PROPN
bjp-16772	206	2	kj	kj	PROPN
bjp-16772	206	3	,	,	PUNCT
bjp-16772	206	4	jardine	jardine	PROPN
bjp-16772	206	5	ag	ag	PROPN
bjp-16772	206	6	.	.	PUNCT
bjp-16772	207	1	the	the	DET
bjp-16772	207	2	use	use	NOUN
bjp-16772	207	3	of	of	ADP
bjp-16772	207	4	fluvastatin	fluvastatin	NOUN
bjp-16772	207	5	in	in	ADP
bjp-16772	207	6	cardiovascular	cardiovascular	ADJ
bjp-16772	207	7	risk	risk	NOUN
bjp-16772	207	8	management	management	NOUN
bjp-16772	207	9	.	.	PUNCT
bjp-16772	208	1	expert	expert	NOUN
bjp-16772	208	2	opin	opin	NOUN
bjp-16772	208	3	pharmacother	pharmacother	NOUN
bjp-16772	208	4	.	.	PUNCT
bjp-16772	209	1	2008	2008	NUM
bjp-16772	209	2	;	;	PUNCT
bjp-16772	209	3	9	9	NUM
bjp-16772	209	4	:	:	SYM
bjp-16772	209	5	1407	1407	NUM
bjp-16772	209	6	-	-	SYM
bjp-16772	209	7	14	14	NUM
bjp-16772	209	8	.	.	PUNCT
bjp-16772	210	1	mcelduff	mcelduff	PROPN
bjp-16772	210	2	p	p	X
bjp-16772	210	3	,	,	PUNCT
bjp-16772	210	4	jaefarnezhad	jaefarnezhad	VERB
bjp-16772	210	5	m	m	PROPN
bjp-16772	210	6	,	,	PUNCT
bjp-16772	210	7	durrington	durrington	PROPN
bjp-16772	210	8	pn	pn	PROPN
bjp-16772	210	9	.	.	PROPN
bjp-16772	210	10	american	american	PROPN
bjp-16772	210	11	,	,	PUNCT
bjp-16772	210	12	british	british	ADJ
bjp-16772	210	13	and	and	CCONJ
bjp-16772	210	14	european	european	ADJ
bjp-16772	210	15	recommendations	recommendation	NOUN
bjp-16772	210	16	for	for	ADP
bjp-16772	210	17	statins	statin	NOUN
bjp-16772	210	18	in	in	ADP
bjp-16772	210	19	the	the	DET
bjp-16772	210	20	primary	primary	ADJ
bjp-16772	210	21	408	408	NUM
bjp-16772	210	22	bangladesh	bangladesh	NOUN
bjp-16772	210	23	j	j	PROPN
bjp-16772	210	24	pharmacol	pharmacol	PROPN
bjp-16772	210	25	2013	2013	NUM
bjp-16772	210	26	;	;	PUNCT
bjp-16772	210	27	8	8	NUM
bjp-16772	210	28	:	:	SYM
bjp-16772	210	29	401	401	NUM
bjp-16772	210	30	-	-	SYM
bjp-16772	210	31	409	409	NUM
bjp-16772	210	32	prevention	prevention	NOUN
bjp-16772	210	33	of	of	ADP
bjp-16772	210	34	cardiovascular	cardiovascular	ADJ
bjp-16772	210	35	disease	disease	NOUN
bjp-16772	210	36	applied	apply	VERB
bjp-16772	210	37	to	to	ADP
bjp-16772	210	38	british	british	ADJ
bjp-16772	210	39	men	man	NOUN
bjp-16772	210	40	studied	study	VERB
bjp-16772	210	41	prospectively	prospectively	ADV
bjp-16772	210	42	.	.	PUNCT
bjp-16772	211	1	heart	heart	NOUN
bjp-16772	211	2	2006	2006	NUM
bjp-16772	211	3	;	;	PUNCT
bjp-16772	211	4	92	92	NUM
bjp-16772	211	5	:	:	SYM
bjp-16772	211	6	1213	1213	NUM
bjp-16772	211	7	-	-	SYM
bjp-16772	211	8	18	18	NUM
bjp-16772	211	9	.	.	PUNCT
bjp-16772	212	1	milias	milias	PROPN
bjp-16772	212	2	ga	ga	PROPN
bjp-16772	212	3	,	,	PUNCT
bjp-16772	212	4	panagiotakos	panagiotakos	NOUN
bjp-16772	212	5	db	db	PROPN
bjp-16772	212	6	,	,	PUNCT
bjp-16772	212	7	pitsavos	pitsavos	PROPN
bjp-16772	212	8	c	c	PROPN
bjp-16772	212	9	,	,	PUNCT
bjp-16772	212	10	xenaki	xenaki	PROPN
bjp-16772	212	11	d	d	NOUN
bjp-16772	212	12	,	,	PUNCT
bjp-16772	212	13	panagopoulos	panagopoulos	NOUN
bjp-16772	212	14	g	g	PROPN
bjp-16772	212	15	,	,	PUNCT
bjp-16772	212	16	stefanadis	stefanadis	PROPN
bjp-16772	212	17	c.	c.	PROPN
bjp-16772	212	18	prevalence	prevalence	NOUN
bjp-16772	212	19	of	of	ADP
bjp-16772	212	20	self	self	NOUN
bjp-16772	212	21	-	-	PUNCT
bjp-16772	212	22	reported	report	VERB
bjp-16772	212	23	hypercholesterolaemia	hypercholesterolaemia	NOUN
bjp-16772	212	24	and	and	CCONJ
bjp-16772	212	25	its	its	PRON
bjp-16772	212	26	relation	relation	NOUN
bjp-16772	212	27	to	to	ADP
bjp-16772	212	28	dietary	dietary	ADJ
bjp-16772	212	29	habits	habit	NOUN
bjp-16772	212	30	,	,	PUNCT
bjp-16772	212	31	in	in	ADP
bjp-16772	212	32	greek	greek	ADJ
bjp-16772	212	33	adults	adult	NOUN
bjp-16772	212	34	;	;	PUNCT
bjp-16772	212	35	a	a	DET
bjp-16772	212	36	national	national	ADJ
bjp-16772	212	37	nutrition	nutrition	PROPN
bjp-16772	212	38	&	&	CCONJ
bjp-16772	212	39	health	health	PROPN
bjp-16772	212	40	survey	survey	NOUN
bjp-16772	212	41	.	.	PUNCT
bjp-16772	213	1	lipids	lipids	ADP
bjp-16772	213	2	health	health	NOUN
bjp-16772	213	3	dis	dis	PROPN
bjp-16772	213	4	.	.	PUNCT
bjp-16772	214	1	2006	2006	NUM
bjp-16772	214	2	;	;	PUNCT
bjp-16772	214	3	5	5	NUM
bjp-16772	214	4	:	:	SYM
bjp-16772	214	5	5	5	NUM
bjp-16772	214	6	.	.	X
bjp-16772	214	7	mohamed	mohame	VERB
bjp-16772	214	8	in	in	ADV
bjp-16772	214	9	,	,	PUNCT
bjp-16772	214	10	helms	helms	VERB
bjp-16772	214	11	pj	pj	PROPN
bjp-16772	214	12	,	,	PUNCT
bjp-16772	214	13	simpson	simpson	PROPN
bjp-16772	214	14	cr	cr	PROPN
bjp-16772	214	15	,	,	PUNCT
bjp-16772	214	16	mclay	mclay	PROPN
bjp-16772	214	17	js	js	PROPN
bjp-16772	214	18	.	.	PUNCT
bjp-16772	215	1	using	use	VERB
bjp-16772	215	2	routinely	routinely	ADV
bjp-16772	215	3	collected	collect	VERB
bjp-16772	215	4	prescribing	prescribing	NOUN
bjp-16772	215	5	data	datum	NOUN
bjp-16772	215	6	to	to	PART
bjp-16772	215	7	determine	determine	VERB
bjp-16772	215	8	drug	drug	NOUN
bjp-16772	215	9	persistence	persistence	NOUN
bjp-16772	215	10	for	for	ADP
bjp-16772	215	11	the	the	DET
bjp-16772	215	12	purpose	purpose	NOUN
bjp-16772	215	13	of	of	ADP
bjp-16772	215	14	pharmacovigilance	pharmacovigilance	NOUN
bjp-16772	215	15	.	.	PUNCT
bjp-16772	216	1	j	j	PROPN
bjp-16772	216	2	clin	clin	PROPN
bjp-16772	216	3	pharmacol	pharmacol	PROPN
bjp-16772	216	4	.	.	PUNCT
bjp-16772	217	1	2011	2011	NUM
bjp-16772	217	2	;	;	PUNCT
bjp-16772	217	3	51	51	NUM
bjp-16772	217	4	:	:	SYM
bjp-16772	217	5	279	279	NUM
bjp-16772	217	6	-	-	SYM
bjp-16772	217	7	84	84	NUM
bjp-16772	217	8	.	.	PUNCT
bjp-16772	218	1	ohsfeldt	ohsfeldt	PROPN
bjp-16772	218	2	rl	rl	PROPN
bjp-16772	218	3	,	,	PUNCT
bjp-16772	218	4	gandhi	gandhi	PROPN
bjp-16772	218	5	sk	sk	PROPN
bjp-16772	218	6	,	,	PUNCT
bjp-16772	218	7	fox	fox	PROPN
bjp-16772	218	8	km	km	PROPN
bjp-16772	218	9	,	,	PUNCT
bjp-16772	218	10	mckenney	mckenney	PROPN
bjp-16772	218	11	jm	jm	PROPN
bjp-16772	218	12	.	.	PROPN
bjp-16772	218	13	statin	statin	PROPN
bjp-16772	218	14	costeffectiveness	costeffectiveness	NOUN
bjp-16772	218	15	comparisons	comparison	NOUN
bjp-16772	218	16	using	use	VERB
bjp-16772	218	17	real	real	ADJ
bjp-16772	218	18	-	-	PUNCT
bjp-16772	218	19	world	world	NOUN
bjp-16772	218	20	effectiveness	effectiveness	NOUN
bjp-16772	218	21	data	datum	NOUN
bjp-16772	218	22	:	:	PUNCT
bjp-16772	218	23	formulary	formulary	NOUN
bjp-16772	218	24	implications	implication	NOUN
bjp-16772	218	25	.	.	PUNCT
bjp-16772	219	1	value	value	NOUN
bjp-16772	219	2	health	health	NOUN
bjp-16772	219	3	.	.	PUNCT
bjp-16772	220	1	2008	2008	NUM
bjp-16772	220	2	;	;	PUNCT
bjp-16772	220	3	11	11	NUM
bjp-16772	220	4	:	:	SYM
bjp-16772	220	5	106169	106169	NUM
bjp-16772	220	6	.	.	PUNCT
bjp-16772	221	1	packham	packham	PROPN
bjp-16772	221	2	c	c	PROPN
bjp-16772	221	3	,	,	PUNCT
bjp-16772	221	4	pearson	pearson	PROPN
bjp-16772	221	5	j	j	PROPN
bjp-16772	221	6	,	,	PUNCT
bjp-16772	221	7	robinson	robinson	PROPN
bjp-16772	221	8	j	j	PROPN
bjp-16772	221	9	,	,	PUNCT
bjp-16772	221	10	gray	gray	ADJ
bjp-16772	221	11	d.	d.	PROPN
bjp-16772	221	12	use	use	NOUN
bjp-16772	221	13	of	of	ADP
bjp-16772	221	14	statins	statin	NOUN
bjp-16772	221	15	in	in	ADP
bjp-16772	221	16	general	general	ADJ
bjp-16772	221	17	practices	practice	NOUN
bjp-16772	221	18	,	,	PUNCT
bjp-16772	221	19	1996	1996	NUM
bjp-16772	221	20	-	-	SYM
bjp-16772	221	21	8	8	NUM
bjp-16772	221	22	:	:	PUNCT
bjp-16772	221	23	cross	cross	VERB
bjp-16772	221	24	sectional	sectional	ADJ
bjp-16772	221	25	study	study	NOUN
bjp-16772	221	26	.	.	PUNCT
bjp-16772	222	1	bmj	bmj	PROPN
bjp-16772	222	2	.	.	PROPN
bjp-16772	222	3	2000	2000	NUM
bjp-16772	222	4	;	;	PUNCT
bjp-16772	222	5	320	320	NUM
bjp-16772	222	6	:	:	PUNCT
bjp-16772	222	7	1583	1583	NUM
bjp-16772	222	8	-	-	SYM
bjp-16772	222	9	84	84	NUM
bjp-16772	222	10	.	.	PUNCT
bjp-16772	223	1	pedersen	pedersen	NOUN
bjp-16772	223	2	tr	tr	VERB
bjp-16772	223	3	,	,	PUNCT
bjp-16772	223	4	faergeman	faergeman	NOUN
bjp-16772	223	5	o	o	PROPN
bjp-16772	223	6	,	,	PUNCT
bjp-16772	223	7	kastelein	kastelein	PROPN
bjp-16772	223	8	jjp	jjp	PROPN
bjp-16772	223	9	et	et	PROPN
bjp-16772	223	10	al	al	PROPN
bjp-16772	223	11	.	.	PROPN
bjp-16772	223	12	high	high	ADJ
bjp-16772	223	13	-	-	PUNCT
bjp-16772	223	14	dose	dose	NOUN
bjp-16772	223	15	atorvastatin	atorvastatin	NOUN
bjp-16772	223	16	vs.	vs.	ADP
bjp-16772	223	17	usual	usual	ADJ
bjp-16772	223	18	-	-	PUNCT
bjp-16772	223	19	dose	dose	NOUN
bjp-16772	223	20	simvastatin	simvastatin	NOUN
bjp-16772	223	21	for	for	ADP
bjp-16772	223	22	secondary	secondary	ADJ
bjp-16772	223	23	prevention	prevention	NOUN
bjp-16772	223	24	after	after	ADP
bjp-16772	223	25	myocardial	myocardial	ADJ
bjp-16772	223	26	infarction	infarction	NOUN
bjp-16772	223	27	:	:	PUNCT
bjp-16772	224	1	the	the	DET
bjp-16772	224	2	ideal	ideal	ADJ
bjp-16772	224	3	study	study	NOUN
bjp-16772	224	4	:	:	PUNCT
bjp-16772	224	5	a	a	DET
bjp-16772	224	6	randomized	randomized	ADJ
bjp-16772	224	7	controlled	control	VERB
bjp-16772	224	8	trial	trial	NOUN
bjp-16772	224	9	.	.	PUNCT
bjp-16772	225	1	jama	jama	PROPN
bjp-16772	225	2	.	.	PUNCT
bjp-16772	226	1	2005	2005	NUM
bjp-16772	226	2	;	;	PUNCT
bjp-16772	226	3	294	294	NUM
bjp-16772	226	4	:	:	PUNCT
bjp-16772	226	5	2437	2437	NUM
bjp-16772	226	6	-	-	SYM
bjp-16772	226	7	45	45	NUM
bjp-16772	226	8	.	.	PUNCT
bjp-16772	227	1	petty	petty	PROPN
bjp-16772	227	2	d	d	PROPN
bjp-16772	227	3	,	,	PUNCT
bjp-16772	227	4	lloyd	lloyd	PROPN
bjp-16772	227	5	d.	d.	PROPN
bjp-16772	227	6	can	can	AUX
bjp-16772	227	7	cheap	cheap	VERB
bjp-16772	227	8	generic	generic	ADJ
bjp-16772	227	9	statins	statin	NOUN
bjp-16772	227	10	achieve	achieve	VERB
bjp-16772	227	11	national	national	ADJ
bjp-16772	227	12	cholesterol	cholesterol	NOUN
bjp-16772	227	13	lowering	lower	VERB
bjp-16772	227	14	targets	target	NOUN
bjp-16772	227	15	?	?	PUNCT
bjp-16772	228	1	j	j	PROPN
bjp-16772	228	2	health	health	NOUN
bjp-16772	228	3	serv	serv	PROPN
bjp-16772	228	4	res	re	NOUN
bjp-16772	228	5	policy	policy	NOUN
bjp-16772	228	6	.	.	PUNCT
bjp-16772	229	1	2008	2008	NUM
bjp-16772	229	2	;	;	PUNCT
bjp-16772	229	3	13	13	NUM
bjp-16772	229	4	:	:	SYM
bjp-16772	229	5	99	99	NUM
bjp-16772	229	6	-	-	SYM
bjp-16772	229	7	102	102	NUM
bjp-16772	229	8	.	.	PUNCT
bjp-16772	230	1	rosa	rosa	PROPN
bjp-16772	230	2	jcl	jcl	PROPN
bjp-16772	230	3	,	,	PUNCT
bjp-16772	230	4	grundy	grundy	PROPN
bjp-16772	230	5	sm	sm	PROPN
bjp-16772	230	6	,	,	PUNCT
bjp-16772	230	7	waters	waters	PROPN
bjp-16772	230	8	dd	dd	VERB
bjp-16772	230	9	,	,	PUNCT
bjp-16772	230	10	shear	shear	NOUN
bjp-16772	230	11	c	c	NOUN
bjp-16772	230	12	,	,	PUNCT
bjp-16772	230	13	barter	barter	NOUN
bjp-16772	230	14	p	p	NOUN
bjp-16772	230	15	,	,	PUNCT
bjp-16772	230	16	fruchart	fruchart	PROPN
bjp-16772	230	17	jc	jc	PROPN
bjp-16772	230	18	et	et	PROPN
bjp-16772	230	19	al	al	PROPN
bjp-16772	230	20	.	.	PROPN
bjp-16772	230	21	treating	treat	VERB
bjp-16772	230	22	to	to	ADP
bjp-16772	230	23	new	new	ADJ
bjp-16772	230	24	targets	target	NOUN
bjp-16772	230	25	(	(	PUNCT
bjp-16772	230	26	tnt	tnt	NOUN
bjp-16772	230	27	)	)	PUNCT
bjp-16772	230	28	investigators	investigator	NOUN
bjp-16772	230	29	;	;	PUNCT
bjp-16772	230	30	intensive	intensive	ADJ
bjp-16772	230	31	lipid	lipid	NOUN
bjp-16772	230	32	lowering	lower	VERB
bjp-16772	230	33	with	with	ADP
bjp-16772	230	34	atorvastatin	atorvastatin	NOUN
bjp-16772	230	35	in	in	ADP
bjp-16772	230	36	patients	patient	NOUN
bjp-16772	230	37	with	with	ADP
bjp-16772	230	38	stable	stable	ADJ
bjp-16772	230	39	coronary	coronary	ADJ
bjp-16772	230	40	disease	disease	NOUN
bjp-16772	230	41	.	.	PUNCT
bjp-16772	231	1	n	n	PROPN
bjp-16772	231	2	engl	engl	PROPN
bjp-16772	231	3	j	j	PROPN
bjp-16772	231	4	med	med	PROPN
bjp-16772	231	5	.	.	PUNCT
bjp-16772	231	6	2005	2005	NUM
bjp-16772	231	7	;	;	PUNCT
bjp-16772	231	8	352	352	NUM
bjp-16772	231	9	:	:	PUNCT
bjp-16772	231	10	1425	1425	NUM
bjp-16772	231	11	-	-	SYM
bjp-16772	231	12	35	35	NUM
bjp-16772	231	13	.	.	PUNCT
bjp-16772	232	1	schuster	schuster	PROPN
bjp-16772	232	2	h	h	PROPN
bjp-16772	232	3	,	,	PUNCT
bjp-16772	232	4	barter	barter	PROPN
bjp-16772	232	5	pj	pj	PROPN
bjp-16772	232	6	,	,	PUNCT
bjp-16772	232	7	stender	stender	NOUN
bjp-16772	232	8	s	s	PART
bjp-16772	232	9	,	,	PUNCT
bjp-16772	232	10	cheung	cheung	PROPN
bjp-16772	232	11	rc	rc	PROPN
bjp-16772	232	12	,	,	PUNCT
bjp-16772	232	13	bonnet	bonnet	NOUN
bjp-16772	232	14	j	j	PROPN
bjp-16772	232	15	,	,	PUNCT
bjp-16772	232	16	jonathan	jonathan	PROPN
bjp-16772	232	17	m	m	PROPN
bjp-16772	232	18	et	et	PROPN
bjp-16772	232	19	al	al	PROPN
bjp-16772	232	20	.	.	PUNCT
bjp-16772	233	1	effects	effect	NOUN
bjp-16772	233	2	of	of	ADP
bjp-16772	233	3	switching	switch	VERB
bjp-16772	233	4	statins	statin	NOUN
bjp-16772	233	5	on	on	ADP
bjp-16772	233	6	achievement	achievement	NOUN
bjp-16772	233	7	of	of	ADP
bjp-16772	233	8	lipid	lipid	ADJ
bjp-16772	233	9	goals	goal	NOUN
bjp-16772	233	10	:	:	PUNCT
bjp-16772	233	11	measuring	measure	VERB
bjp-16772	233	12	effective	effective	ADJ
bjp-16772	233	13	reductions	reduction	NOUN
bjp-16772	233	14	in	in	ADP
bjp-16772	233	15	cholesterol	cholesterol	NOUN
bjp-16772	233	16	using	use	VERB
bjp-16772	233	17	rosuvastatin	rosuvastatin	ADJ
bjp-16772	233	18	therapy	therapy	NOUN
bjp-16772	233	19	(	(	PUNCT
bjp-16772	233	20	mercury	mercury	NOUN
bjp-16772	233	21	i	i	PROPN
bjp-16772	233	22	)	)	PUNCT
bjp-16772	233	23	study	study	NOUN
bjp-16772	233	24	.	.	PUNCT
bjp-16772	234	1	ahj	ahj	PROPN
bjp-16772	234	2	.	.	PROPN
bjp-16772	234	3	2004	2004	NUM
bjp-16772	234	4	;	;	PUNCT
bjp-16772	234	5	147	147	NUM
bjp-16772	234	6	:	:	PUNCT
bjp-16772	234	7	705	705	NUM
bjp-16772	234	8	-	-	SYM
bjp-16772	234	9	12	12	NUM
bjp-16772	234	10	.	.	PUNCT
bjp-16772	235	1	shepherd	shepherd	PROPN
bjp-16772	235	2	j	j	PROPN
bjp-16772	235	3	,	,	PUNCT
bjp-16772	235	4	blauw	blauw	PROPN
bjp-16772	235	5	gj	gj	PROPN
bjp-16772	235	6	,	,	PUNCT
bjp-16772	235	7	murphy	murphy	PROPN
bjp-16772	235	8	mb	mb	PROPN
bjp-16772	235	9	,	,	PUNCT
bjp-16772	235	10	bollen	bollen	PROPN
bjp-16772	235	11	elem	elem	PROPN
bjp-16772	235	12	,	,	PUNCT
bjp-16772	235	13	buckley	buckley	PROPN
bjp-16772	235	14	bm	bm	PROPN
bjp-16772	235	15	,	,	PUNCT
bjp-16772	235	16	cobbe	cobbe	NOUN
bjp-16772	235	17	sm	sm	PROPN
bjp-16772	235	18	et	et	PROPN
bjp-16772	235	19	al	al	PROPN
bjp-16772	235	20	.	.	PROPN
bjp-16772	235	21	pravastatin	pravastatin	PROPN
bjp-16772	235	22	in	in	ADP
bjp-16772	235	23	elderly	elderly	ADJ
bjp-16772	235	24	individuals	individual	NOUN
bjp-16772	235	25	at	at	ADP
bjp-16772	235	26	risk	risk	NOUN
bjp-16772	235	27	of	of	ADP
bjp-16772	235	28	vascular	vascular	ADJ
bjp-16772	235	29	disease	disease	NOUN
bjp-16772	235	30	(	(	PUNCT
bjp-16772	235	31	prosper	prosper	NOUN
bjp-16772	235	32	):	):	PUNCT
bjp-16772	235	33	a	a	DET
bjp-16772	235	34	randomised	randomised	ADJ
bjp-16772	235	35	controlled	control	VERB
bjp-16772	235	36	trial	trial	NOUN
bjp-16772	235	37	.	.	PUNCT
bjp-16772	236	1	lancet	lancet	PROPN
bjp-16772	236	2	2002	2002	NUM
bjp-16772	236	3	;	;	PUNCT
bjp-16772	236	4	360	360	NUM
bjp-16772	236	5	:	:	PUNCT
bjp-16772	236	6	1623	1623	NUM
bjp-16772	236	7	-	-	SYM
bjp-16772	236	8	30	30	NUM
bjp-16772	236	9	.	.	PUNCT
bjp-16772	237	1	shepherd	shepherd	PROPN
bjp-16772	237	2	j	j	PROPN
bjp-16772	237	3	,	,	PUNCT
bjp-16772	237	4	cobbe	cobbe	NOUN
bjp-16772	237	5	sm	sm	PROPN
bjp-16772	237	6	,	,	PUNCT
bjp-16772	237	7	ford	ford	PROPN
bjp-16772	237	8	i	i	PROPN
bjp-16772	237	9	,	,	PUNCT
bjp-16772	237	10	isles	isles	PROPN
bjp-16772	237	11	cg	cg	PROPN
bjp-16772	237	12	,	,	PUNCT
bjp-16772	237	13	lorimer	lorimer	PROPN
bjp-16772	237	14	ar	ar	PROPN
bjp-16772	237	15	,	,	PUNCT
bjp-16772	237	16	macfarlane	macfarlane	PROPN
bjp-16772	237	17	pw	pw	PROPN
bjp-16772	237	18	et	et	PROPN
bjp-16772	237	19	al	al	PROPN
bjp-16772	237	20	.	.	PROPN
bjp-16772	237	21	prevention	prevention	NOUN
bjp-16772	237	22	of	of	ADP
bjp-16772	237	23	coronary	coronary	ADJ
bjp-16772	237	24	heart	heart	NOUN
bjp-16772	237	25	disease	disease	NOUN
bjp-16772	237	26	with	with	ADP
bjp-16772	237	27	pravastatin	pravastatin	NOUN
bjp-16772	237	28	in	in	ADP
bjp-16772	237	29	men	man	NOUN
bjp-16772	237	30	with	with	ADP
bjp-16772	237	31	hypercholesterolemia	hypercholesterolemia	NOUN
bjp-16772	237	32	.	.	PUNCT
bjp-16772	238	1	west	west	PROPN
bjp-16772	238	2	of	of	ADP
bjp-16772	238	3	scotland	scotland	PROPN
bjp-16772	238	4	coronary	coronary	ADJ
bjp-16772	238	5	prevention	prevention	NOUN
bjp-16772	238	6	study	study	NOUN
bjp-16772	238	7	group	group	NOUN
bjp-16772	238	8	(	(	PUNCT
bjp-16772	238	9	woscops	woscop	NOUN
bjp-16772	238	10	)	)	PUNCT
bjp-16772	238	11	.	.	PUNCT
bjp-16772	239	1	n	n	PROPN
bjp-16772	239	2	engl	engl	PROPN
bjp-16772	239	3	j	j	PROPN
bjp-16772	239	4	med	med	PROPN
bjp-16772	239	5	.	.	PROPN
bjp-16772	239	6	1995	1995	NUM
bjp-16772	239	7	;	;	PUNCT
bjp-16772	239	8	333	333	NUM
bjp-16772	239	9	:	:	SYM
bjp-16772	239	10	1301	1301	NUM
bjp-16772	239	11	-	-	SYM
bjp-16772	239	12	07	07	NUM
bjp-16772	239	13	.	.	PUNCT
bjp-16772	240	1	simpson	simpson	PROPN
bjp-16772	240	2	cr	cr	PROPN
bjp-16772	240	3	,	,	PUNCT
bjp-16772	240	4	hannaford	hannaford	PROPN
bjp-16772	240	5	pc	pc	PROPN
bjp-16772	240	6	,	,	PUNCT
bjp-16772	240	7	williams	williams	PROPN
bjp-16772	240	8	d.	d.	PROPN
bjp-16772	240	9	evidence	evidence	NOUN
bjp-16772	240	10	for	for	ADP
bjp-16772	240	11	inequalities	inequality	NOUN
bjp-16772	240	12	in	in	ADP
bjp-16772	240	13	the	the	DET
bjp-16772	240	14	management	management	NOUN
bjp-16772	240	15	of	of	ADP
bjp-16772	240	16	coronary	coronary	ADJ
bjp-16772	240	17	heart	heart	NOUN
bjp-16772	240	18	disease	disease	NOUN
bjp-16772	240	19	in	in	ADP
bjp-16772	240	20	scotland	scotland	PROPN
bjp-16772	240	21	.	.	PUNCT
bjp-16772	241	1	heart	heart	NOUN
bjp-16772	241	2	2005	2005	NUM
bjp-16772	241	3	;	;	PUNCT
bjp-16772	241	4	91	91	NUM
bjp-16772	241	5	:	:	SYM
bjp-16772	241	6	630	630	NUM
bjp-16772	241	7	-	-	SYM
bjp-16772	241	8	34	34	NUM
bjp-16772	241	9	.	.	PUNCT
bjp-16772	242	1	stein	stein	PROPN
bjp-16772	242	2	ea	ea	PROPN
bjp-16772	242	3	,	,	PUNCT
bjp-16772	242	4	laskarzewski	laskarzewski	PROPN
bjp-16772	242	5	p.	p.	NOUN
bjp-16772	242	6	comparison	comparison	NOUN
bjp-16772	242	7	of	of	ADP
bjp-16772	242	8	statins	statin	NOUN
bjp-16772	242	9	in	in	ADP
bjp-16772	242	10	hypertriglyceridemia	hypertriglyceridemia	NOUN
bjp-16772	242	11	.	.	PUNCT
bjp-16772	242	12	am	be	AUX
bjp-16772	242	13	j	j	PROPN
bjp-16772	242	14	cardiol	cardiol	NOUN
bjp-16772	242	15	.	.	PUNCT
bjp-16772	243	1	1998	1998	NUM
bjp-16772	243	2	;	;	PUNCT
bjp-16772	243	3	81	81	NUM
bjp-16772	243	4	:	:	PUNCT
bjp-16772	243	5	66	66	NUM
bjp-16772	243	6	-	-	SYM
bjp-16772	243	7	69	69	NUM
bjp-16772	243	8	.	.	PUNCT
bjp-16772	244	1	study	study	NOUN
bjp-16772	244	2	of	of	ADP
bjp-16772	244	3	the	the	DET
bjp-16772	244	4	effectiveness	effectiveness	NOUN
bjp-16772	244	5	of	of	ADP
bjp-16772	244	6	additional	additional	ADJ
bjp-16772	244	7	reductions	reduction	NOUN
bjp-16772	244	8	in	in	ADP
bjp-16772	244	9	cholesterol	cholesterol	NOUN
bjp-16772	244	10	and	and	CCONJ
bjp-16772	244	11	homocysteine	homocysteine	NOUN
bjp-16772	244	12	(	(	PUNCT
bjp-16772	244	13	search	search	NOUN
bjp-16772	244	14	)	)	PUNCT
bjp-16772	244	15	collaborative	collaborative	ADJ
bjp-16772	244	16	group	group	NOUN
bjp-16772	244	17	:	:	PUNCT
bjp-16772	244	18	intensive	intensive	ADJ
bjp-16772	244	19	lowering	lowering	NOUN
bjp-16772	244	20	of	of	ADP
bjp-16772	244	21	ldl	ldl	NOUN
bjp-16772	244	22	cholesterol	cholesterol	NOUN
bjp-16772	244	23	with	with	ADP
bjp-16772	244	24	80	80	NUM
bjp-16772	244	25	mg	mg	NOUN
bjp-16772	244	26	versus	versus	ADP
bjp-16772	244	27	20	20	NUM
bjp-16772	244	28	mg	mg	PROPN
bjp-16772	244	29	simvastatin	simvastatin	PROPN
bjp-16772	244	30	daily	daily	PROPN
bjp-16772	244	31	in	in	ADP
bjp-16772	244	32	12064	12064	NUM
bjp-16772	244	33	survivors	survivor	NOUN
bjp-16772	244	34	of	of	ADP
bjp-16772	244	35	myocardial	myocardial	ADJ
bjp-16772	244	36	infarction	infarction	NOUN
bjp-16772	244	37	:	:	PUNCT
bjp-16772	244	38	a	a	DET
bjp-16772	244	39	double	double	ADJ
bjp-16772	244	40	-	-	PUNCT
bjp-16772	244	41	blind	blind	ADJ
bjp-16772	244	42	randomised	randomised	ADJ
bjp-16772	244	43	trial	trial	NOUN
bjp-16772	244	44	.	.	PUNCT
bjp-16772	245	1	lancet	lancet	PROPN
bjp-16772	245	2	2010	2010	NUM
bjp-16772	245	3	;	;	PUNCT
bjp-16772	245	4	376	376	NUM
bjp-16772	245	5	:	:	PUNCT
bjp-16772	245	6	1658	1658	NUM
bjp-16772	245	7	-	-	SYM
bjp-16772	245	8	69	69	NUM
bjp-16772	245	9	.	.	PUNCT
bjp-16772	246	1	toth	toth	PROPN
bjp-16772	246	2	pp	pp	PROPN
bjp-16772	246	3	,	,	PUNCT
bjp-16772	246	4	cadman	cadman	PROPN
bjp-16772	246	5	cj	cj	PROPN
bjp-16772	246	6	.	.	PUNCT
bjp-16772	247	1	implications	implication	NOUN
bjp-16772	247	2	of	of	ADP
bjp-16772	247	3	recent	recent	ADJ
bjp-16772	247	4	statin	statin	ADJ
bjp-16772	247	5	trials	trial	NOUN
bjp-16772	247	6	for	for	ADP
bjp-16772	247	7	primary	primary	ADJ
bjp-16772	247	8	care	care	NOUN
bjp-16772	247	9	practice	practice	NOUN
bjp-16772	247	10	.	.	PUNCT
bjp-16772	248	1	j	j	PROPN
bjp-16772	248	2	clin	clin	PROPN
bjp-16772	248	3	lipidol	lipidol	VERB
bjp-16772	248	4	.	.	PUNCT
bjp-16772	249	1	2007	2007	NUM
bjp-16772	249	2	;	;	PUNCT
bjp-16772	249	3	1	1	NUM
bjp-16772	249	4	:	:	SYM
bjp-16772	249	5	182	182	NUM
bjp-16772	249	6	-	-	SYM
bjp-16772	249	7	90	90	NUM
bjp-16772	249	8	.	.	PUNCT
bjp-16772	250	1	weng	weng	PROPN
bjp-16772	250	2	tc	tc	PROPN
bjp-16772	250	3	,	,	PUNCT
bjp-16772	250	4	yang	yang	PROPN
bjp-16772	250	5	ykh	ykh	PROPN
bjp-16772	250	6	,	,	PUNCT
bjp-16772	250	7	lin	lin	PROPN
bjp-16772	250	8	sj	sj	PROPN
bjp-16772	250	9	,	,	PUNCT
bjp-16772	250	10	tai	tai	PROPN
bjp-16772	250	11	sh	sh	PROPN
bjp-16772	250	12	.	.	PUNCT
bjp-16772	251	1	a	a	DET
bjp-16772	251	2	systematic	systematic	ADJ
bjp-16772	251	3	review	review	NOUN
bjp-16772	251	4	and	and	CCONJ
bjp-16772	251	5	meta	meta	NOUN
bjp-16772	251	6	-	-	PUNCT
bjp-16772	251	7	analysis	analysis	NOUN
bjp-16772	251	8	on	on	ADP
bjp-16772	251	9	the	the	DET
bjp-16772	251	10	therapeutic	therapeutic	ADJ
bjp-16772	251	11	equivalence	equivalence	NOUN
bjp-16772	251	12	of	of	ADP
bjp-16772	251	13	statins	statins	PROPN
bjp-16772	251	14	.	.	PUNCT
bjp-16772	252	1	j	j	PROPN
bjp-16772	252	2	clin	clin	PROPN
bjp-16772	252	3	pharm	pharm	PROPN
bjp-16772	252	4	ther	ther	ADV
bjp-16772	252	5	.	.	PUNCT
bjp-16772	253	1	2010	2010	NUM
bjp-16772	253	2	;	;	PUNCT
bjp-16772	253	3	35	35	NUM
bjp-16772	253	4	:	:	SYM
bjp-16772	253	5	139	139	NUM
bjp-16772	253	6	-	-	SYM
bjp-16772	253	7	51	51	NUM
bjp-16772	253	8	.	.	PUNCT
bjp-16772	254	1	wilson	wilson	PROPN
bjp-16772	254	2	k	k	PROPN
bjp-16772	254	3	,	,	PUNCT
bjp-16772	254	4	marriott	marriott	PROPN
bjp-16772	254	5	j	j	PROPN
bjp-16772	254	6	,	,	PUNCT
bjp-16772	254	7	fuller	full	ADJ
bjp-16772	254	8	s	s	PROPN
bjp-16772	254	9	,	,	PUNCT
bjp-16772	254	10	lacey	lacey	PROPN
bjp-16772	254	11	l	l	PROPN
bjp-16772	254	12	,	,	PUNCT
bjp-16772	254	13	gillen	gillen	PROPN
bjp-16772	254	14	d.	d.	PROPN
bjp-16772	254	15	a	a	DET
bjp-16772	254	16	model	model	NOUN
bjp-16772	254	17	to	to	PART
bjp-16772	254	18	assess	assess	VERB
bjp-16772	254	19	the	the	DET
bjp-16772	254	20	cost	cost	NOUN
bjp-16772	254	21	effectiveness	effectiveness	NOUN
bjp-16772	254	22	of	of	ADP
bjp-16772	254	23	statins	statin	NOUN
bjp-16772	254	24	in	in	ADP
bjp-16772	254	25	achieving	achieve	VERB
bjp-16772	254	26	the	the	DET
bjp-16772	254	27	uk	uk	PROPN
bjp-16772	254	28	national	national	PROPN
bjp-16772	254	29	service	service	NOUN
bjp-16772	254	30	framework	framework	NOUN
bjp-16772	254	31	target	target	NOUN
bjp-16772	254	32	cholesterol	cholesterol	NOUN
bjp-16772	254	33	levels	level	NOUN
bjp-16772	254	34	.	.	PUNCT
bjp-16772	255	1	author	author	NOUN
bjp-16772	255	2	info	info	PROPN
bjp-16772	255	3	isa	isa	PROPN
bjp-16772	255	4	naina	naina	PROPN
bjp-16772	255	5	mohamed	mohamed	PROPN
bjp-16772	255	6	(	(	PUNCT
bjp-16772	255	7	principal	principal	ADJ
bjp-16772	255	8	contact	contact	NOUN
bjp-16772	255	9	)	)	PUNCT
bjp-16772	255	10	e	e	NOUN
bjp-16772	255	11	-	-	NOUN
bjp-16772	255	12	mail	mail	NOUN
bjp-16772	255	13	:	:	PUNCT
bjp-16772	255	14	isa@medic.ukm.my	isa@medic.ukm.my	ADP
bjp-16772	255	15	bangladesh	bangladesh	PROPN
bjp-16772	255	16	j	j	PROPN
bjp-16772	255	17	pharmacol	pharmacol	PROPN
bjp-16772	255	18	2013	2013	NUM
bjp-16772	255	19	;	;	PUNCT
bjp-16772	255	20	8	8	NUM
bjp-16772	255	21	:	:	SYM
bjp-16772	255	22	401	401	NUM
bjp-16772	255	23	-	-	SYM
bjp-16772	255	24	409	409	NUM
bjp-16772	255	25	409	409	NUM
bjp-16772	255	26	http://www.ncbi.nlm.nih.gov/pubmed?term=%22shepherd%20j%22%5bauthor%5d	http://www.ncbi.nlm.nih.gov/pubmed?term=%22shepherd%20j%22%5bauthor%5d	NOUN
bjp-16772	255	27	http://www.ncbi.nlm.nih.gov/pubmed?term=%22lorimer%20ar%22%5bauthor%5d	http://www.ncbi.nlm.nih.gov/pubmed?term=%22lorimer%20ar%22%5bauthor%5d	NOUN
bjp-16772	255	28	http://www.ncbi.nlm.nih.gov/pubmed?term=%22macfarlane%20pw%22%5bauthor%5d	http://www.ncbi.nlm.nih.gov/pubmed?term=%22macfarlane%20pw%22%5bauthor%5d	PROPN
bjp-16772	255	29	http://www.thelancet.com/search/results?fieldname=authors&searchterm=%20study%20of%20the%20effectiveness%20of%20additional%20reductions%20in%20cholesterol%20and%20homocysteine%20(search)%20collaborative%20group	http://www.thelancet.com/search/results?fieldname=authors&searchterm=%20study%20of%20the%20effectiveness%20of%20additional%20reductions%20in%20cholesterol%20and%20homocysteine%20(search)%20collaborative%20group	NOUN
bjp-16772	255	30	http://www.thelancet.com/search/results?fieldname=authors&searchterm=%20study%20of%20the%20effectiveness%20of%20additional%20reductions%20in%20cholesterol%20and%20homocysteine%20(search)%20collaborative%20group	http://www.thelancet.com/search/results?fieldname=authors&searchterm=%20study%20of%20the%20effectiveness%20of%20additional%20reductions%20in%20cholesterol%20and%20homocysteine%20(search)%20collaborative%20group	PROPN
bjp-16772	255	31	http://www.thelancet.com/search/results?fieldname=authors&searchterm=%20study%20of%20the%20effectiveness%20of%20additional%20reductions%20in%20cholesterol%20and%20homocysteine%20(search)%20collaborative%20group	http://www.thelancet.com/search/results?fieldname=authors&searchterm=%20study%20of%20the%20effectiveness%20of%20additional%20reductions%20in%20cholesterol%20and%20homocysteine%20(search)%20collaborative%20group	PROPN
bjp-16772	255	32	dateprinted	dateprinte	VERB
bjp-16772	255	33	:	:	PUNCT
bjp-16772	255	34	this	this	DET
bjp-16772	255	35	article	article	NOUN
bjp-16772	255	36	was	be	AUX
bjp-16772	255	37	downloaded	download	VERB
bjp-16772	255	38	by	by	ADP
bjp-16772	255	39	you	you	PRON
bjp-16772	255	40	on	on	ADP
bjp-16772	255	41	:	:	PUNCT
bjp-16772	255	42	aug	aug	PROPN
bjp-16772	255	43	29	29	NUM
bjp-16772	255	44	,	,	PUNCT
bjp-16772	255	45	2018	2018	NUM